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ABSTRACT
Pharmaceuticals and personal care products in New Hampshire: prevalence and the influence of
microbial communities on removal during wastewater treatment
By
Carmela Antonellis
University of New Hampshire, September 2021
Pharmaceuticals and personal care products (PPCPs) represent a class of 10,000+ emerging
contaminants that are widely used in communities for a variety of medical, health, and care
applications. Many PPCPs are biologically active compounds, are typically unregulated in
drinking water and surface waters, and may be incompletely removed in our municipal wastewater
treatment systems. Understanding the sources and fate of PPCPs in the environment is important
to protecting ecosystems because some compounds may pose toxicity or result in behavioral
impacts to aquatic species. This thesis evaluated the presence and concentration of PPCPs in
surface water sample locations in New Hampshire's Great Bay Estuary. It also investigated PPCP
removal in context with the microbial community diversity and metabolic for potential in four
municipal wastewater treatment facilities (WWTFs) discharging to tributaries of the Great Bay
Estuary. Microbial community composition of secondary wastewater samples was assessed
through sequencing the 16S rRNA biomarker gene while microbial metabolic potential was
evaluated through metagenomic sequencing. Nonmetric multidimensional scaling analyses was
used to evaluate drivers for water quality changes and PPCP removal based on 16S rRNA amplicon
sequence variants in Qiime. Pathways for PPCP biodegradation were elucidated from
metagenomic data using MG-Rast and KBASE. Results reveal bacteria as the dominant microbial
domain in each WWTF, with Proteobacteria, Bacteroidetes, Actinobacteria, and Firmicutes as the
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most dominant phyla. Xenobiotic biodegradation and metabolism accounted for less than 2% of
all metabolic activity at each WWTF. This research advances our understanding of the occurrence
and fate of PPCPs during wastewater treatment.
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CHAPTER 1
Background and Motivation
Pharmaceuticals and Personal Care Products as Compounds of Emerging Concern
It is well known that anthropogenic activity and human waste have posed a threat to the natural
environment for many years (Tang et al. 2016). Pharmaceuticals and personal care products
(PPCPs) are biologically active compounds that pose a potential risk to ecosystem and human
health (Gaffney et al. 2017, Baran et al. 2011, Liu et al. 2018) due to their incomplete removal in
wastewater treatment (Blair et al. 2015, Gago-Ferrero et al. 2017, Golovko et al. 2014, Jelic et al.
2011, Sörengård et al. 2019), increasing human consumption (Jelic et al. 2011), and frequent
detection in wastewater streams and natural ecosystems around the world (Dubey et al. 2021,
Halling-Sorensen et al. 1998, Kummerer et al. 2009). The global scientific community has come
to a consensus that PPCPs are ubiquitous in wastewater treatment facilities (WWTFs), and thus in
wastewater effluent entering receiving water bodies (Golovko et al. 2021, Pomiès et al. 2013). We
have yet to identify the thousands of pharmaceutical compounds and personal care products that
are suspected to exist in the environment (Yin et al. 2017). Therefore, these compounds are
recognized as contaminants of emerging (CECs) concern across aquatic matrices (Kovalakova et
al. 2020).

Human consumption of PPCPs shows an increasing trend (Baran et al. 2011), and currently there
are no legal regulations concerning the concentrations of micropollutants and CECs entering the
natural environment via WWTF effluent in the United States (Angeles et al. 2020, Liu et al. 2018).
There are also no regulations restricting antibiotic concentrations in wastewater effluent
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(Kovalakova et al. 2020). These compounds are constantly being discharged into receiving water
bodies (Yin et al. 2017, Archer et al. 2017), and are usually reported in the range of ng/L to ug/L
concentrations (Archer et al. 2017, Golovko et al. 2021). Contaminants of emerging concern can
exhibit toxic effects on non-target organisms and bioaccumulate in the environment (Meyer et al.
2019, Petrie et al. 2015, Sörengård et al. 2019), causing concern regarding their presence in aquatic
environments.

Although there are multiple sources for PPCPs entering the natural environment, this review
focuses on the effluent of municipal wastewater treatment facilities (WWTFs) because these
facilities are regarded as major dischargers of micropollutants to receiving water bodies (Angeles
et al. 2020). There are many sources from which these compounds originate, including human
excretion, pharmaceutical industries, hospitals, and incorrect disposal (Archer et al. 2017,
Kovalakova et al. 2020).

Runoff from livestock manure into surrounding ecosystems and

discharge of landfill leachate into municipal WWTFs are also considered sources for these
micropollutants (Yin et al. 2017, Kovalakova et al. 2020, Archer et al. 2017, Bilal et al. 2020).
Figure 1.1 shows the main sources of PPCPs entering WWTFs and entering the natural
environment.

Although some technologies may be efficient when it comes to removing

pharmaceutical residues, secondary treatment was not originally designed with these compounds
in mind (Angeles et al. 2020). In order to fully understand the risks that PPCPs present in the
natural environment, more research is needed regarding the occurrence of PPCPs, their toxicity,
and the fate of both the parent compound and their transformation products (Yin et al. 2017).
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Figure 1.1: The main sources, domestic and industrial/commercial, of PPCPs in WWTFs and their routes to the natural
environment. Taken from Yang et al. 2017.

Pharmaceuticals and Personal Care Products Detected in WWTFs and in Surface
Water
Pharmaceuticals and personal care products (PPCPs) have been detected in aquatic matrices in
addition to being detected in WWTFS (Dubey et al. 2021, Hidrovo et al. 2020, Kovalakova et al.
2020) indicating that they are being released into the natural environment (Sörengård et al. 2019).
Wastewater treatment facilities have been noted as main routes for contaminants of emergence
concern into aquatic matrices (Sörengård et al. 2019). It is important to note that WWTFs are not
necessarily original sources for PPCPs, but rather the conduits for these compounds to enter the
natural environment. Routes for PPCPs in environment include the direct discharge of effluent
(also known as treated wastewater) into aquatic ecosystems, the use of effluent to fertilize soil, and
the use of sludges as soil amendments (Garcia-Santiago et al. 2016). The continued use of
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biosolids for agricultural purposes has been found to increase the presence and concentration of
PPCPs in soils (Garcia-Santiago et al. 2016). The season, as well as the location of the WWTF,
can influence the concentration of PPCPs detected in surface water (Archer et al. 2017).

Depending on the type of pharmaceutical compound, it may be metabolized anywhere from 10%
up to 90% before excretion from the human body (Kovalakova et al. 2020). Once excreted, the
compound enters the municipal wastewater stream then flows to the local WWTF. The constant
use of PPCPs, as well as the inefficient removal of these compounds in WWTFs, means that
aquatic organisms are regularly exposed to PPCPs (Angeles et al. 2020, Yin et al. 2017, Liu et al.
2018). Many antibiotics, a pharmaceutical class of PPCPs, are water soluble, and therefore
persistent in the environment (Liu et al. 2018). Antibiotics have been detected in seawater, surface
water, ground water, and even drinking water (Bilal et al. 2020).

Antibiotics are typically found in concentrations of tens or hundreds of ng/L in aquatic ecosystems
(Kovalakova et al. 2020) and can have negative impacts on the food chain (Liu et al. 2018).
Sulfonamide antibiotics, a specific category of antibiotics, can bioaccumulate in food chain
organisms and also have the potential to impact the development of plants and plant growth. (Baran
et al. 2011). Bioaccumulation of sulfonamides in the food chain can increase the toxic effects seen
in non-target organisms (Baran et al. 2011). Kovalakova et al. (2020) classified Sulfamethoxazole,
a type of sulfonamide antibiotic, as a very toxic compound to photosynthetic organisms. The most
sensitive biological entities were aquatic plants, cyanobacteria and algae (Kovalakova et al. 2020).
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It is crucial to note that many of the metabolites and transformation products of PPCPs that may
arise during wastewater treatment remain unknown, as well as their toxicity on non-target
organisms (Yin et al. 2017). It is therefore important to evaluate the removal of these compounds
from WWTFs due to their potential to harm aquatic organisms, including their chronic toxicity.
Chronic toxicity indicates a low dose of a chemical over a long period of time, which is a much
more realistic picture of what is happening in aquatic environments (Golovko et al. 2021).

Antibiotic Compounds
Antibiotics are natural, semi-synthetic, or synthetic compounds that are used to fight bacterial
infections and inhibit bacterial growth in humans and animals (Bilal et al. 2020, Liu et al. 2018).
Compounds with antibacterial properties are used widely in animal husbandry for the prevention
and cure of diseases, as well as the promotion of animal growth (Liu et al. 2018). Due to their
wide consumption, as well as their environmental persistence, antibiotics are also regarded as
compounds of emerging concern (Bilal et al. 2020, Liu et al. 2018, Archer et al. 2017). Similar to
PPCP consumption, antibiotic usage is increasing worldwide (Kovalakova et al. 2020). Owing to
this increase as well as the inefficient CEC removal in WWTFs, antibiotics are typically detected
in the environment in ng/L to ug/L (Kovalakova et al. 2020, Liu et al. 2018). Large amounts of
these drugs are detected in the aquatic environment because they are incompletely metabolized in
humans and animals and inefficiently removal in wastewater treatment (Baran et al. 2011, Liu et
al. 2018). Therefore, antibiotic parent compounds and their associated metabolites are commonly
released into the environment (Bilal et al. 2020). Antibiotics are not fully metabolized by the
human body nor in animals, thus they are excreted in urine and feces as an unchanged compound,
in the form of a sulphuric or glucuronic acid conjugate, or as a metabolite (Kovalakova et al. 2020).
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This constant presence of antibiotics potentially poses a threat to aquatic organisms as well as
humans.

Antibiotics are of particular concern due to the impacts they can exert on non-target organisms.
Figure 1.2 exhibits the toxicity of eight different antibiotics on different aquatic organisms. Many
studies indicate that antibiotics are not effectively being removed in conventional wastewater
treatment, thus they are considered poorly degradable compounds (Bilal et al. 2020, Kovalakova
et al. 2020).

Golovko et al. (2021) found that most of the antibiotics included in their study,

including amoxicillin, azithromycin, ciprofloxacin, sulfamethoxazole, and trimethoprim,
displayed insignificant removal efficiencies. This was also true for the antidepressants included
in the study, including fluoxetine (Golovko et al. 2021). Additional studies have also observed
incomplete removal trends for PPCPs (Bendz et al. 2005, Gobel et al. 2007, Kasprzyk-Hordern et
al. 2009). However, there is some micropollutant removal occurring during wastewater treatment.
Removal of antibiotics during the secondary treatment process can occur through either
biodegradation of the compounds by microorganisms, or via sludge adsorption (Kovalakova et al.
2020). The pathways regarding PPCP removal in wastewater treatment will be discussed further
in this review.
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Figure 1.2: The Ecotoxicity of eight antibiotics towards different organisms, compiled from a review of the current
literature, indicating that even low concentrations of antibiotic compounds can exhibit significant toxicity. Figure
retrieved from Kovalakova et al. 2020.

Sulfonamide Antibiotics
Sulfonamides are a group of antibiotics that are known as synthetic drugs, with bacteriostatic and
antibacterial properties (Baran et al. 2011). They are effective against both gram-negative and
gram-positive bacteria and may also be used against fungi and protozoa. Sulfonamides have been
administered in animals since the 1940s and are also used often in humans (Baran et al. 2011).
Baran et al. (2011) reported that over 80% of sulfonamides are excreted via waste from humans
and animals as unchanged compounds. Sulfonamides are of concern due to their wide use and
presence in the environment (Baran et al. 2011). They are detected frequently in the environment
and are suspected to be hazardous to human health and the receiving water’s microbial
communities (Baran et al. 2011).

There is concern regarding even low concentration of

sulfonamides in the environment because they have a high biological activity. This means that
trace amounts of sulfonamide antibiotics have the potential to greatly alter the biosphere (Baran et
al. 2011). Additionally, sulfonamides have even been reported to occur in 27% of all streams and
rivers in the United States, and in most of the surface waters tested for the compounds in Taiwan
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and France, as well as in 1005 wastewater samples in one study by Baran et al. (2011) (Baran et
al. 2011). Not only is current research concerned with the toxicity and effects of sulfonamides in
aquatic organisms, but there is also worry with regard to sulfonamides exhibiting synergism.
Synergism is used to describe the toxicity levels caused by a mixture of pharmaceutical
compounds, (Baran et al. 2011) and remains an understudied area of research within the field
CECs.

Removal of Pharmaceuticals and Personal Care Products in Wastewater Treatment
As stated earlier in this review, PPCPs are commonly released into the natural environment via
WWTF effluent (Golovko et al. 2021, Kovalakova et al. 2020, Yin et al. 2017). Activated sludge
(AS) is a type of secondary, biological treatment process utilized in many WWTFs to reduce the
concentration of various nutrients, including carbon, nitrogen, and phosphorous, as well as
chemical oxygen demand (COD). Although the AS process does decrease the concentrations of
some pharmaceuticals, the process is not always efficient in removing these contaminants (Angeles
et al. 2020, Archer et al. 2017, Bilal et al. 2020, Kovalakova et al. 2020, Yin et al. 2017). Many
factors impact PPCP transformation and fate in wastewater treatment, which can be seen in Table
A1.1. The main removal mechanisms, that is aqueous phase removal for PPCPS in wastewater
treatment, include biodegradation via microorganisms, sorption to sludges, and volatilization
(Pomiès et al. 2013).

Pollutant Fractionation in Wastewater Treatment
The main routes of PPCP removal discussed in the current literature include microbial degradation
(also known as biodegradation) (Jelic et al. 2011, Joss et al. 2006, Ternes et al 2004), sorption to
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sludge/solids (Jelic et al, 2011, Joss et al. 2006, Ternes et al. 2006), chemical transformation (Jelic
et al. 2011), and volatilization (Joss et al. 2006). Due to the nature of many PPCPs, volatilization
is not regarded as a significant removal pathway (Joss et al. 2006). The removal of PPCPs in
wastewater treatment can vary greatly (Jelic et al. 2011, Miege 2009, Oulton 2010, Verlicchi
2012). Compounds that belong to the same pharmaceutical class do not exhibit similar sorption
behavior.

This is because compounds within the same class can vary greatly in their

physicochemical properties (Hörsing 2011).

In a study evaluating the removal efficiencies of PPCPs in a South African WWTF, Archer et al.
(2017) found varying removal efficiencies, including negative removal for one antibiotic, one antidepressant, one anticonvulsant, and two analgesics (Figure 1.3). In multiple studies, contaminants
of emerging concern were found in significantly high concentration in sludges (Camacho-Munoz
et al. 2012, Golovko et al. 2021). These findings support the theory that compounds are at least
partially sequestering in sludge during wastewater treatment. The partition of PPCPs to sludges is
cause for concern because sludges are often applied to for land uses (Dubey et al. 2021), including
as fertilizer and soil amendments (Golovko et al. 2021, Luo et al. 2014, Yang et al. 2017). Even
though sludges are processed prior to use, the contaminants remaining in land-applied sludges may
runoff into the surrounding aquatic ecosystems (Golovko et al. 2021). Sludges that are not applied
for land use may be incinerated or disposed of through landfilling, which can percolate into
groundwater sources (Golovko et al. 2021).
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Figure 1.3: The percent removal efficiencies for PPCPs in a South African WWTF. Figure retrieved from Archer et
al. 2017.

A study by Golovko et al. (2021) focused on evaluating the presence of CECs in wastewater. The
study concluded that the removal efficiency for the 164 compounds evaluated in the study greatly
varied. On average, the total concentration of CECs from influent to effluent decreased 60%.
Previous studies also concur with this result (Fick et al. 2011). The field of wastewater treatment
needs dedicated research towards understanding the removal efficiency of PPCPs, as well as the
impact these compounds have in the receiving ecosystems (Golovko et al. 2021)

Predicting PPCP Behavior during Wastewater Treatment
While there are many approaches used to determine the behavior PPCPs may exhibit during
wastewater treatment, there are two compound-specific variables that are commonly used; the
partition coefficient (KD) and the octanol-water partitioning coefficient (Kow). KD has been termed
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a sorption coefficient, as it is used to describe a compound’s ability to sorb to solids or sludge,
while Kow is often described as the hydrophobicity of a molecule (Pomiès et al. 2013). The
partition coefficient KD is calculated as the division between the sorption kinetic constant and the
desorption kinetic constant of a compound, chemical, or metal (Pomiès et al. 2013). In other
words, the KD of a pollutant is defined as the dissolved concentration multiplied by the liqueur
suspended solids concentration, divided by the fraction of the pollutant that is sorbed to solids
(Pomiès et al. 2013). Sorption and desorption can take place simultaneously, and sorption can
describe an aqueous (dissolved) or solid phase of a compound (Pomiès et al. 2013). While the KD
values of PPCPs are experimentally determined, it is important to stress that these values may
change based on the matrix utilized (such as activated sludge, sediment, or soil) and environmental
conditions (including pH, carbon content, oxygen content, and temperature) (Pomiès et al. 2013).
This causes high variability in KD values for PPCPs and difficulty in predicting compound
behavior (Pomiès et al. 2013). Despite this variability, researchers still suggest that KD is useful
in indicating a compound’s removal efficiency (Pomiès et al. 2013). Both of these coefficients
have been used to predict PPCP behavior during wastewater treatment.
Compounds that are more water soluble have low values for KD and Kow (Golovko et al. 2021). It
has also been suggested that compounds with a log KD less than 2.5 have a higher likelihood of
partitioning to the aqueous phase, while compounds with a log KD greater than 3.2 have a higher
likelihood of ending up in the solid phase (Luo et al. 2014). Although, it should be noted that
some researchers have not observed a correlation between removal efficiency and log KD (Govolko
et al. 2021). A study by Dubey et al. (2021) found that chemicals that have a log KD value less
than 2 have a lower ability to adsorb to sludge, while chemicals that have a log KD greater than 4
are removed via sorption at significant levels. Thompson et al. (2011) observed that significant
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compound removal occurred when a compound had a log Kow greater than 4.0. Additionally,
temperature and pH have been noted to impact sorption potential described by the KD variable
(Dubey et al. 2021). Temperature decreases can cause compounds to have higher KD values, which
may result in a higher sorption of a pollutant to sludge (Dubey et al. 2021). It is also worthy to
note that the octanol-carbon distribution coefficient, also known as Koc, can be used to evaluate
how a compound may sorb to sludge depending on its organic carbon content (Dubey et al. 2021).
While many studies have investigated the use of KD, Kow, and even Koc, to predict PPCP behavior
and partitioning to sludge, this is still a developing field of research as the partition coefficients
for PPCPs can vary greatly based on the media to which sorption is evaluated, and the fact that
there is such a wide array of PPCPs in wastewater that need to be evaluated.

Factors Influencing Sludge Partitioning
While there is a wide array of factors impacting the removal and degradation of PPCPs in
wastewater treatment, there are some factors that have a significant influence on how these
compounds partition to sludges in secondary wastewater treatment. Physicochemical properties
of PPCPs, including molecular weight, acid dissociation constant (Pka), and the octanol water
partition coefficient (Kow) have been noted to influence how likely a compound is to partition to
sludge during secondary treatment. Oxidation-reduction conditions may also be involved in
sorption (Pomiès et al. 2013). It is also possible that by increasing solids retention time (SRT),
microbial diversity is encouraged by allowing slower growing organisms to thrive, which may
increase the potential for biodegradation (Kreuzinger et al. 2004, Suarez et al. 2010).
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Micropollutants may sorb to sludge as “dissolved-colloidal particles” based on the composition of
the sludge (Dubey et al. 2021). The influential sludge properties can include aromatic properties,
physical properties (such as density), the degree to which the sludge is oxidized, and sludge protein
content (Dubey et al. 2021). It has also been proposed that a longer hydraulic retention time (HRT)
may increase pollutant removal because it increases the contact time that microorganisms have
with wastewater containing PPCPs (Pomiès et al. 2013). A full list of the factors described to
influence PPCP removal during wastewater treatment can be seen in Table A1.1, along with their
corresponding references.

Research has mainly focused on the aqueous concentrations of micropollutants (Jelic 2011),
perhaps because sludge is such a complex matrix. Micropollutants, including pharmaceuticals,
have been found in sludges (Lillenberg et al. 2009, Lindberg et al. 2010, McClellan and Halden
2010, Radjenovic et al. 2009), and sometimes in elevated concentrations (Dubey et al. 2021). A
survey by the U.S. Environmental Protection Agency surveyed WWTFs around the country and
found that there were 145 emerging contaminants detected in the sludges from 74 WWTFs.
Concentrations were found up to several hundred parts per million, or mg/L (Venkatesan et al.
2015). Nations, including the United States, need to regulate the reuse of biosolids to address
emerging micropollutants (Garcia-Santiago et al. 2016). There is limited information regarding
micropollutants like PPCPs, as well as the lack of a homogeneous methodology to evaluate PPCP
sorption to sludges (Pomiès et al. 2013). Inadequate data on micropollutant behavior during
wastewater treatment hinders the environment policies and regulations that require this
information to implement PPCP concentrations in wastewater biosolids and effluent (Dubey et al.
2021).
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Negative Removal and Transformation Products
Negative removal is described as a higher concentration of a compound in a WWTF’s treated
effluent than in the influent (Golovko et al. 2021) and is a phenomenon that has been observed in
numerous studies (Archer et al. 2015, Blair et al. 2015, Golovko et al. 2021, Hidrovo et al. 2020,
Verlicchi et al. 2012). A few theories exist that try to explain negative PPCP removal in
wastewater treatment. These include the following: (1) the activity of microorganisms breaking
down fecal waste solids in wastewater may release PPCP particles, which assumes that the solidsassociated fraction of a compound was not detected in the influent (Blair et al. 2015, Gobel et al.
2007), (2) there may be PPCP metabolites that remain undetected and have the ability to transform
into their original parent compound via biotransformation (Blair et al. 2015, Jelic et al. 2011, Plosz
et al 2010, Salgado et al. 2012, Verlicchi et al. 2012), and (3) partitioning to the aqueous phase
may change as treatment time progresses (Golovko et al. 2021, Jelic et al. 2011, Ternes et al. 2004).
There has also been speculation suggesting that as aqueous concentrations of PPCPs decrease
during treatment, compounds are desorbed from sludges in the process of maintaining a “sorptive
equilibrium” (Blair et al. 2015). It is possible that negative removal is a result of a combination
of the proposed theories, however Blair et al. (2015) emphasized that negative removal depends
heavily upon the specific compound in question.

In order to fully understand the life cycle of PPCPs in wastewater treatment and beyond, it is also
important to evaluate the metabolites and transformation products of these compounds.
Transformation products of PPCPs, which may be more or less reactive or toxic than their parent
compounds, can arise from the incomplete removal of PPCPs (Donner et al. 2012, Dubey et al.
2021).

This has been seen with the antiepileptic carbamazepine (Donner et al. 2012).
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Unfortunately, many PPCP metabolites remain unknown due to a lack the of research in their
biodegradation pathways (Pomiès et al. 2013). The bioanalytical techniques needed to evaluate
these unknown products also remain underdeveloped (Pomiès et al. 2013). It is also crucial to note
that when concentrations of PPCPs are found close to the detection limit for a specific compound,
it introduces uncertainty regarding the accuracy of PPCP detections (Golovko et al. 2021). In
cases such as this, possible analytical errors may have occurred (Ort et al. 2010). This is likely
due to the fact that wastewater is such a complex matrix.

The Microbial Communities of Wastewater Treatment
The wastewater treatment system typically consists of two to three stages; primary treatment,
secondary treatment, and tertiary treatment. Primary treatment is the separation of debris and large
solids from the wastewater. Secondary treatment, also known as biological treatment, consists of
nutrient removal, and oftentimes activated sludge is utilized to perform denitrification and
phosphate removal (Saunders et al., 2016).

Wastewater also goes through some type of

disinfection before being released into the aquatic environment and can include the utilization of
ultraviolet rays or chlorination/dichlorination. Tertiary treatment consists of advanced removal of
specific constituents in wastewater and is implemented in some treatment facilities.

While there are many different processes of biological treatment of wastewater, activated sludge
is the most common engineered secondary treatment process currently being used in WWTFs
around the world (Saunders et al. 2016, Zhang et al. 2019). This process depends on a diversity
of microorganisms to transform nutrients, nitrify ammonia, and remove carbon under aerobic
conditions (Saunders et al. 2016, Seviour et al. 2010, Wu et al. 2019). Biological treatment of
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wastewater is also dependent upon the interaction and activity of microbial species (Fang et al.
2018), and different types of treatment and different environmental parameters will structure
different microbial communities (Zhang et al. 2019). Many of the members responsible for the
productivity of wastewater treatment, as well as the conditions influencing these microbial
communities, are not completely defined or understood (Wu et al. 2019).

Microorganisms are Integral to the Biological Treatment of Wastewater
Biological wastewater treatment processes, specifically the activated sludge process, are known to
contain a wide, diverse array of microorganisms. Wu et al. (2019) suggested that the activated
sludge microbial community was unique and showed no overlap with other habitats. Zhang et al.
(2012) referred to the activated sludge treatment process as a microbially diverse environment,
with over 700 genera. In one study, it was found that around 30 taxa comprise the global activated
sludge core community (Wu et al. 2019). The same study used a lognormal model to predict the
number of species in the global activated sludge system and determined a prediction of
1.1±0.07x109 species (Wu et al. 2019).

Based upon the available literature, dominant microbial phyla have been identified in WWTFs
around the globe, indicating a consistent prevalence of certain microbial community members in
municipal WWTFs. In a study by Saunders et al. 2016, it was found that the 63 core genera found
in 13 Danish WWTFs made up 68% of the total reads corresponded to core communities found in
other studies (Zhang et al. 2012). In a study on microbial communities in 5 municipal WWTFs in
China by Zhang et al. (2019), the most dominant phyla were, in order, Proteobacteria, Chloroflexi,
Actinobacteria, Acidobacteria, Bacteroidetes, and Firmicutes. In a global analysis of activated
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sludge systems, it was found that Proteobacteria were the most dominant community members,
constituting 82% of the core community (Wu et al. 2019). Yang et al (2011) also found the most
abundant phylum to be Proteobacteria, followed by Bacteroidetes and Firmicutes. In a review by
Tian and Wang (2020), the most dominant phyla found in WWTFs serving municipalities around
the world consisted of Proteobacteria, Bacteroidetes, and Chloroflexi (Figure 1.4). Firmicutes
and Fusobacteria were also observed to be dominant phyla in the study. The available literature
indicates that the dominant phyla in WWTFs include Proteobacteria, Bacteroidetes, Firmicutes,
Chloroflexi, Actinobacteria, and Acidobacteria, alongside many other less abundant phyla.

Figure 1.4: Variations in the abundant phyla in different wastewater treatment processes can be seen. The relative
abundances of different phyla for activated sludge (CAS=conventional activated sludge) can be seen in the boxed
section. Proteobacteria, Bacteroidetes, Chloroflexi, and Acidobacteria appear to be the most relatively frequent phyla
for this particular study. Retrieved from Tian and Wang (2020).

Some of the most frequently identified phyla in wastewater treatment play important roles in the
treatment process. The main role of Proteobacteria in the wastewater treatment process is to
remove nitrogen, phosphorous, and organic pollutants (Zhang et al. 2012). Bacteroidetes have
been attributed with the ability to degrade organic matter (Thomas et al. 2011). Firmicutes are
frequently found in AS and are comprised of bacteria regarded to have the ability to perform
pollutant decomposition (Zhang et al. 2019). One type of Firmicutes, the genus Bacillus, has been
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noted to produce enzymes that can decompose organics in sewage wastewater (Zhang et al. 2019).
Chloroflexi are filamentous bacteria associated with sludge bulking, flocculation, and phosphorous
removal (Mielczarek et al. 2012, Zhang et al. 2019). Wang et al. (2012) claimed that Chloroflexi
are omnipresent in WWTFs and may serve as important degraders of organics and nutrient
removers. The Saccharibacteria phylum was also omnipresent in activated sludge and is attributed
with the removal organic matter and protein hydrolysis (Ibarbalz et al. 2013, Mielczarek et al.
2012).
The primary purpose of secondary treatment is to remove and transform carbon and nutrients,
effectively reducing the concentration of nitrogen and phosphorous entering the natural
environment (Saunders et al. 2016, Wu et al. 2019, Seviour et al. 2010). Among the many
members of the activated sludge microbial community, ammonia oxidizing and nitrite oxidizing
bacteria (AOB and NOB, respectively) play important roles in treatment processes. AOBs consist
of five main genera including Nitrosospira, Nitrosomonas, Nitrosovibrio, Nitrosolobus, and
Nitrosococcus, while NOBs consist mainly of the genera Nitrospina, Nitrobacter, and
Nitrococccus (Zeng et al. 2015). Two types of competing bacteria are associated with phosphorous
removal; Glyogen accumulating organisms (GAOs) and phosphate accumulating organisms
(PAOs). GAOs consist of members from Competibacter, Accumulibacter, and Fluviicoccus, and
PAOs consist of Accumulibacter and Tetrasphaera. (Fang et al. 2018).

In a global survey of activated sludge systems, the top genus associated with ammonium nitrogen
removal was Nitrospira (Wu et al. 2019). Nitrospira has been referred to as a key nitrite oxidizing
bacteria (NOB) (Griffin and Wells, 2017). While it is generally accepted that Nitrospira dominate
nitrate oxidation in activated sludge, Saunders et al. (2016) found that Nitroga nitrifiers were the
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most abundant NOB throughout all samples included in their study. Zhang et al. (2019) found
low diversity of nitrifying bacteria across 5 WWTFs in China, with the two dominant nitrifiers
being Nitrosomonas (AOB) and Nitrospira (NOB). In a study by Griffin and Wells (2017),
Nitrosomonas was found to be the dominant ammonia oxidizing genus of bacteria. While the most
abundant nitrifiers differs between WWTFs, there appears to be a core group of nitrifiers found in
wastewater treatment processes around the world.

The Parameters Influencing Microbial Assemblage
Temperature has been regarded by many studies as a key driver of microbial growth and the
structure of microbial communities (Griffin and Wells, 2017, Zhang et al. 2019, Wu et al., 2019).
Therefore, it is expected that temperature is also important when evaluating microorganisms in
activated sludge (Griffin and Wells, 2017, Seib et al. 2016). Changes in temperature are even
suspected to create temporal variations in how a microbial community is structured (Griffin and
Wells, 2017). In a study by Zhang et al. (2019), temperature was not found to be a driving factor
behind microbial assemblage, however it is important to note that in this particular study the
temperature between the 5 WWTFs in focus fluctuated very little. This could mean that in order
to see the impact temperature may have on the microbial community in WWTFs, larger
temperature fluctuations are needed between samples. Overall, temperature has been deemed as
extremely influential on the diversity of a microbial community, especially in WWTFs (Seib et al.
2016, Tian and Wang 2020).

In a study on the composition of the microbial communities in sludge from high-altitude WWTPs
in Tibet, the dominant phyla, in order of dominance, included Proteobacteria, Bacteroidetes,
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Chloroflexi, Planctomycetes, Acidobacteria, Nitrospirae, and Firmicutes (Chen et al. 2019). It has
been noted that WWTFs in colder, higher altitude regions of the world , known as plateau WWTFs,
have unique microbial communities (Fang et al. 2018). Interestingly, plateau WWTFs showed a
lower nutrient and organic material removal compared to non-plateau WWTFs (Fang et al. 2018).
Temperature-sensitive WWTF microorganisms cannot survive in environments below 4°C, and
therefore correlations between altitude and temperature can be made (Fang et al. 2018). Fang et
al. (2018) found that WWTFs in higher altitudes with colder temperatures contained a lower
microbial diversity attributed to temperature. Fang et al (2018) also found that across all of the
WWTF samples, Proteobacteria were the most abundant phylum, followed by phyla including
Bacteroidetes, Chloroflexi, and Firmicutes. Details on the phyla found to be most abundant in the
WWTFs in Fang et al.’s 2018 study can be seen in Figure 1.5. The most abundant phyla found in
this study correlated with what has been found in the literature. Acidobacteria, Chlorobi,
Saccharibacteria, Actinobacteria, and Spirochaetae were also dominant phyla in the plateau
WWTFs.

Identified phyla, in much smaller abundance, also included Planctomycetes,

Verrucomicrobia, and Nitrospirae.
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Figure 1.5: The microbial compositions of bacterial phyla in plateau and non-plateau (control) WWTFs. It can be
seen that while Proteobacteria, Bacteroidetes, and Chloroflexi dominate all WWTF samples, there are obvious
differences between plateau and control treatment plants. Retrieved from Fang et al. 2018.

Although there were differences in the dominant phyla, classes, and genera of microorganisms in
plateau and control WWTFs, 26 of the top 50 genera in all samples were the same. These included
members of the following genera; Flavobacterium, Anaerolineaceae_uncultured, Thauera,
Bacteroidetes, Terrimonas, Xanthomonadaceae_uncultured, and Arcobacter. (Fang et al. 2018).
In Fang and coauthor’s study (2018), organic removal was attributed mostly to aerobic
heterotrophic bacteria (HET). Overall, Fang et. al. 2018 concluded that altitude and temperature
can impact the types of microorganisms found in WWTFs, as well functional population
abundance. Details regarding the relationship between temperature, altitude, and microorganisms
found in the evaluated WWTFs can be seen below, in Figure 1.6.
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Figure 1.6(A-C): A Conical Correlation Analysis (CCA) on environmental variables and microbial community
members. It can be seen that temperature and altitude both influence the types of phyla, classes, and genera found in
the observed WWTFs. Retrieved from Fang et al. 2018.

Influent composition is another factor to consider when assessing microbial communities in
WWTFs and in activated sludge. Griffin and Wells (2017) and Chen et al. (2017) suggested that
the composition in the influent wastewater and differences in operating parameters between
WWTFs influence the structure of microbial communities. In a study by Wu et al. (2019), the
concentration of BOD in the influent wastewater also had a significant influence on the
composition of bacteria. Tian and Wang (2020) also found pollutant concentration in wastewater
influent could impact microbial communities.

Dissolved oxygen was also found to be an important water parameter in wastewater treatment
processes, especially in biological treatment (Niu et al. 2016, Seib et al. 2016). For example,
nitrification is driven by the dissolved oxygen concentration in the influent (Gonzales-Martinez et
al. 2016). In a meta-analysis on WWTFs around the world, Tian and Wang (2020) found that
dissolved oxygen impacted the WWTF bacterial community. While multiple studies found DO
influenced the microbial communities in WWTFs, more research is needed to fully understand this
correlation.
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The operating conditions and composition of the influent wastewater may also select for the
microorganisms present in a WWTF (Zhang et al. 2019).

In one wastewater sample, the

distribution and structure of the microbial community in a municipal WWTF was influenced
heavily by COD (Zhang et al. 2019). Additionally, the results from a study on WWTFs with
activated sludge in Denmark indicated that the microbial diversity within a single plant remained
stable over time, leading the authors to state that variation in microorganisms found between
WWTFs was greater than those found in a single WWTF over time (Saunders et al. 2016). While
pH has been speculated to influence the microbial community in a WWTF, Tian and Wang (2020)
did not find any strong correlation between pH and microbial communities. Griffin and Wells
(2017) observed a seasonal change in microbial communities in the studied WWTFs, with
diversity peaking in the fall and reaching a minimum in December and March, depending upon
the specific facility. Spring and summer also showed a significant increase in diversity (Griffin
and Wells, 2017). Solids retention time, which is the length of time sludge is kept in the secondary
treatment bioreactor, has also been observed to impact the structure of a bacterial community (Wu
et al. 2019, Chen et al. 2017). Sludge retention time may also cause differences in the year-to-year
structure of microbial populations (Griffin and Wells, 2017).

Wu et al. 2019 found that the structure of the activated sludge community varied across continents,
with Asia showing the most diversity and South America showing the lowest. It was also
determined that process type and climate greatly impacted the structure of the microbial
communities. This is an area of research that should be investigated further. Covariation should
also be considered when evaluating microbial community structure, as WWTFs operate with many
different variables involved their treatment processes (Griffin and Wells, 2017). It is possible that
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multiple factors (e.g. temperature and pH combined) have a great impact on the type of
microorganisms present in a WWTF.

Species and Enzymes Linked to PPCP Biodegradation
An evaluation of enzymes associated with the degradation of pollutants, including PPCPs, can give
insight into the metabolic potential of a microbial community. While research regarding the field
of PPCP degradation is ongoing, some enzymes have been identified that aid in the breaking down
of PPCPs. The most frequently identified classes in the literature, which can be seen in Table 1.1
below, include Monooxygenase, Laccase, Tyrosinase, and Peroxidase enzymes. Monooxygenases
have bene regarded to catalyze degradation reactions of organic contaminants (Tran et al. 2013),
including sulfonamide antibiotics (Deng et al. 2018). More specifically, Flavin Monooxygenases
have been identified to aid in the degradation of tetracyclines and sulfonamides by Oberoi et al.
(2019) and Reis et al. (2018), respectively. Laccase enzymes have also been described as some of
the most researched micropollutant-degrading enzymes (Varga et al. 2019). Another group of
enzymes, Tyrosinases, have been generally described to degrade pharmaceuticals (Becker et al.
2016, Varga et al. 2019). Additionally, the breakdown of Ciprofloxacin, as well other organic
pollutants, have been ascribed to lignin and manganese peroxidases (Chowdhardy et al. 2018,
Inoue et al. 2010, Mao et al. 2010, Oberoi et al. 2019, Torres et al. 2003). A detailed description
of the most commonly described enzymes that catalyze PPCP degradation can be seen below in
Table 1.1.
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Table 1.1: The major enzyme classes described to catalyze PPCP degradation reactions. Included in this table are the
class and specific type of enzyme, as well as the specific types of reactions they catalyze and their corresponding
sources.
Enzyme
Reactions Catalyzed
References
Monooxygenases
•

Flavin
Monooxygenase

Laccases

Emerging Organic Contaminants
Sulfonamides
•

Tran et al. 2013, Deng et al. 2018
•

Tetracyclines; Sulfonamides

Oberoi et al. 2019, Reis et al.
2018

Pharmaceuticals; Sulfonamides;

Varga et al. 2019; Yang et al 2017;

Tetracyclines; Ciprofloxacin

Oberoi et al. 2019

Tyrosinases

Pharmaceuticals

Becker at al. 2016, Varga et al. 2019

Peroxidases

Pharmaceuticals

Varga et al. 2019

•

Lignin Peroxidase

•

Manganese
Peroxidase

•
•

Ciprofloxacin; Organic

•

Oberoi et al. 2019, Mao et al.

Pollutants

2010; Torres et al. 2003; Wen et

Xenobiotics; Organic

al. 2010

Pollutants; Ciprofloxacin

•

Chowdhardy et al. 2018, Inoue
et al. 2010; Oberoi et al. 2019

It is also worth noting that there are microbial groups observed to degrade and even utilize PPCPs.
Table A1.4, included in Appendix A, provides a description of the microbial groups and species
that have been identified with the ability to biodegrade and mineralize sulfonamide antibiotics.
Interestingly, many of the organisms described to degrade sulfonamides fall within the
Pseudomonas species. Many studies also attributed Pseudomonas species with the degradation of
sulfamethoxazole, a type of sulfonamide antibiotic. It is important to note that while an enzyme
or species may be associated with the degradation or break down of a pollutant, further analysis is
needed to determine whether a specific biodegradation pathway is active within a sample.
The importance of Understanding the Microbial Aspects of Wastewater Treatment
It is crucial to understand the types of organisms that are found in wastewater treatment, as well
as their metabolic functions to take advantage of the benefits microorganisms provide in
wastewater treatment (Saunders et al. 2016). By observing the dynamics of WWTF microbial
populations, researchers can better understand the metabolic functions that these communities
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serve (Saunders et al. 2016). It is also necessary to validate if the organisms found in WWTFs are
active (Saunders et al. 2016). By understanding the microorganisms and community structures
involved with the treatment of wastewater, engineers and scientists can improve the biological
treatment system to be the most efficient and effective (Wu et al. 2019).

Regarding the activated sludge treatment process, it is important to understand the ecology of AS
processes in order of optimize wastewater treatment systems (McIlroy et al. 2015).

By

understanding the microbial communities found in AS and the dynamics surrounding their
formation, engineers can optimize WWTF process and design, therefore improving the wastewater
treatment process (Nielsen et al. 2012). It is possible that organisms that are found in low
abundance contribute to micropollutant removal, having an advantage through a specialized niche
(Saunders et al. 2016). The microorganisms and the functions they serve ultimately determine the
performance of wastewater treatment (Fang et al. 2018).

There are many organisms that are not found abundantly in AS microbial communities, and it is
possible that they have a significant role in the function of the AS ecosystem (Saunders et al. 2016).
Saunders et al. (2016) indicated that less abundant microorganisms may take on the role of a seed
bank for the AS community, providing stability during fluctuations of environmental conditions,
and perhaps even play an important role in the degradation of micropollutants. Microbial diversity
has been linked with positive pollutant removal, and an understanding of the factors influencing
how a microbial community is structured allows for the optimization of biological treatment
processes, increased biodiversity, and improvement of nutrient and pollutant removal (Wu et al.
2019, Zhang et al. 2016). Ma et al. (2013) indicated that treatment systems are more stable with
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higher microbial diversity. Understanding the ecological, physiological, and genetic traits of
members of the WWTF community can help engineers select microorganisms based on the
functions desired for treatment (Wu et al. 2019). For these reasons, more research dedicated
towards understanding these complex communities and their metabolic potential is needed.

Following Chapters
The purpose of this chapter was to provide an overview of current research within the field of
pharmaceuticals and personal care products in wastewater treatment, as well as provide the
framework for original research regarding the biotransformation and fate of these contaminants.
My thesis consists of three separate projects, each with PPCPs as the main theme tying the projects
together. Chapter 2 will include details for the sampling and detection of PPCPs in surface water,
while Chapter 3 will describe my research on the partitioning of PPCPs in wastewater treatment.
Chapter 4 will cover the last project of my thesis research, which investigates the microbial
community members of wastewater treatment and possible PPCP degradation enzymes. Each
chapter will provide the methodology, results, and discussions for my original thesis research. The
final section of the thesis, Chapter 5, will discuss the direction for future work and next steps within
my areas of research.

Main Research Objectives
Motivation
Secondary wastewater treatment has been observed to perform removal of PPCPs despite
wastewater treatment processes not being designed for the removal of these contaminants.
However, further questions remain regarding the mechanisms of compound removal, as well as
the life cycle and fate of PPCPs. Prior research has shown that removal efficiency of PPCPs can
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vary greatly, even for compounds within the same pharmaceutical class. The main mechanisms
of removal include; (1) biodegradation, (2) sorption to sludges, and (3) volatilization. Due to the
structure and nature of PPCPs, volatilization is not considered a significant mechanism of removal,
leaving biodegradation and sorption to sludge as the focus for my research.

The goal of this thesis is to expand the following fields of knowledge within environmental
engineering: (A) monitoring of PPCPs in regional surface water, (B) the sequestration of PPCPs
into sludges during wastewater treatment (2) the microbial communities attributed with PPCP
biodegradation, (3) the influence of PPCPs on the wastewater microbiome, (4) and the enzymes
associated with PPCP biodegradation in regional WWTFs. Research has identified microbial taxa
present in WWTFs that have the ability to degrade PPCPs, however questions still remain
regarding the specific species and enzymes involved, as well as the conditions that influence
microbial assemblage. Prior studies, including one by former M.S. student Alexandria Hidrovo,
detected PPCPs in both the aqueous and sludge phases of wastewater treatment. The information
presented in this literature review indicates difficulty with predicting PPCP behavior during
treatment, including their sorption to sludge.
Research Aims
My research aims to: (1) sample for a large list of pharmaceutical compounds and personal care
products, including a large subset of antibiotics, in regional surface water locations (2) analyze
16S rRNA sequences received from prior research (Hidrovo et al. 2020) to evaluate how microbial
communities change based on treatment type, (3) perform metagenomic sequencing on regional
WWTF samples to evaluate the microbial taxa present and identify biodegradation pathways, and
(4) evaluate trends regarding PPCP fractionation to sludges in secondary wastewater treatment.
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Research Hypotheses
In Chapter 2, I will evaluate pharmaceuticals and personal care products in regional surface water
locations.
Hypotheses:
(1) With an expanded list of 46 PPCPs included in our analysis, a total of 10 different PPCPs
will be detected in Great Bay Estuary surface water locations, including at least 5
antibiotics, in July 2020.
(2) Sulfamethoxazole will be detected in all surface water locations in July 2020.
(3) A least one of the two personal care products included in our analysis will be detected
across all surface water locations in July 2020.
Rationale (a): Multiple WWTFs have effluent outfalls in rivers that lead to the Great Bay Estuary,
indicating that an evaluation of the compounds present in the surface waters of this region may
give insight into which compounds are not being fully removed from wastewater streams, and
subsequently entering the natural environment. Surface water sampling in the Great Bay Estuary
of New Hampshire in the summer of 2020 will help identify contaminants of emerging concern
that are present in the region. Prior research has indicated the presence of PPCPs, including
antibiotics, in the Great Bay Estuary. If a larger range of antibiotics are included in sample
screening, then more compounds within this class may be detected.
Rational (b): A prior study by Hidrovo et al. (2020) detected nine different PPCPs in the Great
Bay Estuary, including three antibiotics. Many PPCPs that are present in surface water samples
may not be detected simply because the screening is not broad enough to account for them.
Literature indicates that the continued monitoring of PPCPs in surface water is needed to fully
understand the extent of their presence in aquatic matrices. Therefore, we are including an
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expanded list of PPCPs, with a larger number of antibiotics included compared to 2019, to evaluate
the presence of these compounds in the context of a larger PPCP analysis.

Chapter 3 will consist of a fractionation analysis of PPCP sequestration into sludge during
wastewater treatment.
Hypotheses:
(1) Pharmaceuticals will dominate aqueous samples, and personal care products will dominate
sludge samples (both in abundance by weight).
(2) All five antibiotics included in screening will be detected within the secondary effluent
and/or sludge samples of each WWTF.
(3) The KD values found in existing literature will be predictive for the behavior of personal
care products in wastewater treatment, while the KD values associated with pharmaceuticals
will not serve as good indicators of their sorption behavior.

Rationale: Certain PPCPs in WWTFs may fractionate to sludge more readily than others, which
could be explained by their assigned KD values. Prior research has shown that the physiochemical
properties of a PPCP, as well as the operational conditions of a WWTF, may predict whether it
will partition to sludges or exist in the aqueous phase. By combining the results of sludge analysis
and PPCP detections, we may be able to better predict the behavior of these compounds during
treatment processes. Evaluating the compounds that are partitioning to sludges during wastewater
treatment produces implications far beyond wastewater treatment. Despite there being a high
inconsistency in the KD values reported for PPCPs, due to lack of research and variability by
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matrix, many people working within the field of contaminants of emerging concern agree that KD
is a useful tool for predicting the fate of these contaminants.

In chapter 4, I will evaluate the microbial communities in regional wastewater treatment facilities
and their ability to degrade PPCPs.
Hypotheses:
(1) Bacterial will comprise >90% of microbial samples, eukaryotes will comprise <10% of
samples, and viruses will comprise <1% of samples analyzed using Illumina Sequencing.
For 16s rRNA Sequencing, bacteria will encompass >90% of microbial samples, and
archaea will encompass <10% of samples.
(2) Temperature will be the most influential factor driving microbial assemblage in the
WWTFs sampled, while pH will be the second most influential factor.
(3) Sludge samples will have a higher microbial diversity and species richness than aqueous
samples.
(4) Samples with a higher number and concentration of antibiotics detected will exhibit lower
microbial diversity.
(5) Micropollutant metabolism will comprise <10% of cellular activities within each WWTF.
(6) At least one enzyme class associated with PPCP biodegradation will be observed for each
WWTF, via the metagenomic sequencing results.

Rationale: Based on current literature and previous research, the wastewater microbial community
is mostly made up of bacteria, with some eukaryotes, viruses and archaea present. A comparison
of the metagenomics and 16S rRNA results will instill confidence in our data and provide a basis
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for subsequent analyses. In accordance with prior research in the field, it is hypothesized that
temperature will be the most influential condition shaping the microbial communities of
wastewater treatment. Different temperatures may favor the growth of certain microbial taxa,
influencing abundance and members that can be detected via sequencing. Additionally, multiple
studies have shown that pH is a highly influential factor not only in pollutant removal, but also for
microbial community structure, and may be influenced by the season. Therefore, it is expected
that pH will have a strong influence on the current study’s microbial communities as well.

The influence of PPCPs on microbial growth and assemblage is still an evolving field of research,
however studies have indicated that PPCPs have some sort of influence on the microbial
communities in wastewater treatment. It is hypothesized that samples with higher concentrations
of PPCPs, specifically pharmaceuticals, may exhibit lower microbial diversity. This is based upon
the knowledge that many pharmaceuticals, particularly antibiotics, are designed to inhibit
microbial growth. Prior research in the field (Hidrovo et al. 2020) has observed removal of some
PPCP compounds, including acetaminophen, caffeine, atorvastatin, and cotinine. This indicates
that there is a possibility that biodegradation could be occurring for some of the PPCPs included
in the analysis of the four WWTFs.
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CHAPTER 2
Presence and Concentration of an Extended Antibiotic List in the
Great Bay Estuary, New Hampshire
Introduction and Background
Pharmaceuticals and personal care products (PPCPs) are biologically active compounds that pose
a potential risk to ecosystem and human health (Gaffney et al. 2017, Baran et al. 2011, Liu et al.
2018) due to their incomplete removal in wastewater treatment (Blair et al. 2015, Gago-Ferrero et
al. 2017, Golovko et al. 2014, Jelic et al. 2011, Sörengård et al. 2019), increasing human
consumption (Jelic et al. 2011), and frequent detection in wastewater streams and natural
ecosystems around the world (Dubey et al. 2021, Halling-Sorensen et al. 1998, Kummerer et al.
2009).

Pharmaceuticals include antibiotics, anticonvulsants, and other types of prescribed

medications. Personal care products consist of non-medical compounds used for a variety of
applications, including as flame retardants and insect repellents. While previous studies have
observed varied rates of removal for some PPCPs (Archer et al. 2017, Golovko et al. 2021),
conventional wastewater treatment was not designed to handle these complex compounds.
Subsequently, PPCPs are released into and detected in surface water environments varying in
concentrations from ng/L to mg/L (Archer et al. 2017, Golovko et al. 2021, Sörengård et al. 2019).
Research in the field has identified a need for continued monitoring of these compounds in surface
water (Bilal et al. 2020, Brausch and Rand 2011, Hidrovo et al. 2020) to fully understand the
present of these contaminants, in addition to identifying which compounds should be prioritized
for legislative action.
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Research completed by former master’s student Alexandria Hidrovo (Hidrovo et al. 2020) focused
on identifying PPCPs in regional WWTFs and local surface water locations in the Great Bay
Estuary, NH in order to determine compounds that posed the greatest risk the natural environment.
Her study focused on 21 PPCPs, including the following pharmaceutical compounds; an analgesic,
antibiotics, anticonvulsants, sedatives, a B-blocker, a narcotic, a statin, a selective serotonin
reuptake inhibitor, and sedatives. Personal care products included in her study included flame
retardants, an insect repellent, a stimulant, and a tobacco metabolite. Hidrovo et al. (2020) found
that incomplete removal was occurring for some of the PPCPs in the four WWTFs sampled,
including meprobamate, phenytoin, TCPP, carbamazepine, TDCPP, and fluoxetine. A full list of
the compounds and their corresponding detections can be seen in the supplemental information
(Table B1.1). Fourteen of the twenty-one compounds tested were detected in surface water, with
concentrations ranging from 1.1 to 150 ng/L. Five surface water locations were chosen (Figure
2.1) in and around the Great Bay Estuary (GBE) in New Hampshire. Hilton Park was sampled in
both March and July of 2019 the Portsmouth Mill Pond, Adams Point, the middle of the GBE, and
Squamscott river locations were sampled in August of the same year. Compounds detected in
surface water included five antibiotics, an anticonvulsant, a B-blocker, and six personal care
products. Hidrovo et al. (2020) concluded that incomplete removal of PPCPs in wastewater
treatment led to their presence and detection in surface water environments and recommended
further monitoring of these compounds in surface water ecosystems.

In a continuation of the research completed by Hidrovo et al. (2020), we chose to focus on
continued monitoring of a larger list of PPCPs in the Great Bay Estuary, NH. The Great Bay
Estuary (GBE) was chosen based on previous research in the field (Hidrovo et al. 2020) in addition
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to the fact that multiple WWTFs have effluent outfalls in rivers leading into the GBE. This makes
the GBE a location that could be used to indicate the PPCPs that exit WWTFs due to incomplete
removal in treatment, subsequently entering the natural environment. The goal of this chapter was
to evaluate whether or not the same compounds would be detected in July 2020 as were in July
2019, and to determine which compounds were present given an extended list of screened PPCPs.
It was predicted that a total of 10 different PPCPs will be detected in the selected surface water
locations, including at least 5 antibiotics, in July of 2020. We also expected the antibiotic
sulfamethoxazole to be detected in all surface water locations. In addition, it was predicted that at
least two personal care products would be detected across all surface water locations. Predictions
were based on previous research conducted in the Great Bay Estuary (Hidrovo et al. 2020). The
main objective of this study was to identify which PPCPs are present in regional surface water
locations, and to compare these results with the findings of 2019 surface water sampling completed
by Hidrovo et al. (2020).

Methodology
Five surface water locations were sampled in July 2020 (Figure 2.1), including Hilton Park, Adams
Point, the middle of the Great Bay Estuary, where the Squamscott River enters the Great Bay, and
the North Mill Pond. A MasterFlex E/S Portable Sampler (model 07516-12) was used to collect
samples approximately one meter below the water’s surface. Two sterile, 500-mL HDPE bottles
were used to collect samples at each location; one for PPCP analysis (conducted by a commercial
lab) and one for water quality analysis conducted at the University of New Hampshire, Gregg Hall
Environmental Engineering Microbiology Laboratory. Bottles and caps were rinsed three times
with sample water before sample was collected. All surface water samples were taken at low tide.
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Field parameters, including temperature, pH, conductivity, salinity, and dissolved oxygen
(Appendix B, Table B1.5), were taken at each location using a Thermo Scientific Orion Star A329
Portable pH/ISE/Conductivity/RDO/DO Meter calibrated before use. Equipment was rinsed with
sterilized MilliQ water between sample collection, and all samples were kept on ice.

Surface water samples were shipped overnight to SGS AXYS Analytical Services Ltd. (Sidney,
British Columbia, Canada) for PPCP analysis via Acid Extraction according to Method MLA-075
REV 07 VER 08 (US EPA, 2007). A list of the 46 compounds included in our analysis, including
their classifications, is included in Table 2.1. Water quality analysis performed at UNH included
ammonia nitrogen using Hach Method 10205 TNT Plus 831, chemical oxygen demand using Hach
Method 8000 TNT plus 821/82, and orthophosphate using Hach Method 8048 (Appendix B, Table
B1.6).

Figure 2.1: Image of Great Bay Estuary located in southeast New Hampshire. Boxed numbers indicate surface water
sampling locations, while colored circles indicate WWTF effluent outfalls. Size and color of circles indicate the flow,
in million gallons per day, for each facility. Image source Hidrovo et al. (2020).
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Table 2.1: Full list of analytes (46 total) included in surface water sampling analysis, including their general and
specific classifications.
Class
Analgesic
Anthelminitic

Pharmaceuticals

Antibiotic

Anticonvulsant
Antifungal
Antihistamine
Calcium Channel Blocker
Hormone

General Name
Acetaminophen
Thiabendazole
Azithromycin
Carbadox
Cefotaxime
Ciprofloxacin
Clarithromycin
Clinafloxacin
Cloxacillin
Enrofloxacin
Erythromycin
Flumequine
Lincomycin
Lomefloxacin
Norfloxacin
Ofloxacin
Ormetoprim
Oxacillin
Oxolinic acid
Penicillin G
Penicillin V
Roxithromycin
Sarafloxacin
Sulfachloropyridazine
Sulfadiazine
Sulfadimethoxine
Sulfamerazine
Sulfamethazine
Sulfamethizole
Sulfamethoxazole
Sulfanilamide
Sulfathiazole
Trimethoprim
Tylosin
Virginiamycin M1
Carbamazepine
Miconazole
Diphenhydramine
Dehydronifedipine (metabolite of nifedipine)
Diltiazem
Norgestimate

Personal
Care
Products

Selective Serotonin Reuptake
Inhibitor (SSRI)
Fluoxetine
Steroid
Digoxigenin
Steroid Ester
Digoxin
Stimulant

1,7-Dimethylxanthine (metabolite of caffeine)
Caffeine
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Data Analysis
Results received from SGS AXYS were imported into R Studio (Version 1.3.1073). Relative
abundance of PPCPs and relative percent abundance of PPCPs were calculated from total detected
concentrations in ng/L, and data was visualized through bar plots and scatterplots with Base R.

Results
In July of 2020, 46 compounds (including 33 antibiotics) were included in a follow up surface
water sampling event conducted at approximately the same locations as those included by Hidrovo
et al. (2020). Nine PPCPs were detected by Hidrovo et al. (2020) across surface water locations
during March 2019, while twelve were detected across surface water locations in July 2019 (Table
2.1). Sulfamethoxazole, carbamazepine, atenolol, TCPP, TDCPP, caffeine, and DEET were
detected in both March and July of 2019. However, only five of 46 compounds were detected
across surface locations in 2020 (Table 2.2), with the remaining 41 below analytical detection
limits (Table 2.3). The concentrations of these five compounds in 2020 ranged from 0.65 to 11.6
ng/L.

The highest concentration detected was for the Squamscott River location, with

carbamazepine detected at 8.48 ng/L. The highest number of PPCPs detected was also seen for
Squamscott River, with a total of 5 different compounds which can be seen in Figure 2.2.
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Figure 2.2: A map of the
surface water locations
sampled in 2019 and 2020.
Detection
comparisons
between the two years can
be
seen,
with
sulfamethoxazole
and
carbamazepine being the
only two compounds that
were detected in both
sampling years.

PPCPs measured in July 2020 included three antibiotics (ciprofloxacin, clarithromycin, and
sulfamethoxazole), one anti-convulsant (carbamazepine), one calcium channel blocker
(Diltiazem), and one antihistamine (Diphenhydramine). As can be seen in Figure 2.2, no PPCPs
were detected at the North Mill Pond and Adam’s Point locations.

Interestingly, all five

compounds detected in 2020 were detected in the Squamscott River location, while only two were
detected in the middle of GBE, and one in Hilton Park. Sulfamethoxazole and diphenhydramine
were detected at 0.985 and 0.653 ng/L in the GBE location. The one PPCP detected at Hilton Park
was Sulfamethoxazole (1.25 ng/L). The most frequently detected compound was the antibiotic
sulfamethoxazole, which was detected in its highest concentration at the Squamscott River site, at
11 ng/L. The second-highest concentration at this location was 8.48 ng/L for carbamazepine. The
only detections for clarithromycin (1.6 ng/L) and diltiazem (1.04) ng/L were also found in the
Squamscott River location.
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A comparison of the 2019 and 2020 surface water sampling events can be seen in Figure 2.2. Two
compounds, sulfamethoxazole and carbamazepine, were the only PPCPs detected both years. In
2019, sulfamethoxazole was detected at 5.8 and 3.6 ng/L in March and July respectively while this
same compound was detected at 1.1 ng/L in July of 2020. Similarly, carbamazepine was detected
in concentrations of 2.8 and 4.5 ng/L in March and July of 2019 while in July 2020 it was detected
at 2.1 ng/L.
Table 2.2: Table of the analytes detected in SW samples for March and July 2019, and July 2020. White indicates no
detection, blue indicates detection, and gray indicates that a specific analyte was not analyzed.
Compound Class

General Name

Analgesic

Acetaminophen
Amoxicillin
Azithromycin

Antibiotic

Ciprofloxacin

2019 (March)

2019 (July)

2020 (July)

Legend
Detected
Not Detected
Not included
in analysis

Clarithromycin
Sulfamethoxazole

Pharmaceuticals

Trimethoprim
Carbamazepine
Anti-convulsant

Phenytoin

Antihistamine

Diphenhydramine

Primidone
B-blocker

Atenolol

Calcium Channel
Blocker

Diltiazem

Narcotic

Methadone

Personal Care Products

Sedative

Diazepam
Meprobamate

SSRI

Fluoxetine

Statin

Atorvastatin
TCEP

Flame retardants

TCPP
TDCPP

Insecticide

DEET

Stimulant

Caffeine

Tobacco metabolite

Cotinine
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Table 2.3: Analytes measured in the July 2020 surface water sampling analysis that were below analytical detection
limits for all samples, and therefore described as undetected.

Personal
Care
Products

Pharmaceuticals

Compound Class

General Name

Cefotaxime
Sulfadimethoxine
Clarithromycin
Sulfamethazine
Cloxacillin
Sulfamethizole
Enthrofloxacin
Sulfanilamide
Erythromycin
Sulfathiazole
Flumequine
Tylosin
Lincomycin
Virginiamycin M1
Antibiotic
Ormetoprim
Carbadox
Oxacillin
Clinafloxacin
Penicillin G
Lomefloxacin
Penicillin V
Norfloxacin
Roxithromycin
Ofloxacin
Sarafloxacin
Oxolinic Acid
Sulfachloropyridazine Sulfadiazine
Antihistamine
Diphenhydramine
Antifungal
Miconazole
Antiparasitic
Thiabendazole
Calcium Channel Blocker Dehydronifedipine (metabolite of Nifedipine)
Digitalis Glycoside
Digoxin
Steroid
Digoxigenin
Steroid Ester
Norgestimate
Stimulant

Caffeine
1,7-Dimethylxanthine (metabolite of Caffeine)

Discussion
PPCPs are frequently detected in natural environments around the world and are still being
detected in surface water locations in New Hampshire, as observed in this study. PPCPs were
detected in the GBE both in 2019 and in 2020. While the overall number of PPCPs detected in
surface water sampling in 2020 was lower than those detected in 2019, sulfamethoxazole and
carbamazepine were detected in both sampling events. Overall, a smaller number of PPCPs were
detected in 2020, despite the expansion of compounds included in our analysis, from 21
compounds in 2019 to 46 in 2020. A total of only five compounds were detected across all surface
water locations sampled including 2 antibiotics, 1 anticonvulsant, 1 antihistamine, and 1 calcium
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channel blocker.

The antibiotics clarithromycin and sulfamethoxazole were detected in

concentrations of 1.6 ng/L and 0.985–11.6 ng/L, respectively. The anticonvulsant carbamazepine
was detected at one location, the Squamscott River site, at a concentration of 8.48 ng/L.
Diphenhydramine, an antihistamine, was detected in the GBE (0.653 ng/L) and Squamscott River
(1.47 ng/L) locations. The calcium channel blocker diltiazem was detected at 1.03 ng/L in the
Squamscott River location as well.

It has been speculated that the COVID-19 pandemic and subsequent lockdown may have impacted
the number and concentration of PPCPs detected in 2020 surface water sampling. With less people
interacting with each other, non-COVID-19 viral and bacterial infections may have been reduced,
resulting in a lower prescription of antibiotics. In study by Rawson et al. (2020) on the impact of
the COVID-19 pandemic on antimicrobial resistance, the potential impacts of COVID-19
healthcare precautions were discussed. Through social distancing between individuals in a
community, there was a decrease in infections, and thus reductions in the prescription of
antimicrobial medications (Rawson et al. 2020). Additionally, Oster et al. (2021) stated that the
prevention of non-COVID-19 respiratory pathogens may have been a consequence of the increased
measures taken in healthcare to prevent the rise of COVID-19. It was suggested that social
distancing, school closures, and the utilization of face masks in the fight against COVID-19
infections may have also restrained the frequency of other respiratory pathogens (Oster et at. 2021).
Additionally, Nieuwlaat et al. (2021) also indicated that the interventions put in place to prevent
COVID-19 from spreading may have decreased other infections from spreading from human to
human, and subsequently decreased the use of medications prescribed. A study completed by Wee
et al. (2021) on a heath care campus in Singapore observed a decrease in hospital-acquired-
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infections, including respiratory viral infections and MRSA, during the COVID-19 pandemic in
2020. The authors attributed this decrease to the increased COVID-19 precautions taken on the
health care campus (Wee et al. 2021).

In addition to current research in the field regarding antibiotic usage during the COVID-19
pandemic, the United States Center for Disease Control (CDC) also identified changes in antibiotic
prescription during the year of 2020 (Center for Disease Control 2021). The CDC preliminarily
concluded that prescription of antibiotics in outpatient and nursing home settings decreased in the
months of April and May 2020, when compared to these two months in 2019 (Center for Disease
Control 2021, Srinivasan 2020). The CDC stated that more patients chose not to visit healthcare
centers or hospitals for needs that were not urgent during this time, and also recognized that social
distancing practices and the closure of schools may have also influenced a decrease in infections,
and subsequently a decrease in antibiotic prescription (Center for Disease Control 2021).
However, it is important to note that the CDC did observe an increase in the usage of azithromycin
and ceftriaxone, antibiotics used to treat community-acquired pneumonia, during April and May
of 2020 (Srinivasan 2020). Based upon the current literature and findings from the CDC, it is
possible that the COVID-19 lockdown impacted PPCP detections in our 2020 sampling event.
With less people interacting with each other, non-COVID-19 infection rates may have fallen in
New Hampshire, resulting in a lower prescription of antibiotics, lower consumption, and lower
discharge of these compounds from WWTFs. However, it is important to note these changes in
antibiotic prescription may not have been significant enough to impact our PPCP detections in
surface water. Additionally, New Hampshire experienced a severe drought in the summer of 2020,
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which may have also impacted the transport and concentration ranges of detected PPCPs in the
Great Bay Estuary.

While 46 PPCPs were included in our analysis in July of 2020, only five compounds were detected
across the surface water locations. The anticonvulsant carbamazepine, the calcium channel blocker
diltiazem, and antihistamine diphenhydramine were detected. Carbamazepine is used to treat
conditions such as epilepsy and trigeminal neuralgia, while diltiazem is used to treat angina
pectoris and hypertension (PubChem 2021). Out of the 33 antibiotics included in our screening,
clarithromycin and sulfamethoxazole were the only two detected. As is indicated by their
antibiotic classification, these two compounds can be used against an array of bacterial infections
in humans. Clarithromycin is a semisynthetic macrolide that has been used to treat patients
suffering from a wide array of ailments, including; urinary tract infections, skin infections, lower
respiratory tract infections, cholera, and bacterial meningitis (National Institute of Health Office
of Aids Research 2021, PubChem 2021). Many of these infections could continue despite COVID19 lockdown procedures. Similarly, sulfamethoxazole is sulfonamide antibiotic that is frequently
prescribed alongside the antibiotic trimethoprim (, PubChem 2021). Patients are given these
antibiotic(s) if they are suffering from urinary tract infections, gastrointestinal tract infections,
respiratory infections, diarrhea, and some cases of chronic bronchitis (National Institute of Health
Office of Aids Research 2021, PubChem 2021). The detection of only two antibiotics in 2020
indicates that 31 antibiotics were not detected. Considering the current research related to
antibiotic usage during the COVID-19 pandemic, it is plausible that the COVID-19 lockdown may
have influenced the number of antibiotics that were or were not detected in the Great Bay Estuary
in July of 2020. However, more data are needed to instill confidence in this notion.
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A broader list of screening did not necessarily mean more PPCPs were detected. In addition, it is
important to note that there could also be compounds that were not included in our screening that
may be present in the surface water locations sampled. Additionally, some of the compounds that
were included in our study could have been present below the detection limit of Method MLA075 REV 07 VER 08, which was used for PPCP analysis. Boxall (2004) stated that wide ranges
of pharmaceutical compounds, including antibiotics, have been found in the environment in low
concentrations. This preludes to the possibility that there may be many different types of
compounds in the environment that remain undetected via current analytical technology detection
limits. This is alarming, considering that many studies indicate that the chronic toxicity of PPCPs
on non-target organisms can occur at low concentrations, even those below the therapeutic doses
for humans (Brausch and Rand 2011, Daughton and Ternes 1999, Galus et al. 2013,). A study by
Brain et al. (2004) that focused on the toxicity of 25 pharmaceuticals, including 22 antibiotics, on
the aquatic plant Lemna gibba. The authors determined that tetracycline, sulfonamide, and
fluoroquinolone antibiotics exhibited the greatest toxicity on L. gibba. Sulfamethoxazole was
found the be the most toxic of the sulfonamide antibiotic class, causing growth inhibition, chlorotic
injury, chlorosis, necropsy, and root detachment at varying concentrations (Brain et al. 2004).
Other toxic sulfonamides included sulfamethazine and sulfadimethoxine (Brain et al. 2004).
Fluoroquinolone antibiotics, including ciprofloxacin, were observed to cause new plant fronds to
bleach, as well as growth inhibition depending on the test concentration (Brain et al. 2004).
Additionally, Brandhof and Montforts (2010) observed lack of hatching of Zebra fish (Danio
rerio) embryos, in addition to growth delay, when exposed to carbamazepine. Effects observed at
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varying concentrations of carbamazepine also included tail deformation and heart abnormalities
(Brandhof and Montforts, 2010).

The chronic exposure of aquatic organisms and plants to PPCPs remains a field of research that is
developing, which heightens the concern for the presence of even low concentrations of these
compounds in the environment, in addition to the impact that mixtures of different PPCPs may
have on an aquatic ecosystem (Baran et al. 2011, Brausch and Rand, 2011, Daughton and Ternes,
1999, Galus et al. 2013). We suggest continued monitoring of PPCPs in the Great Bay Estuary,
especially for sulfamethoxazole and carbamazepine, as these compounds were detected in both
2019 and 2020. We also recommend studies that investigate toxicity of mixtures of PPCPs, as this
is more realistic to what is occurring in the natural environment (Boxall, 2004). While the presence
of all PPCPs in the natural environment should be addressed, a prioritization of specific
compounds or classes of PPCPs can help aid in the creation of legislation regarding regulations
for these compounds in wastewater effluent and the protection of natural resources.
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CHAPTER 3
Partitioning of 21 Pharmaceuticals and Personal Care Products into
Aqueous and Solid Phases During Wastewater Treatment
Abstract
Pharmaceuticals and personal care products (PPCPs) are contaminants of emerging concern that
have been detected in municipal wastewater treatment systems across the globe. In the current
study, grab samples were taken from the treatment processes of four wastewater treatment facilities
(WWTFs) in seacoast New Hampshire. Secondary influent, secondary effluent, chlorinated
effluent, dechlorinated effluent, and sludges were tested for 21 PPCPs, including 15
pharmaceuticals and six personal care products. A range of 19-20 PPCPs were detected in
secondary effluent samples, and a range of 5-11 PPCPs were detected in sludges. Personal care
products were detected in higher parts per billion (ppb) concentrations on average than
pharmaceuticals across all wastewater samples. Antibiotics and fire retardants dominated sludge
samples in percent abundance by weight, indicating that these compounds classes are sorbing to
sludges more readily than others. The usage of treated biosolids for land applications highlights
the importance of evaluating the behavior of PPCPS during wastewater treatment, and the presence
of these contaminants in sludges.

Introduction
The removal of PPCPs in wastewater treatment has been observed to vary greatly (Jelic et al. 2011,
Miege 2009, Oulton 2010, Verlicchi 2012), and compounds that belong to the same
pharmaceutical class may not necessarily exhibit similar sorption behavior. This is because
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compounds within the same class can vary greatly in their physicochemical properties (Hörsing
2011). The main routes of PPCP removal include biodegradation via microorganisms (Jelic et al.
2011, Joss et al. 2006, Ternes et al 2004), sorption to sludges and solids (Jelic et al, 2011, Joss et
al. 2006, Ternes et al. 2006), chemical transformation (Jelic et al. 2011), and volatilization (Joss
et al. 2006). This current chapter focusses on the sorption of PPCPs to sludges during wastewater
treatment, as contaminants of emerging concern have been found to sorb to sludges in previous
studies (Camacho-Munoz et al. 2012, Golovko et al. 2021). Although sludges are processed prior
to use in different applications, the contaminants remaining in land-applied sludges may runoff
into the surrounding aquatic ecosystems (Golovko et al. 2021) in addition to possible uptake by
plants (Al-Farsi et al. 2017, Carter et al. 2014, Dodgen et al. 2013, and Shenker et al. 2011).
Sludges that are not applied for land use may be incinerated or disposed of through landfilling,
which can percolate into groundwater sources (Golovko et al. 2021). Therefore, determining
partitioning behavior of contaminants of emerging concern can help aid in the prediction of PPCP
behavior and give insight into their ultimate fate.

A study by former master’s student Alexandria Hidrovo (Hidrovo et al. 2020) focused on the
analysis of 21 PPCPs in four wastewater treatment facilities (WWTFs) in seacoast New
Hampshire. Her study found a total of 12 PPCPs in the sludge samples of the four WWTFs.
Fluoxetine, ciprofloxacin, TDCPP, TCPP, and DEET were detected in the sludge samples from
each WWTF. Hidrovo et al. (2020) concluded that fewer PPCPs were detected in the solid phase
compared to the liquid phase at each facility, indicating that the majority of the PPCPs included in
the study remained in the aqueous phase. However, the study also found ciprofloxacin to be the
most concentrated compound within the sludge samples, in addition high concentrations of TCPP
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and TDCPP. The remaining WWTF PPCP detection data from Hidrovo et al.’s (2020) research
were used in our current study to further investigate the behavior of PPCPs during wastewater
treatment.

The main objective of this chapter was to evaluate the behavior of PPCPs in wastewater treatment,
specifically secondary (or biological) treatment. Previous studies have discussed PPCP fate and
predicting compound behavior during secondary treatment (Gurung et al. 2019; Hörsing et al.,
2011; Sertillanges et al. 2020; Shah et al. 2020) however more research is needed to fully
understand the fate of PPCPs during different treatment processes. We expected to observe the
majority of pharmaceutical detections in the aqueous phase, and the majority of the personal care
products to be detected in the sludges. Also expected was the detection of all five antibiotics
within the secondary effluent and/or sludge samples of each WWTF included our analysis. We
also aimed to investigate whether or not partition coefficients (KD) found in the existing literature
for the target PPCPs will have any prediction in compound behavior during wastewater treatment.
Our study was also geared towards observing trends in PPCP detections along the treatment train,
especially for antibiotics.

Methodology
Discrete grab samples were taken from four regional wastewater treatment facilities (WWTFs) by
Hidrovo et al. (2020) in five locations along the treatment process (Figure 3.1). Aqueous phase
samples were collected into amber glass bottles containing ascorbic acid and sodium azide as
preservatives, and sludge samples were collected into glass jars without preservatives. All samples
were kept on ice during sampling and shipped overnight to Weck Laboratories, Inc. (Hacienda
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Heights, CA), after which PPCP analysis was carried out according to EPA Method 1694 (U.S.
EPA, 2007), with the use of mass spectrometry (MS), liquid chromatography (LC) and
electrospray ionization (ESI). Water quality measurements were also taken for secondary influent
and effluent with a calibrated Thermo Scientific Orion Star A329 Portable pH/ISE/Conductivity/
RDO/DO Meter, and included pH, conductivity, dissolved oxygen, redox potential, temperature,
chemical oxygen demand, ammonia content, non-purgeable organic carbon, and total dissolved
nitrogen (Table 3.1).

Figure 3.1: Sampling locations within each WWTF included secondary influent (1), secondary effluent (2),
chlorination (3), dechlorination (4), and sludge (5). Image adapted from Hidrovo et al. (2020).
Table 3.1:The water quality parameters for secondary influent and secondary effluent samples at each WWTF.
WWTF is indicated by the number in front of the sample ID. DO=dissolved oxygen, REDOX=oxidation reduction
potential, Temp=temperature, COD=chemical oxygen demand, NPOC=non-purgeable organic carbon, TDN=total
dissolved nitrogen. Sin and Sout indicate secondary influent and secondary effluent, respectively.
Sample ID
1-Sin
1-Sout
2-Sin
2-Sout
3-Sin
3-Sout
4-Sin
4-Sout

pH
7.7
7
7.3
6.5
7.5
6.7
7.3
6.6

Conductivity DO
885.1
731.1
839.2
667.2
877.6
755.8
1124
816.7

4.4
0.3
4.2
1
1.6
0.9
2.1
1.9

REDOX
Temp
-34.4
-4
-22.5
26.8
-31.3
14.5
-22.1
18.7

COD
20.6
22.5
22.8
23.9
21.3
22.2
23
23.5

288.5
16.4
88.2
24.3
182.4
36.6
314.3
19.8

Ammonia
NPOC
TDN
44.5
42.4
1
5.3
30.7
26.9
1
7.3
38.6
40.3
1
8.8
51.5
54.4
1
6.4
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12.4
31
3.1
37.8
3.7
46.1
3.4

Data Analysis
Detected concentrations for PPCPs were received from Weck Laboratories, Inc in ng/L. Data were
imported into R Studio (Version 1.3.1073) and MATLAB (R2019a), and average cpncentrations,
relative and percent abundances of PPCPs were calculated according to molecular mass. Results
were visualized using bar plots in R Studio and MATLAB, which compared the concentrations of
PPCPS at different treatment stages in parts per billion concentrations (ppb) and in percent
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abundance by weight. The secondary aqueous and sludge samples were also visualized for
comparison using R Studio.

Results
A comparison on the percent abundance of pharmaceuticals and personal care products across
treatment phases can be seen in Figure 3.2, below. Percent abundances for each phase were found
by first calculating the average atomic weight of each compound across the WWTFs. The percent
abundance by weight was then calculated by dividing the compound average atomic weight by the
summed atomic weight for all PPCPs. The results presented in Figure 3.2 indicate that the
dominant major classes of PPCPS remained generally the same along the treatment process.
Pharmaceuticals dominated both the aqueous and sludge samples, comprising about 53.7% of
secondary influent, 64.6% of secondary effluent, 50.4% of chlorination, 55.4% of dechlorination,
and 68.9% of sludge detections by weight. Personal care products were found to be most abundant
in chlorination (49.6%), and least abundant in sludge samples (31.1%).
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Figure 3.2: The percent abundance of pharmaceuticals and personal care products by weight, according to treatment
stage. Abundances presented in this figure were determined by taking the average concentration across all four
WWTFs. The average, maximum, and minimum values are indicated by the standard deviation bars.

An analysis on the ppb of PPCPs was also performed (Figure 3.3). Parts per billion concentrations
of pharmaceuticals and personal care products were calculated by taking the average of each
compound concentration in ng/L for aqueous concentrations and converting to ppb. For sludge
samples, concentrations in ng/kg were also converted to ppb. The ppb concentrations were then
visualized with bar plots using MATLAB. As seen in Figure 3.3, personal care products dominated
ppb detections for all treatment stages. The aqueous sample with the highest average ppb
concentration of PPCPs was secondary influent (1.4 ppb), while the sludge was found to contain
the highest concentration at about 6.6 ppb total.

The significant decrease in total PPCPs in ppb from secondary influent (~1.4 ppb) to secondary
effluent (~0.1 ppb) indicates that there was a decrease in PPCP concentrations in the aqueous phase
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during secondary treatment processes. We observed about a 92% decrease in the average ppb
concentration for both pharmaceuticals and personal care products from secondary influent to
secondary effluent. An additional decrease of about 78% and 44% was seen for pharmaceuticals
and personal care products from chlorination, respectively. While the concentration of personal
care products dropped about 4.5% during dechlorination, there was about a 14% increase in the
concentration of pharmaceuticals during this treatment stage. Sludge contained about 64 times
higher PPCPs ppb than secondary effluent.

Figure 3.3: The average parts per billion concentrations of pharmaceuticals and personal care products by weight in
parts per billion (ppb) for aqueous and sludge phases. The inner y-axis correlates to the aqueous phase samples;
secondary influent, secondary effluent, chlorination, and dechlorination. The outer y-axis correlates to sludges.

To find out which compounds made up the PPCPs detected in aqueous and sludge samples, the
average percent abundance of chemical classes by weight was calculated. This was done by
calculating the molecular weight (mol/L aqueous, mol/kg sludge) for each pharmaceutical
compound, and averaging these across the four WWTFs for compound classes. We observed that
the relative abundances of PPCP compound classes changed with the different treatment stages
(Figure 3.4). Analgesics dominated secondary influent, comprising about 50% of detections in
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this phase, but these compounds are removed on an undetectable level after secondary treatment.
Anticonvulsants and flame retardants dominated chlorination (24.5% and 37%) and dechlorination
samples (25.7% and 35.7%) while antibiotics dominated sludges and secondary effluent, making
up about 41% and 61% of the compounds detected for each phase, respectively. The highest
relative abundance of any one PPCP class by weight was observed in the sludge sample, indicating
that antibiotics and fire retardants may readily sorb to sludges in the specific facilities we sampled.

Figure 3.4: The average percent abundance by weight of PPCP classes in wastewater samples by weight for each
treatment process, representing the average all 4 WWTFs sampled.

To evaluate the specific compounds that were being detected in the sludge samples of each WWTF,
the percent abundance by weight of each PPCP compound in mol/kg was calculated using
molecular mass. Figure 3.5 presents these results and reveals ciprofloxacin, TCPP, and TDCPP
as prevalent compounds across all sludge samples. The sludge of WWTF 2 was dominated by
TCPP (28.4%), followed by TDCPP (20.1%) and caffeine (18.7%). Ciprofloxacin was most the
most abundant compound in WWTF 2, comprising about 83.9%, followed by TCPP (9.1%) and
fluoxetine (3.3%). The most abundant compound by weight for WWTF 3 was also ciprofloxacin
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(64.2%), after which the following two most abundant compounds were TCPP (10.7%) and
caffeine (5.9%). The most abundant compounds by weight for WWTF 4 followed a similar trend
as those seen for WWTF 1, with the top three most abundant compounds being TCPP (42.5%),
Ciprofloxacin (26.8%), and TDCPP (14.9 %). Five compounds, including ciprofloxacin, TCPP,
TDCPP, DEET, and fluoxetine, were detected in all sludge samples taken from the WWTFs.

Figure 3.5: The percent abundance of specific compounds detected in sludges by weight for each WWTF.

Most of the antibiotics we analyzed in this study were detected at least once in the secondary
treatment samples of each WWTF, except amoxicillin and azithromycin (Table 3.2). These two
antibiotics were not detected in any of the secondary treatment samples or sludge of WWTFs 1
and 2. Interestingly, azithromycin was detected in the secondary effluent of WWTF 3, however
not in the secondary influent. Ciprofloxacin was the only compound that was detected in the
sludge samples in all WWTFs, which concurs with the results displayed in Figure 3.4.
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Table 3.2: Detection table of antibiotics in secondary treatment aqueous samples and sludge. Secondary influent
samples are signified by “Sin” and the secondary effluent samples are indicated by “Sout.” An orange box indicates
that a specific antibiotic was detected in a WWTF sample, while a gray box indicates no detection.
Antibiotic
Compound

Sin

WWTF 1
Sout Sludge

Sin

WWTF 2
Sout Sludge

Sin

WWTF 3
Sout Sludge

Sin

WWTF 4
Sout Sludge

Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Detected

Not Detected

Discussion
A review of the current literature surrounding the sorption coefficient (KD) values of PPCPs was
completed (Table 3.03. A KD value was found for all 21 compounds analyzed in this study, with
the exception of two flame retardants (TCPP and TDCPP), and one tobacco metabolite (cotinine).
Table 3.3 presents the KD values found in the literature, the ranges of these values for each
compound, and the media that was used to experimentally determine the coefficients. Based on
the information summarized in this table, it was expected that the compounds with the highest KD
value ranges (e.g. azithromycin, ciprofloxacin, trimethoprim, phenytoin, primidone, diazepam,
fluoxetine, and DEET) would be found in the highest relative abundances in the sludges. This
trend was observed for ciprofloxacin and TCPP in the sludge samples but was not always the case
for trimethoprim, phenytoin, primidone, diazepam, and fluoxetine, DEET. Some compounds with
a reportedly higher KD range were not observed in high abundances in sludges compared to those
with a lower reported KD range. To demonstrate this, consider the antibiotics trimethoprim and
ciprofloxacin. Trimethoprim (KD = 1.4 – 4.8) constituted less than 1% abundance by weight in
each sludge samples, except for WWTF 1, in which this compound constituted about 2.6%.
Azithromycin (KD = 2.4 – 7.1) remained below detection limit in the sludges of WWTFs 1, 2, and
4, and constituted less than 1% of abundance by weight in the sludge. Additionally, a comparison
of the antibiotics ciprofloxacin and trimethoprim may support the prediction of compounds using
their assigned KD values. Ciprofloxacin was detected in high concentrations in the sludges than
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trimethoprim and was found in the literate to have a larger range of KD values. Ciprofloxacin (KD
= 3.6 – 7.3) was detected at a concentration of 300 ng/L in secondary effluent and 580 ng/L in
sludges, while trimethoprim (KD = 1.4 – 4.8) was detected at 270 ng/L in secondary effluent and
7.6 ng/L in sludges of the same facility.

57

Table 3.3: Compiled KD values found from the literature for the PPCP analyzed this thesis.
Analyte
Acetaminophen
Amoxicillin

Range
1.6232
0.0253

Azithromycin

2.4472-7.1

Ciprofloxacin

2.5527-7.3

Sulfamethoxazole

0.98722-5.1

Trimethoprim

1.4048-4.8

Carbamazepine

<0-2.1303

Phenytoin (Dilantin)

Primidone

Atenolol

Methadone

Diazepam

Meprobamate

Fluoxetine

Atorvastatin
TCEP
TCPP
TDCPP

Source
Kreuzig et al. 2003
Jones et al. 2002
Giebułtowicz et al. 2020
Sidhu et al. 2019
Joss et al. 2006
Gobel et al. 2005
Abegglen et al. 2009
Giebułtowic et al. 2020
Golet et al. 2003
Sidhu et al. 2019
Hörsing et al. 2011
Hörsing et al. 2011
Hörsing et al. 2011
Giebułtowic et al. 2020
Huang et al. 2019
Fernandez-Fontaina et al. 2013
Abegglen et al. 2009
Stevens-Garmon et al. 2011
Radjenovic et al. 2009
Joss et al. 2006
Gobel et al. 2005
Hyland et al. 2012
Hörsing et al. 2011
Hörsing et al. 2011
Hörsing et al. 2011
Giebułtowic et al. 2020
Fernandez-Fontaina et al. 2013
Stevens-Garmon et al. 2011
Hyland et al. 2012
Gobel et al. 2005
Xue et al. 2010
Radjenovic et al. 2009
Abegglen et al. 2009
Jones et al. 2002
Huang et al. 2019
Fernandez-Fontaina et al. 2013
Abegglen et al. 2009
Ternes et al. 2004
Wick et al. 2009
Urase and Kikuta 2005
Stevens-Garmon et al. 2011
Hyland et al. 2012
Radjenovic et al. 2009
Hörsing et al. 2011

1.5051-3.6628

Stevens-Garmon et al. 2011
Hyland et al. 2012
Hörsing et al. 2011
<1.477-3.2041
Stevens-Garmon et al. 2011
Abegglen et al. 2009
Hörsing et al. 2011
Jones et al. 2002
(-0.6778) to (3.2788) Wick et al. 2009
Stevens-Garmon et al. 2011
Radjenovic et al. 2009
1.8808
Wick et al. 2009
Hörsing et al. 2011
Ternes et al. 2004
1.3010-4
Wick et al. 2009
Hyland et al. 2012
Stevens-Garmon et al. 2011
Hörsing et al. 2011
<1.4771-3.7782
Stevens-Garmon et al. 2011
Hörsing et al. 2011
Stevens-Garmon et al. 2011
0.69897-3.7559
Muñoz et al. 2009
Hyland et al. 2012
1.9685-2.2967
Stevens-Garmon et al. 2011
1.8129-2.3636
Stevens-Garmon et al. 2011

DEET

<1.4771-3.3784

Caffeine

<1.4771-2.7482

Hyland et al. 2012
Stevens-Garmon et al. 2011
Xue et al. 2010
Stevens-Garmon et al. 2011
Xue et al. 2010

Media
test sludge
sludge
sludge
biosolids (referring to sludge)
activated sludge
activated sludge
activated sludge
sludge
activated sludge
biosolids (referring to sludge)
primary sludge
secondary sludge, long sludge age
secondary sludge, short sludge age
sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
primary sludge
secondary sludge, long sludge age
secondary sludge, short sludge age
sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
primary sludge
activated sludge
activated sludge
secondary sludge, long sludge age
activated sludge
activated sludge
secondary sludge, short sludge age
sludge
activated sludge
activated sludge
activated sludge
activated sludge
primary sludge
activated sludge
activated sludge
activated sludge
activated sludge
secondary sludge, long sludge age
activated sludge
secondary sludge, short sludge age
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge

activated sludge
activated sludge
activated sludge
activated sludge
activated sludge

Cotinine
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Compounds with larger experimentally determined KD values were expected to sorb to sludges
more readily than those with lower KD values. However, the large ranges of KD values reported
in literature make prediction difficult, and a deeper understanding of the behavior of these
compounds during different treatment process, and in the face of different operational parameters,
is needed to gain confidence in predicting the fate of contaminants. Unfortunately, due to the lack
of prior research and information regarding the KD values of PPCPs, a partition coefficient could
not be found for TCPP or TDCPP, compounds that were both found in high abundances in sludges
in this study. The wide range in KD values for PPCPs found in literature can be partially attributed
to the matrix used to determine experimentally these coefficients (Pomiès et al. 2013), which
introduces some error and uncertainty into our interpretation of the results presented in this chapter.
The results of our partitioning study in combination with experimentally calculated KD values from
the literature indicate that there is a range of behavior that can be expected for these compounds
during wastewater treatment.

Factors that may influence PPCP partitioning behavior during wastewater treatment, as well as
experimental KD values, are continuously being explored by researchers. Previous studies have
found that the pH (Sertillanges et al. 2020), temperature (Hörsing et al. 2011, Sertillanges et al.
2020; Shah et al. 2020), and solids retention time (Gurung et al. 2019) of a WWTFs unit processes
can influence the distribution and fate of PPCPs during wastewater treatment. Hörsing et al. (2011)
found pH to directly impact the sorption of eight pharmaceutical compounds to secondary sludge,
including fluoxetine, chloropramine, fuloxetine, levomeprobamazine, nefadezone, loperamide,
sertraline, and chloprothixene. Carbamazepine and naproxen were also observed to display a
higher sorption to sludge at lower pH levels (Hörsing et al. 2011). Hörsing et al. (2011) also found
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that an increase in pH from 6 to 8 decreased the percent fractionation of certain pharmaceuticals
to the aqueous phase, including the selective serotonin reuptake inhibitor fluoxetine.
Carbamazepine, which was detected in two sludge samples in this study, has been described to
have a higher affinity for sludge at low pH levels (Hörsing et al. 2011). All WWTFs in our study
exhibited a drop in pH from secondary influent to secondary effluent, with the greatest drops in
pH observed for WWTTs 2 and 4. Wastewater treatment facility 1 had the highest measured pH
for secondary effluent (pH = 7), while facility 2 had the lowest for secondary effluent (pH = 6.5).
A correlation analysis evaluating the secondary effluent concentration of carbamazepine versus
secondary effluent pH for our study indicated there was no significant relationship between
carbamazepine detections and pH in the selected WWTFs secondary effluent samples (Figure
C1.1). Interestingly, a correlation analysis comparing the concentration of fluoxetine and pH
levels for secondary influent indicated a slight correlation (R2 ≈ 0.6097), which is shown in Figure
3.6.
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Figure 3.6: A correlation analysis of secondary effluent pH levels versus secondary effluent concentration of
fluoxetine (ng/L) for the four sampled WWTFs.

Temperature, a less-investigated factor, is also suggested to impact sorption behavior of PPCPs
(Sertillanges et al. 2020, Shah et al. 2020). Additionally, Hidrovo et al. (2020) found that higher
solid retention times in wastewater treatment correlated positively with higher removal of PPCPs
from the aqueous phase. Additionally, current literature has also highlighted the importance of
hydrophilicity and hydrophobicity of compounds in influencing their behavior (Gurung et al. 2019,
Shah et al. 2020). The differences in pH, SRT and temperature, as well as basin operation and
secondary treatment process type, are suspected to influence the average percent abundances of
PPCPs in liquid versus sludge for the present study. However, it is important to note that the
results of this study cannot definitively support if these specific parameters influenced the
compounds that were detected within in the WWTFs included in our study. This is an area that
should be further explored in future research.

Pharmaceuticals were observed to dominate all aqueous samples and sludge in our study,
sometimes with only a slight majority over personal care products. Pharmaceuticals comprised an
average of 53% of secondary influent, 65% of secondary effluent, about 50.4% of chlorination,
and 55% of dechlorination samples, averaged across the four WWTFs. This can perhaps be
explained by the nature and usage of pharmaceuticals, and how these compounds were designed
to act when prescribed in humans and animals, in addition to their biodegradability. Additionally,
pharmaceuticals encompassed about 69% of sludges, compared to only 31% of personal care
products. When evaluating PPCP detections in ppb, personal care products were observed to have
higher abundances by weight than pharmaceuticals for all samples, as can be seen in Figure 3.3.
It was also expected that all five antibiotics would be detected within at least one of the secondary
treatment samples of each WWTF. Each antibiotic was detected at least once across all secondary
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treatment samples, as seen in Table 3.2. Each antibiotic was also detected in the secondary
treatment samples for each WWTF, except for amoxicillin, which was not detected in the
secondary influent, secondary effluent, or sludge sample for WWTF 1. These results highlight the
fact that these compounds are not only present in wastewater entering municipal WWTFs for
treatment, but also in the treated effluent and the sludges.

The detection of compounds in secondary effluent samples but not in secondary influent samples,
an example of which can be seen in Table 3.2, is a phenomenon that can be described as negative
removal. Negative removal is when a compound is detected in a higher concentration in the
effluent leaving treatment than in the untreated influent entering treatment. Current research
indicates that negative removal may be attributed to microbial activity releasing PPCP particles in
fecal waste, which assumes that PPCPs remain undetected when entering WWTFs in this form
(Blair et al. 2015, Gobel et al. 2007). It is important to note that matrix issues are very likely the
cause of negative removal seen in our study, due to dilution or matrix interference of dirty samples
in which compounds may not be as well detected as well. Other explanations include PPCP
metabolites transforming into their original parent compound through biotransformation (Blair et
al. 2015, Jelic et al. 2011, Plosz et al. 2010, Salgado et al. 2012, Verlicchi et al. 2012), and even
the partitioning of compounds to the aqueous phase as treatment time progresses (Golovko et al.
2021, Jelic et al. 2011, Ternes et al. 2004). While the mechanisms behind negative removal are
not fully understood, it is important to note that negative removal is highly dependent upon the
compound in question (Blair et al. 2015).
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The utilization of processed, treated sludges from WWTFs for land use is very common throughout
the world (Dubey et al. 2021) and has been described as a prominent route for PPCPs to enter the
environment (Ternes et al. 2004). PPCP compounds can also enter the natural environment
through the reclamation of treated wastewater for irrigation purposes (Al-Farsi et al. 2017). Many
species of plants have been observed to have the ability to uptake PPCPs present in the terrestrial
environment (Al-Farsi et al. 2017, Dodgen et al. 2013, Carter et al. 2014, and Shenker et al. 2011).
PPCPs can subsequently accumulate in plant tissues, possibly posing a hazard to humans and
animals if ingested (Al-Farsi et al. 2017). This is alarming considering that there is currently no
federal or state legislature limiting the concentrations of PPCPs in sludges or wastewater effluent.
In order to protect the environment, human health, and to minimize the risks PPCPs pose, research
needs to be dedicated towards monitoring PPCPs and evaluating their behavior in treatment
processes, in addition to effective legislative measures that can mitigate the impact of contaminants
of emerging concern.

The current study evaluated the partitioning of PPCPs between aqueous and sludge phases in four
seacoast New Hampshire WWTFs. Antibiotics and fire retardants made up very high percent
abundances by weight in the sludge samples of the WWTFs. Based on the result of this study, we
recommend further research into the KD values in different wastewater matrices of the 21 PPCPs
included in our analysis, in addition to research that investigates the behavior of these compounds
during different wastewater treatment processes and operational parameters. We also recommend
the prioritization of monitoring for fire retardants and antibiotics in sludge treatment. Continued
research on PPCP partitioning during treatment processes can help researchers understand the
behavior and fate of PPCPs during wastewater treatment.
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CHAPTER 4
The Microbial Communities and PPCP-Degrading Potential of
Wastewater Metagenomes
Abstract
The biological treatment of wastewater has long been referred to as the heart of secondary
wastewater treatment. This process relies on the ability of microbial communities for carbon and
suspended solids removal, in addition to the reduction of nitrogen and phosphorous. There are
multiple methods to perform secondary treatment, including activated sludge, the BardenPho
system and oxidation ditches. While these processes have been credited with removing some
legacy and emerging pollutants in addition to nutrient removal, they were not designed for the
degradation of complex compounds of emerging concern.

Among these compounds,

pharmaceuticals and personal care products (PPCPs) are of concern due to their detection in
aquatic matrices around the world and their wide consumption in humans and animals.
Additionally, these compounds have been speculated to influence the microorganisms present in
wastewater microbial communities. The aim of this study was to investigate the microbial
communities present in four regional wastewater treatment facilities (WWTFs), and to evaluate
the diversity of different secondary treatment methods, as well as the influence water quality
parameters and pollutants have on microbial taxa. Microbial community composition of
wastewater samples targeting the 16S rRNA gene as well as metagenomic sequencing of a subset
of wastewater samples was performed, and bacteria were found to be the dominant domain in each
facility. Diversity indices, including Shannon Diversity and species richness, indicated that sludges
contained some of the highest diversity indices found across all samples. NMDS analyses
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indicated that sulfamethoxazole, TDCPP, and DEET were the most influential PPCPs on microbial
phyla, while five of the nine water quality parameters were found to be statistically significant in
their influence. The study also identified five enzymes of interest detected in in the WWTFs
sampled that have been associated catalyzing PPCP-degrading reactions. This study aimed to shed
light on the diversity of the microorganisms and degradation enzymes present within wastewater
treatment, as well the factors influencing wastewater microbial communities.

Introduction
Contaminants of emerging concern, including pharmaceuticals and personal care products
(PPCPs), have been described as substances that enter the natural environment via incomplete
removal in wastewater treatment facilities (WWTFs) (Blair et al. 2015, Gago-Ferrero et al. 2017,
Golovko et al. 2014, Jelic et al. 2011, Sörengård et al. 2019). Pharmaceuticals describe any
compound that is prescribed for medical use, including antibiotics, anticonvulsants, and pain
relievers, and personal care products include insect repellents, fire retardants, and stimulants.
While WWTFs can degrade PPCPs to some extent, they were originally designed for the removal
of nutrients, including nitrogen and phosphorous. Scientists are concerned with PPCPs not only
because these compounds are frequently detected in surface water around the globe, but because
small concentrations of these compounds can have significant negative impacts on non-target
organisms (Meyer et al. 2019, Petrie et al. 2015, Sörengård et al. 2019). This is especially true for
antibiotic compounds that enter the natural environment. Antibiotics, including sulfamethoxazole,
a common antibiotic prescribed in humans, are not completely metabolized by the body, and can
be excreted as a sulphuric or glucuronic acid conjugate, or as a metabolite (Kovalakova et al.
2020). Additionally, conventional wastewater treatment does not efficiently remove antibiotics

65

that are received into WWTFs for municipal wastewater treatment (Bilal et al. 2020, Kovalakova
et al. 2020). These compounds subsequently exit WWTF in effluent and are received into the
natural environment. Not only is research regarding the overall impacts of PPCPs in the natural
environment lacking, but also the chronic toxicity of these pollutants on non-target organisms
remains an ongoing field of research.

The degradation and removal of PPCPs that has been observed in wastewater treatment can be
attributed to volatilization, sorption to sludge, and biodegradation via microorganisms (Pomiès et
al. 2013). While volatilization and sorption to sludges are methods that should be explored further,
this chapter focused on the microbial communities that degrade these compounds. The secondary
wastewater treatment processes typically employ microbial communities for suspended and
dissolved carbon, nitrogen, and phosphorus removal (Saunders et al. 2016), as well as the removal
of legacy and emerging pollutants. Wu et al. (2019) suggested that activate sludge wastewater
treatment consisted of a microbial community unlike any other and predicted the presence of a
billion species (1.1±0.07x109). While many studies have been oriented on describing the microbial
members of different treatment processes, the extent of the diversity and function of these
communities, particularly related to PPCP removal, is not fully understood.

Based upon the available literature, dominant microbial phyla may occur across WWTFs
worldwide. In a study by Saunders et al. 2016, it was found that the 63 core genera found in 13
Danish WWTFs make up 68% of the total reads corresponded to core communities found in other
studies (Zhang et al. 2012). In a study on microbial communities in 5 municipal WWTFs in China
by Zhang et al. (2019), the most dominant phyla were, in order, Proteobacteria, Chloroflexi,
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Actinobacteria, Acidobacteria, Bacteroidetes, and Firmicutes. In a global analysis of activated
sludge systems, it was found that Proteobacteria was the most dominant community phylum,
constituting 82% of the core community (Wu et al. 2019). Yang et al (2011) also found the most
abundant phylum to be Proteobacteria, followed by Bacteroidetes and firmicutes. In a review by
Tian and Wang (2020), the most dominant phyla found in WWTFs serving municipalities around
the world consisted of Proteobacteria, Bacteroidetes, and Chloroflexi.

Firmicutes and

Fusobacteria were also observed to be dominant phyla in the study. The available literature
indicates that the dominant phyla in WWTFs include Proteobacteria, Bacteroidetes, Firmicutes,
Chloroflexi, Actinobacteria, and Acidobacteria, alongside many other less abundant phyla.

There are many factors described to influence the microbial communities that exist in wastewater
treatment, including temperature (Seib et al. 2016,Tian and Wang 2020, Wu et al. 2019), pH (Tian
and Wang 2020), influent wastewater composition (Griffin and Wells, 2017, Chen et al. 2017,
Zhang et al. 2019), dissolved oxygen (Niu et al. 2016, Seib et al. 2016), and WWTF operational
parameters (Cydzik et al. 2016, Isazadeh et al. 2016, Tian and Wang 2020, Tiwari et al. 2017,
Zhang et al. 2019) such as solids and hydraulic retention time. Pharmaceuticals and personal care
products may also influence microbial communities in wastewater treatment (Tian and Wang
2020). A study by Onesios-Barry et al. (2014) explored the influence of these pollutants on
wastewater microorganisms by evaluating microbial protein concentration. This study applied a
mixture of PPCPs to columns inoculated with WWTF effluent and evaluated microbial community
composition. The authors found that initial PPCP concentration influenced the extent of PPCP
biological removal. A study by Tian and Wang (2020) also stated that pollutant concentrations
may influence wastewater microbial communities. Additionally, a study by Zhang et al. (2020)
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evaluated the influence of the PPCP sulfadiazine, ibuprofen and carbamazepine on moving bed
biofilm reactors. The authors found that concentrations of PPCPs less than 2mg/L stimulated
microbial growth and caused an increase in diversity. However, when PPCPs were present at
5mg/L a decrease in microbial diversity was observed. Zhang et al. (2020) concluded that the
presence of PPCPs produced a different type of microbial community structure within the moving
bed biofilm reactors evaluated.

Metagenomic sequencing is a novel technique that can be used to gain insight into the microbial
communities of wastewater treatment. This method can be used to describe not only the bacterial
and archaeal members of a microbial community found via 16S rRNA sequencing, but also the
eukaryotes, fungi, and viruses present. Metagenomic sequencing using Illumina sequencing has
been used in previous studies to evaluate the microbial communities of wastewater treatment (Guo
et al. 2017, Tian and Wang 2020), the genes present in wastewater microbiomes (Guo et al. 2017b,
Tang et al. 2016), and metabolic pathways (Guo et al. 2017a). Metagenomics sequencing has
allowed researchers to evaluate the function and structure of a microbial community and has been
described to overcome the biases of PCR and culture-dependent methods (Fang et al. 2013). This
novel method is also able to provide a new perspective on microbial community composition as
well as the abundance and diversity of biodegradation genes, especially for organisms that are not
easily cultured (Fang et al. 2013). A study by Fang et al. (2013) found a strong presence of
biodegradation genes in samples from two WWTFs in China, including pmo and p450 genes. This
study also utilized the MG-RAST platform to identify 87 bacterial genera that were described with
the potential to degrade pollutants, including microorganisms belonging to Proteobacteria,
Actinobacteria, and Bacteroidetes phyla.
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As is discussed above, metagenomic sequencing can provide information regarding the function
of microorganisms present in a sample, as well as metabolic potential of the community. The use
of metagenomic sequencing can also be helpful in determining if PPCP biodegradation pathways
and enzymes are present in a given sample. While enzymatic presence is not indicative of an
active biodegradation pathway, it can describe whether or not the microbial community members
have the potential to degrade specific pollutants. For these reasons, metagenomics has been
deemed a useful tool for modeling pollutant biodegradation pathways in addition to describing the
complex and diverse microbiome of wastewater treatment.

Project Background and Motivation
Four regional wastewater treatment facilities located in seacoast New Hampshire were sampled in
July of 2019. Grab samples were taken from secondary treatment influent, within secondary
treatment processes, and from secondary effluent. Sludge samples from the secondary treatment
phase of each facility were also taken, as was de-watered sludge which collects from primary and
secondary phases. A total of 25 samples from the four facilities were included in the analysis of
microbial community members. One composite sample from each facility consisting of
subsamples collected from secondary treatment phases was used for metagenomic sequencing (4
total). Sequencing of the 16S rRNA gene was conducted to gain insight into the bacterial and
archaeal community members present in the samples while metagenomic sequencing was
completed to understand the metabolic potential of the microbial communities in present in
secondary treatment. The secondary wastewater treatment processes for each facility can be seen
below, in Figure 4.1. WWTFs 2, 3, and 4 implement a Bardenpho system for secondary treatment
(Figure 4.1A), while WWTF 1 implements an oxidation ditch (Figure 4.1B).
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Figure 4.1: The Bardenpho method (A) and the oxidation ditch process (B) were implemented by the WWTFs
sampled in the current study.

There were three main goals for the analysis of the wastewater microbial communities in this
study; (1) to gain insight into the diversity of the microorganisms in secondary wastewater
treatment, (2) to evaluate the influence of operational parameters and water quality, and how these
conditions may shape wastewater microbial communities, and (3) to observe any trends for
microbial taxa and metabolic potential associated with measured PPCPs. The following
predictions were formed based on current literature to address our hypotheses; (1) Prokaryotes
(bacteria and archaea) will comprise the majority (>90%) of microbial taxa in these samples, with
eukaryotes (<10%) and viruses (<1%) comprising a minority. For 16S rRNA Sequencing, bacteria
will encompass >90% of microbial samples, and archaea will encompass <10% of samples, (2)
temperature will be the most influential factor driving microbial assemblage in the WWTFs
sampled, while pH will be the second most influential factor, (3) sludge samples will have a higher
microbial diversity and species richness than aqueous samples, (4) samples with a higher number
of antibiotics detected will exhibit lower microbial diversity, (5) micropollutant/xenobiotic
metabolism will comprise <10% of cellular activities within each WWTF, and (6) at least one
enzyme associated with PPCP biodegradation will be present in metagenomic data for each
WWTF. These goals and specific aims are addressed using the following methods described.
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Methodology
Field Methods
Four wastewater treatment facilities (WWTFs) located in the seacoast region of New Hampshire
were chosen for the study, sampled in July 2019, and stored in sterile sample containers at -80C
before processing.

Three of the WWTFs implement Bardenpho design while the fourth

implements an oxidation ditch design. Grab samples were retrieved from the secondary treatment
basins for each WWTF, with samples taken from each individual zone. Samples were shipped
overnight to Weck Laboratories, Inc. in California, where sample extraction followed by PPCP
analysis via liquid chromatography followed by mass spectrometry via electrospray ionization was
implemented according to EPA method 1694 (U.S. EPA, 2007).

DNA Extraction and Sequencing
Microbial total nucleic acids were extracted from samples using a Qiagen DNEasy Powersoil
extraction kit. This extraction kit has been used in previous research to evaluate the microbial
community members of wastewater, including bacteria, eukaryotes, and viruses (Albastaki et al.
2021, Petrini et al. 2020, Redhead et al. 2020, Ren et al. 2021, Trebuch et al. 2021). A silica
membrane was used to capture, rinse, and elute genomic DNA, which was then stored at -80 ºC
until samples were sequenced. Microbial community analysis was conducted using universal
primers obtained from the Earth Microbiome Project (Earth Microbiome Project, 2021) that
targeted the V4 region of the 16S rRNA gene in accordance with the protocol set out by Caporaso
et al. (2012).

Sequencing was performed using an Illumina HiSeq 2500 with Rapid Run

chemistries at the Hubbard Center for Genome Studies at the University of New Hampshire
(Durham, NH). Gel electrophoresis was utilized to check fragment length, including positive and
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negative controls. Amplicons were then sent for analysis using 16S rRNA sequencing at the
Hubbard Center for Genome Studies at the University of New Hampshire.

Remaining DNA samples were pooled according to WWTF and sent for metagenomic sequencing.
Shotgun metagenomics via Illumina sequencing using Illumina HiSeq 2500 was performed at the
University of New Hampshire’s Hubbard Center for Genome Studies. Both ends of the DNA
strands were sequenced, known as paired-end sequencing (Illumina, 2017). Paired-end sequencing
produces forward and reverse strands, which can be paired for more accurate alignment (Illumina,
2017). This method also produces twice the number of reads compared to single-red sequencing,
resulting in higher quality reads (Illumina, 2017). During Illumina Sequencing, single-stranded
DNA is hybridized (Voelkerding et al. 2009). This is followed by bridge amplification, after which
clusters are denatured and cleaved (Voelkerding et al. 2009). The next step adds polymerase to
initiate sequencing, which grows chains via nucleotide addition (Voelkerding et al. 2009). The
fluorescence is then recorded, and the next synthesis cycle is started (Voelkerding et al. 2009).
The number of cycles included in sequencing determines the length of the read (Voelkerding et al.
2009). The maximum read length for HiSeq 2500 is 250bp (Illumina, 2021).

Sequence Processing
Data from 16S rRNA sequencing was processed using QIIME2 (Bolyen et al. 2018). Sequences
were demultiplexed, trimmed for quality, and then denoised using DADA2, and an amplicon
sequence variant (ASV) table was subsequently created (Callahan et al. 2016). Metagenomic
databases, including KBase and MG-RAST, were utilized for data analysis of the sequences
received from Illumina sequencing. Workflow within KBase was completed according to Chivian
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et al. (2020). Raw sequences were imported to KBase as fastaq reads and were paired according
to the forward and reverse file pathways. The interleaved setting was indicated, as well as the type
of sequencing. The quality of the files was assessed using FastQC v0.11.5. Read quality was also
read after each subsequent step in the sequence processing. Reads were then trimmed using
Trimmomatic v0.36, after which assembly was carried out via metaSPAdes v3.13.0. Trimming
was done on the reads once more before apps to evaluate microbial taxonomy were utilized.
Taxonomy was evaluated using the KBase applications GOTTCHA2 and Kaiju. Paired, trimmed
reads were run through Kaiju with RefSeq Genomes as the reference database. The GOTTCHA2
viral and bacterial database were used as the reference database for the GOTTCHA2 application.

Raw Illumina sequences were also imported into MG-RAST as unpaired forward and reverse
sequences. The following sequence processing described was done automatically within MGRAST as described in the MG-RAST user manual (MG-RAST, 2019); The reads were first
preprocessed using SolexaQA, which trims low-quality regions of the sequence data. The dataset
was then dereplicated using k-mer to perform rapid identification of 20-character identical
sequences.

Duplicate Read Inferred Sequencing Error Estimation (DRISEE) was also

implemented to analyze the Artificial Duplicate Reads (ARDs), which determined the variation
between sequences. Bowtie was then implemented to screen and remove reads that are associated
with genomes of non-microbial organisms, such as humans, mice, and cows.

For feature

identification within MG-RAST, the following pipeline was used; protein coding gene calling,
rRNA detection, protein filtering, AA clustering at the 90% identity level, and protein
identification, rRNA similarities, profile generation, and database loading. Microbial phylogeny
was evaluated using RefSeq databases, and the enzymes present within each wastewater facility
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sample were determined using KO databases within MG-RAST, using representative hits with
60% identification and an e-value of 6.

Dominant Microbial Domains
To evaluate the abundance of bacteria and archaea, amplicon sequence variant (ASV) data based
on 16S rRNA gene sequences were imported into MATLAB (R2019a), and percent abundances
were calculated from the number of total reads per domain. The results were then visualized using
pie charts in MATLAB to produce a percent abundance representation of the domains present in
each WWTF (Figure 2). A table showing the number of ‘hits’ for each WWTF by domain was
also made to evaluate the domains that were too small in percent abundance to be seen clearly in
the pie charts.

Microbial Diversity
The sequencing results were also imported into R Studio (Version 1.3.1073), and the following
packages were used in the microbial analyses implemented in this study; stats, ade4, vegan, gclus,
FD, BiocManager, ggplot2, MASS, labdsv, cluster, and indispecies. To evaluate the microbial
diversity of the wastewater samples, multiple diversity indices were calculated using R Studio.
These indices included the Inverse Simpson’s index, Simpson’s Evenness, Shannon Diversity,
Species Richness, and the Chao1 index. It is important to note that the Chao1 index is a
measurement of species richness. These diversity indices were calculated using the species level
data, which was part a Qiime2 output. A bar plot was then used to visualize the Shannon Diversity
of the species present in all samples, with an overlaid plot indicating the species richness.
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Multivariate Analyses
Multivariate analyses were implemented to observe the taxonomic relationships across wastewater
samples. Nonmetric multidimensional scaling is a type of ordination technique (Holland, 2008)
that can be used on a wide array of large datasets (Holland, 2008, Jiang et al. 2010). The NMDS
method has been described as a highly flexible and preferred method for evaluating multidimensional data that does not follow normality assumptions (Dexter et al. 2018). Compared to
other types of similar analyses, such as a principal component analysis, NMDS does not assume
linear or modal relationship for a dataset (Holland 2008, Jiang et al. 2010, Kenkel, 1986). The
algorithm utilized by NMDS ranks the distances between points within a dataset, which are then
used to map the objects on a non-linear two-dimensional ordination (Kenkel 1986, Ramette 2007).
Different types of distance measures can be used to evaluate a specific dataset (Holland, 2008),
such as Bray-Curtis or Euclidian distances (Kruskal, 1964). An NMDS can be adjusted by rotation
or inversion to view any preferred data arrangement (Holland, 2008, Jiang et al. 2010). This
method is extremely useful because it allows us to evaluate complex data in reduced dimensions
and has been used to in ecological research to evaluate community abundance (Dexter et al. 2018).
However, the success of NMDS may be dependent upon the standardization of data prior to
analysis (Kenkel, 1986), and the analysis can be very slow with large datasets (Holland, 2008).
Another drawback to NMDS is that the method can fail in determining the best solution for a
dataset if it becomes stuck on minimal solutions that may not be the best solution for a particular
dataset (Holland, 2008). Despite some draw backs of the method, NMDS NMDS been used in
microbial ecology (Ramette, 2007) because it can identify underlying gradients influencing
microorganisms, and then visually represents relationships based on a variety of distance measures
(Ramette, 2007).
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To perform nonmetric multidimensional scaling within R studio, the Jaccard and Bray-Curtis
dissimilarities were found using the vegdist function via the Vegan package. While both of these
distances were calculated, the Bray-Curtis distances was used for non-metric multidimensional
scaling (NMDS). An NMDS was produced using R studio, and the NMDS values for the BrayCurtis distances were extracted from the program. The scores that resulted from the Bray-Curtis
dissimilarities were then analyzed using the isoMDS function in R. This function implements
Kruskal’s non-metric dimensional scaling to minimize the stress values for the points. This
function generates an NMDS from the Bray-Curtis dissimilarities calculated prior in the code. As
a general rule, the lower the stress values for the data points, the more accurate the NMDS analysis.
The metaMDS function was also used to combine inner functions within R to run the NMDS. The
water quality and PPCP data were then put onto an ordination using the envfit function, with 999
permutations specified for all analyses. The scores from the NMDS analyses that were calculated
using R were extracted and then imported into MATLAB for visualization.

Once the data were imported into MATLAB, the NMDS scores for each sample were plotted in a
scatter plot, alongside the NMDS scores for the environmental parameters included in the analysis.
Four NMDS analyses were run in R, and three of these were plotted in MATLAB. The first NMDS
was made to better understand the microbial species diversity of all 25 samples, while the second
NMDS was made to evaluate the influence of water quality parameters on microbial phyla. The
last NMDS included in this study was performed with the goal of evaluating the influence PPCPs
may have upon microbial phyla in the wastewater samples. The NMDS process in R and
MATLAB described above was used for each NMDS presented in this study.

76

Results and Discussion
Dominant Microbial Domains and Phyla
The dominant microbial domain for each wastewater treatment facility was evaluated by summing
up the number of sequence ‘hits’ for each sample by WWTF, and calculating the percent
abundances for each domain. The chart presented in Figure 4.1 indicates that bacteria is the most
dominant domain for each of the four WWTFs, the data from which was obtained through 16S
rRNA gene sequences. Due to difficulty in viewing the archaea and unassigned abundances in
Figure 4.1, a table summarizing this information can be seen in the attached supplemental
information (Table D1.2). As was hypothesized, bacteria comprised greater than 90% of all
samples, with archaea constituting less than 10%. Based on 16S rRNA sequence data, which may
bias results toward bacteria, the only facility where archaea were detected was WWTF 4, which
implements the Bardenpho design. WWTF 2 showed all sequence identified as bacteria, while
WWTFs 1, 3, and 4 had less than 1% unassigned.
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Figure 4.1: The percent abundance of Archaea,
Bacteria, and Unassigned microorganisms using
Illumina16S rRNA gene sequencing results.

Figure 4.2: The percent abundance of Archaea,
Bacteria, Eukaryota, Viruses, and other sequences
using Illumina metagenomic sequencing results

The results from the metagenomic sequencing presents a similar but complimentary story, as this
approach can detect prokaryotes, eukaryotes, and viruses. Metagenomic data (Figure 4.2) showed
bacteria were the dominant domain for all WWTF samples, comprising a minimum of 98% relative
abundance of sequences in each WWTF. Archaea were detected in all facilities, but found to
constitute less than 0.6% relative abundance, while eukaryotes were found to constitute between
0.87 and 1.2% across the WWTFs. Viruses were identified in very small percent abundances across
the facilities, with the highest detection found in WWTF 2 (~0.047%). A table summarizing the
percent abundances for each domain via metagenomics sequencing can be found in the
corresponding supplemental information (Table D1.2). The findings of both the 16S rRNA gene
sequencing and metagenomic sequencing analysis indicate that the majority of the microorganisms
that are present in wastewater treatment are indeed bacteria. These results serve as the basis for a
deeper search into who these members are and what functions they may serve within treatment
processes.
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The dominant microbial phyla for each WWTF were evaluated using the RefSeq database through
MG-RAST. The results of this analysis (Figure 4.3), which shows the percent abundance of
microbial phyla in each facility. These findings are consistent with previous research in the field.
The top six dominant phyla for WWTF 1 included, Proteobacteria, Actinobacteria, Bacteroidetes,
Firmicutes, Planctomycetes, and Chloroflexi.

WWTF 2 was dominated by Proteobacteria,

Bacteroidetes, Actinobacteria, Firmicutes, Verrucomicrobia, and Chloroflexi, respectively.
WWTF 3 consisted of the following top six dominant; Proteobacteria, Bacteroidetes,
Actinobacteria, Chloroflexi, Firmicutes, and Planctomycetes. Lastly, WWTF 4 consisted of the
following dominant phyla; Proteobacteria, Bacteroidetes, Actinobacteria, Firmicutes, and
Verrucomicrobia, and Planctomycetes. Proteobacteria comprised 52 to 61% of the microbial
community members across WWTFs, while Actinobacteria constituted about 7 to 17%.
Wastewater treatment facility 3 contained the largest abundance of Bacteroidetes (18%) and
Firmicutes (3%). This facility also contained the largest percent abundance of Plancomycetes
(~2%), while WWTF 2 contained the least abundance for this phylum (1.6%). Chloroflexi was
also found in high abundance (~5%) in WWTF 4.
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Figure 4.3: The Relative abundance of the microbial phyla within each wastewater treatment facility, detected using
Metagenomics Illumina Sequencing and retrieving matching sequences from KO database in MG-RAST. Phyla are
broken up to those comprising greater than 1% (A), 0.01 to 1% (B), and less than 0.01% of samples.
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Microbial Diversity
The microbial diversity for each sample was determined using the Vegan package in R studio,
using the 16s rRNA sequencing results. The Shannon Diversity as well as the species richness
were visualized in one figure displaying how these indices varied between samples (Figure 4.4).
In Figure 4.4, the Shannon Diversity indices are depicted as bar plots, corresponding to the left yaxis. In general, a larger Shannon Diversity index indicates higher microbial diversity, and a larger
species richness value indicates a higher microbial species richness. The species richness for each
sample is indicated by an asterisk and corresponds to the values indicated on the secondary, right
y-axis. It can be seen that the highest microbial diversity for WWTFs 1 and 4 was observed for
the sludge samples. The highest diversity for WWTF 2 was almost tied for the sludge and Zone 1
of secondary treatment. Interestingly, sludge was found to have the lowest microbial diversity of
all samples for WWTF 3. Although these results were not expected, the sludge Shannon Diversity
indices for WWTFs 1, 2, and 4 support our diversity prediction. WWTF 3, which exhibited the
lowest sludge diversity, was the youngest facility sampled, had the second shortest solids retention
time, and the longest hydraulic retention time. The influence of solids retention time was explored
through NMDS analysis, however statistical analyses deemed it insignificant in the current study.

The treatment facility implementing an oxidation ditch for secondary treatment was expected to
have the lowest microbial diversity out of the WWTFs. The average Shannon Diversity index was
highest for WWTF 2, followed by WWTF’s 4, 1, and 3. Additionally, the top two WWTFs with
the highest Shannon diversity were those that utilized the Bardehpho system. All sludges, except
for WWTF 3, had a species richness above 250. The secondary effluent sample from WWTF 2
exhibited the lowest species richness of any sample, which was calculated at 61. It is important to
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note that the influence of secondary settling, in which settling basin is implemented at end of
secondary treatment to separate liquids and solids before wastewater if sent for the next stage of
treatment, may impact the diversity and richness levels observed in our secondary effluent
samples.

Figure 4.4: A visual representation displaying the Shannon Diversity indices (left y-axis) and species richness (right
y-axis) for each sample. Shannon diversity is represented through the bar plot, while species richness is indicated by
the asterisks. Colors indicate specific treatment facilities; WWTF 1=blue, WWTF 2=pink, WWTF 3=red, and
WWTF=yellow. BH and AH indicate the anoxic and aerobic sections of WWTF 1’s oxidation ditch, respectively. Z1
and Z3 indicate the primary and secondary anoxic sections of 4-stage Bardenpho, while Z2 and Z4 indicate the primary
and secondary aerobic sections of 4-stage Bardenpho for WWTFs 2, 3, and 4.

In addition to evaluating the microbial diversity and species richness for each sample, the presence
of antibiotics in secondary influent, secondary effluent, and sludge was evaluated. As can be seen
in Table 4.1, at least one antibiotic was detected in each sample. The sludge sample for WWTF 2
had the highest Shannon Diversity and species richness, and only one antibiotic was detected in
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the sample. The lowest Shannon Diversity was seen for WWTF 3’s sludge sample, while the
lowest species richness was observed for the secondary effluent of WWTF 2. Three different
antibiotics were detected in each of these facilities. Interestingly, the most frequently detected
antibiotic for all samples was Trimethoprim. While it cannot be explicitly stated that antibiotics
decrease microbial diversity, the results presented in this report support the need for further
research regarding the influence that these compounds of emerging concern may have on
wastewater microbial communities.
Table 4.1: The Shannon Diversity and Species Richness for the secondary influent, secondary effluent, and sludge
samples from each WWTF, alongside the number of antibiotics detected and the PPCP detected at the highest
concentration in each sample. Red indicates the lowest diversity or richness found for all samples, while blue indicates
the highest.

WWTF ID
WWTF 1
WWTF 1
WWTF 1
WWTF 2
WWTF 2
WWTF 2
WWTF 3
WWTF 3
WWTF 3
WWTF 4
WWTF 4
WWTF 4

Sample ID Shannon Diversity Species Richness Antibiotics detected
Sin
3.64
135
3
Sout
4.53
245
3
Sludge
4.65
271
1
Sin
4.66
279
3
Sout
3.61
61
3
Sludge
4.93
306
1
Sin
3.81
169
4
Sout
4.27
190
4
Sludge
3.57
201
3
Sin
4.04
193
4
Sout
4.55
246
4
Sludge
4.90
299
2

Highest Concentration
Azithromycin
Trimethoprim
Trimethoprim
Ciprofloxacin
Trimethoprim
Trimethoprim
Sulfamethoxazole
Ciprofloxacin
Trimethoprim
Ciprofloxacin
Azithromycin
Trimethoprim

It is possible that some of the organisms that constituted some of the diversity seen in the samples
taken within secondary treatment basins (e.g., BH, AH, Z1, Z2...) may be associated with
organisms that prefer to adhere to particles, as opposed to the free swimmers that may be found in
the liquid regions of wastewater treatment. Therefore, the secondary settling basin has the
potential to concentrate these diverse organisms with an affinity for surface growth to settle out
into the sludges, possibly influencing the diversity observed in the sludges for the sampled
WWTFs.
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Multivariate Analyses
Non-metric multidimensional scaling (NMDS) was implemented to observe similarities between
the microbial classes found at the sampled WWTFs via 16s rRNA sequencing, as well how water
quality and the presence of PPCPs may influence the microorganisms in wastewater treatment. An
NMDS was performed using microbial class data for all 25 WWTF samples. The results of this
analysis, seen below in Figure 4.5, indicated that the zones within each secondary treatment
process were closely related by WWTF. Interestingly, the influent samples for WWTFs 1, 3, and
4 are grouped quite a distance away from the other wastewater samples, indicating a significant
difference in their microbial classes when compared to the other samples. The sludge for WWTF
1 is oriented very closely to the samples taken from the secondary treatment zones for that facility,
while the sludge samples for the other WWTFs are oriented at a further distance from their
respective WWTF secondary treatment zone samples. The results from this NMDS indicate that
the microbial classes detected in the outlying samples may be more unique than those that are
grouped closer together, such as the samples taken from within the different secondary treatment
zones. It was expected that the Bardenpho system would select for different taxa based on the
series of aerobic and anoxic environments provided in the treatment process, however these
samples were for the most part grouped closely together within the NMDS.
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Figure 4.5: A non-metric multidimensional scaling (NMDS) analysis calculated using Bray-Curtis distances between
all WWTF samples. WWTF 1 is shown in dark blue, WWTF 2 is shown in light blue, while WWTF’s 3 and 4 are
shown in red and green, respectively. An X indicates a secondary influent sample, and a circle indicates secondary
effluent. A triangle indicates samples taken within secondary treatment basins, while an asterisk is representative of
a sludge sample.

Another goal of this study was to observe the influence PPCPs may have on wastewater microbial
taxa. An NMDS was performed to evaluate this, and three PPCPs were found to be statistically
significant, with p-values less than 0.05 each. The samples analyzed for this NMDS included
secondary influent, secondary effluent, and sludge. As seen in Figure 4.6, the significant PPCPs
included sulfamethoxazole, TDCPP, and DEET. Sulfamethoxazole is a very common antibiotic
used to treat bacterial infections. TDCPP is a type of flame retardant, and DEET is a frequently
used insect repellent. Sulfamethoxazole and TDCPP appear to have a similar trajectory within the
NMDS, indicating that they may have a similar association to the microbial phyla in these
wastewater samples. DEET appears to be driving the separation of the microbial communities
similiar to sulfamethoxazole and TDCPP, but with a more southern trajectory. It can be seen in
Figure 4.6 that these PPCPS may have a higher influence on secondary influent for WWTFs 1, 3,
and 4 than the other samples present. It also appears that the remaining wastewater samples are
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not as heavily influenced by these PPCPs. This seems appropriate, considering that wastewater
entering secondary treatment has not been treated yet and may contain higher concentraitons of
pollutants than wasewater further along the treatment train. A step-by-step procedure on how the
NMDS exhibited in Figure 4.6 was developed can be found in Appendix C. This procedure applies
to all of the NMDS figures developed in this chapter.

Figure 4.6: NMDS calculated using Bray-Curtis distances between secondary influent (Sin, X), secondary effluent
(Sout, •), and sluge (*) samples for each WWTF. WWTF 1 is shown in dark blue, while WWTF 2 is shown in light
blue. WWTFs 3 and 4 are shown in red and green, respectively. Sulfamethoxazole, TDCPP, and DEET were the
only PPCPs found to be significant in the statistical analysis, as they each had a p-value lower than 0.05.

The final objective of this study was to evaluate the influence of water quality parameters and
operational conditions on wastewater microbial taxa. An NMDS was performed to evaluate solids
retention time (SRT) in relation to taxa detected via 16s rRNA sequencing, however statistical
analyses regarded this parameter as insignificant, with a P-value greater than 0.05. An NMDS was
also performed using the water quality parameters recorded for secondary influent and secondary
effluent samples. Five parameters were found to be significant; ammonia, total dissolved nitrogen
(TDN), non-purgeable organic carbon (NPOC), chemical oxygen demand (COD), and redox
potential. Each of these parameters received a P-value less than 0.05. Ammonia and TDN appear
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to have a very similar influence on the microbial taxa, which is reasonable considering that
ammonia is a compound that contains nitrogen. These two parameters, in addition to NPOC,
appear to have an influence on the microbial phyla present in the secondary effluent of WWTFs 3
and 4. COD has a north-west trajectory, and may have a slight impact on secondary effluent as
well. The oxidation-reduction reaction (redox) potential appears to have an influence on the phyla
for some of the secondary effluent samples, including a trajectory directly through secondary
effluent sample for WWTF 3 in Figure 6. The secondary influent sample for WWTF 1 appears to
be an outlier for microbial phyla within the NMDS. WWTF 1 was the only facility sampled that
performs secondary treatment using an oxidation ditch.

Figure 4.7: NMDS evaluating the influence of statistically significant water quality parameters on the microbial Phyla.
Secondary influent (Sin, X), secondary effluent (Sout, •), and sludge (*) samples were included in this specific
analysis. TDN signifies total dissolved nitrogen, non-purgeable organic carbon is specified by NPOC, and COD
indicates chemical oxygen demand.
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Biodegradation Enzymes
To begin an analysis of the enzymes associated with biodegradation that were present in the
wastewater samples for this study, enzyme class abundance for the main groups of enzymes
detected in the samples was evaluated. Metagenomic data was compared with sequences in the
KO database using MG-RAST. This approach gave insight into the dominant types of enzymes in
the secondary treatment basins at each WWTF. The results of this analysis, which can be seen
below in Figure 4.8, indicates that the percent abundance of enzyme classes detected across the
WWTF samples remained fairly consistent. Percent abundance, which was calculated for each
class in comparison to the total number of sequence ‘hits’, was highest for “other” enzymes within
the KO database. The most dominant class for each WWTF was the hydrogenase enzyme group,
which constituted approximately 10% of enzyme classes in each WWTF. Transferase enzymes
constituted about 9% in each facility while the synthases comprised about 8% of detected enzymes
in the four facilities.

Figure 4.8: The percent abundance of different enzyme classes found in each treatment facility using the KO database
through MG-RAST. Abundances were calculated from using the total number of sequence ‘hits’ for each WWTF.
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Figure 4.9: The Percent abundance of cellular activity for each WWTF, retrieved from KO databases. Abundances
were calculated from using the total number of sequence ‘hits’ for each WWTF.

It can be seen in figure 4.9 that the major cellular activities occurring in each facility fell under
‘metabolism,’ accounting for around 60% of all cellular activity for each WWTF. This was
followed by genetic information processing, environmental information processing, cellular
processing, human diseases, and lastly organismal systems. A closer look into the metabolic
activities for the samples can be seen in Figure 4.10, below. The results presented in Figure 4.10
indicate that the majority of metabolic activity at each WWTF is associated with amino acid
metabolism. Amino acids have been regarded as the building blocks of proteins, supporting the
survival and growth of microorganisms (Morowitz et al. 2011). Additionally, amino acids are also
described to promote protein homeostasis and energy regulation (Bergen and Wu, 2009, Metges
2000). Metabolism activity related to xenobiotic biodegradation and metabolism accounted for
less than 2% of all metabolic activity at each WWTF (WWTF=1.84% ; WWTF2=1.89% ;
WWTF3=1.8% ; WWTF4=1.86%). ‘Xenobiotic’ is a general term used to describe any compound
or substance that is not native to an organism or ecosystem, and PPCPs fall under this category. It
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was predicted that metabolism related to micropollutant or xenobiotic degradation would comprise
less than 10% of cellular activity for each WWTF.

It is important to note that the categories defined in Figures 4.9 and 4.10 are defined the KO
database used within MG-RAST to evaluate cellular and metabolic activity. It is quite possible
that PPCP-degrading enzymes are present within the other metabolic activity categories (e.g.
amino acid metabolism, energy metabolism). This current chapter focused on the “xenobiotics
biodegradation and metabolism” category from the KO database. Therefore, it import to recognize
that there are thousands of other enzymes included in the categories displayed in Figure 4.10, some
of which may have the ability to catalyze PPCP-degradation reactions, and possibly even enzymes
that play a part in these reactions that have not been identified yet.

Figure 4.10: The percent abundance of metabolic activity for each WWTF.

While there are many enzymes suspected to play a role in the biodegradation of different PPCP
compounds, this study focused on four enzymes that have been described to aid in the degradation
of four compounds highlighted in our research. These compounds included carbamazepine,

90

sulfamethoxazole, DEET, and caffeine. A 2012 study by Keen et al. found that the advanced
oxidation of carbamazepine facilitated catechol deoxygenate in opening the aromatic rings of the
compound, allowing the products to be further mineralized and degraded by microorganisms
within activated sludge. A search for PPCP-degrading enzymes on the Swiss Federal Institute of
Aquatic Science and Technology (EAWAG) Biocatalysis/Biodegradation Database also identified
degradation enzymes of interest (Swiss Federal Institute of Aquatic Science and Technology,
2017).

This

database

indicated

that

trimethylamine

dehydrogenase

and

xanthine

dehydrogenase/oxidase have been documented to degrade DEET and caffeine, respectively.
Additionally, Larcher et al. (2011) described the enzyme arylamine N-acetyltransferase as capable
of degrading sulfamethoxazole, due to its ability to use the antibiotic as a substrate by utilizing its
aromatic amine. An analysis exhibiting the percent abundance of PPCP biodegradation enzymes
of interest discussed in Chapter 1 (Table 1.1) can be seen in Figure 4.11, below. Our findings
suggest that the most abundance degradation enzymes that were targeted based on the literature
presented in Table 1.1 were Catalase-Peroxidase, Nitronate Monooxygenase, and Glutathione
Peroxidase. Current literature indicates that the classes these enzymes belong to can catalyze the
biodegradation of pharmaceuticals (Varga et al. 2019) and emerging organic contaminants (Deng
et al. 2018, Tran et al. 2013).
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Figure 4.11: The relative abundance of enzymes indicated by literature to catalyze PPCP biodegradation. Results are
shown in relative abundance of individual enzymes.

The four enzymes described to degrade carbamazepine, sulfamethoxazole, DEET, and caffeine
were evaluated in the context of the WWTFs sampled in this study. The percent abundance of the
degradation enzymes in each facility can be seen below in Table 4.2. Also presented it the table
are the genes associated with each enzyme, in addition the enzyme identification numbers (EC).
Two types of catechol dioxygenase enzymes were found in the WWTF samples; Catechol 1,2
Dioxygenase and Catechol 2,3 Dioxygenase. Wastewater treatment facility 1 contained the
highest percent abundance of Catechol 1,2 Dioxygenase (0.0062%), while WWTF 4 contained the
highest abundance of Catechol 2,3 Dioxygenase (0.0155%) and Xanthine Dehydrogenase
(0.0063%) . Facility 1 also contained the highest abundance of Trimethylamine Dehydrogenase
(0.0032), while the highest abundance for Arylamine N-Acetyltransferase was observed in WWTF
2 (0.0021%). While the presence of these enzymes in the WWTF microbial samples indicates that
removal of these compounds during treatment processes could be occurring through
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biodegradation, their presence alone does not indicate whether or not a biodegradation pathway is
active.
Table 4.2: Four enzymes that have been suspected to play a role in the degradation of carbamazepine, DEET,
Sulfamethoxazole, and Caffeine. Also included in the table are the genes associated with each enzyme, in addition to
the enzyme identification numbers (EC) and the relative abundance of each enzyme in the WWTFs sampled.
Enzyme
catA; catechol 1,2-dioxygenase [EC:1.13.11.1]
dmpB; catechol 2,3, dioxygenase [EC: 1.13.11.2]

PPCP
Carbamazepine

WWTF 1 WWTF 2 WWTF 3 WWTF 4
0.0062

0.0041

0.0060

0.0033

0.0149

0.0113

0.0129

0.0155

trimethylamine dehydrogenase [EC:1.5.8.2]
nat; arylamine N-acetyltransferase [EC:2.3.1.5]

DEET

0.0032

0.0025

0.0022

0.0019

Sulfamethoxazole

0.0020

0.0021

0.0014

0.0019

XDH; xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]

Caffeine

0.0015

0.0025

0.0014

0.0063

To evaluate the removal efficiency of the four compounds corresponding with the detected
biodegradation enzymes, the percent removal was calculated and plotted alongside enzyme percent
abundance (Figure 4.12). Percent removal was calculated as the difference between secondary
influent and secondary effluent PPCP concentrations (ng/L), divided by the secondary influent
concentration (ng/L). This value was then multiplied by 100 to find percent removal. Enzyme
abundance was calculated by dividing the number of sequence ‘hits’ by the total gene count for
each WWTF sample. The resultant value was then multiplied by 100. DEET and caffeine, both
classified as personal care products, were observed to be removed by greater than 90% for each
facility except for WWTF 2, in which DEET decreased about 79% from secondary influent to
secondary effluent. The greatest percent removal for DEET was observed for WWTF 4 (99.28%).
WWTF 4 had the highest abundance of the caffeine-degrading enzyme Xanthine
Dehydrogenase/Oxidase (0.0063%) and was observed to perform the greatest removal of caffeine
(99.95%) compared to the other WWTFs. The least efficient removal of caffeine was seen in
WWTF 2 (93.93%), a facility that was found to contain about 0.0025% abundance of Xanthine
Dehydrogenase/Oxidase.
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The removal efficiency for the pharmaceuticals carbamazepine and sulfamethoxazole varied
greatly, as can be seen in Figure 4.12. Positive removal for carbamazepine was observed in
WWTFs 2 and 4, at about 44.08% and 83.60% for each facility respectively. Negative removal,
an increase in secondary effluent from influent, was seen in WWTFs 1 and 3. Although WWTF
1 had the highest percent abundance of carbamazepine-degrading enzymes Catechol 1,2
Dioxygenase and Catechol 2,3 Dioxygenase compared to the other facilities (0.021%), this facility
was found to exhibit a significant negative removal of this compound (- 415.5%). WWTF 1 also
contained the highest percent abundance of the sulfamethoxazole-degrading enzyme Arylamine
N-acetyltransferase (0.0032%) and exhibited the greatest percent removal for sulfamethoxazole
(80.40%). Unexpectedly, the lowest removal for sulfamethoxazole was observed in WWTF 2 (64.38%), which contained the highest abundance of arylamine N-acetyltransferase (0.0025%).
Interestingly, while WWTF 1 was observed to have the greatest negative removal of
carbamazepine, this facility had greater than 80% removal for sulfamethoxazole, DEET, and
caffeine. The greatest removal for sulfamethoxazole was seen in WWTF 1 (80.40%) and the
lowest percent removal was observed in WWTF 2 (-64.38%). The highest average percent
removal was seen for WWTF 4, with an average removal of 75.06% for the four target compounds.
These results indicate that WWTF 4, which implements the Bardenpho system for secondary
wastewater treatment, appeared to be the most efficient facility at removing carbamazepine,
sulfamethoxazole, DEET, and caffeine. The results presented in Figure 4.12 indicate that while a
specific WWTF may have a higher abundance of enzymes associate with PPCP biodegradation,
this may not necessarily mean that greater PPCP removal is occurring during treatment. It is also
important to note that this specific analysis focused on only 4 of the 21 compounds detected in the
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four WWTFs, and that there may be many other compounds present that remained below the
detection limit, or that were not included in our PPCP detection analysis.

Figure 4.12: The removal efficiency and enzyme abundance for carbamazepine, sulfamethoxazole, DEET, and
caffeine in the four WWTFs sampled. Blue bars correspond to the left y-axis and indicate percent PPCP removal.
Red dots (•) correspond to the right y-axis and represent the percent abundance of each degradation enzyme
highlighted in Table 4.2. For Carbamazepine, enzyme abundance is representative of the sum of Catechol 1,2
Dioxygenase and Catechol 2,3 Dioxygenase, both enzymes that have been described to catalyze carbamazepinedegradation reactions.

Conclusions and Implications
The findings presented in this study may serve as a foundation for a deeper understanding on the
diversity and function of wastewater microbial communities. Bacteria comprised over 90% of all
microbial samples, while eukaryotes made up less than 10% of each sample, as was hypothesized.
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Archaea was also found to encompass less than 1% of microorganisms within each WWTF. Three
out of the four sludges samples exhibited the highest microbial diversity for their respective
WWTF. The highest species richness was measured in the sludge of WWTF 2, where only one
antibiotic was detected. This same facility also exhibited the highest Shannon Diversity. The
lowest Shannon Diversity index was observed for the sludge sample of WWTF 3, in which three
antibiotics were detected. Interestingly, four antibiotics were detected in the secondary effluent of
WWTF, however this sample had a Shannon Diversity above 4.5 and a species richness of 246,
both of which are relatively high compared to the remaining samples.

While some samples in which a higher number of antibiotics were detected did demonstrate lower
species diversity indices compared to the other samples, more research would be needed to
determine whether or not it the presence of antibiotics that causes lower diversity. Five enzymes
associated with the degradation of four PPCPs were found in small abundances in each facility.
However, this analysis only scratches the surface of the biodegradation enzymes found in
wastewater treatment, a field of research that is still relatively uncharted. The findings of this
study give a glimpse into a complex and diverse microbiome that is not yet fully described. This
research also highlights the potential of wastewater microbial communities to degrade pollutants,
alongside the factors that can influence the efficiently of biodegradation. A deeper exploration of
the wastewater microbiome can lead to advances in wastewater treatment, which can improve the
quality of environmental and human health.

By characterizing the microbial communities found in wastewater treatment unit processes, we
can further understand their metabolic potential, including the presence of enzymes involved in
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PPCP degradation. It is possible that organisms that are found in low abundance contribute to
micropollutant removal, having an advantage through a specialized niche (Saunders et al. 2016).
The microorganisms and the functions they serve ultimately determine the performance of
wastewater treatment (Fang et al. 2018). Microbial diversity has been linked with positive
pollutant removal, and an understanding of the factors influencing how a microbial community is
structured allows for the optimization of biological treatment processes, increased biodiversity,
and improvement of nutrient and pollutant removal (Wu et al. 2019, Zhang et al. 2016). Ma et al.
(2013) indicated that treatment systems were more stable with higher microbial diversity. While
engineers may be able to select microorganisms that are associated with PPCP degradation and
seed treatment systems with these members, the microbial competitors and operational parameters
may hinder their survival. Many factors, such as temperature, pH, solids and hydraulic retention
times, can impact the fate of targeted microorganisms. Therefore, more research dedicated
towards understanding these complex communities is needed. The current study has shed light on
a fraction of the microbial diversity present in wastewater treatment, and more studies dedicated
towards understanding these communities and their associated degradation enzymes is greatly
needed. The next steps within this field of research demand further classification of these
microorganisms, as well as a deeper analysis of the microbial members and the metabolic pathways
responsible for pollutant removal.
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CHAPTER 5
Future Work
Upon reflection on my thesis, the three projects included in my research have highlighted the need
for continued monitoring of PPCPs in surface water, the PPCPs partitioning to sludges in
wastewater treatment that might warrant future monitoring, and the microorganisms and their
enzymes associated with PPCP degradation within wastewater treatment systems. Included in this
chapter is a summary of my findings and recommended future research topics that stem from this
thesis.

Presence and Concentration of an Extended Antibiotic List in the Great Bay Estuary,
New Hampshire
In the analysis of an expanded list of pharmaceuticals and personal care products (PPCPs) in the
Great Bay Estuary (GBE), I determined that select PPCPs were commonly detected in surface
water locations in the seacoast region of New Hampshire. Specifically, carbamazepine and
sulfamethoxazole, an anticonvulsant and antibiotic, respectively, were detected in the Great Bay
Estuary in both 2019 and 2020. These results are concerning because even small concentrations
of antibiotics can have negative effects on aquatic ecosystems and non-target organisms (Meyer
et al. 2019, Petrie et al. 2015, Sörengård et al. 2019). The source of carbamazepine and
sulfamethoxazole could be from wastewater treatment discharge but may also include other
sources unsampled in this thesis (e.g., septic systems). Regardless of their source, given their
human use, their detection in surface water suggests they are not efficiently removed in community
or household wastewater systems. Continued monitoring of these compounds in the GBE would
further our knowledge on the sources, prevalence, and seasonal fluctuation of these compounds.
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Additional monitoring for PPCPs in the GBE may also provide insight into whether COVID-19
lockdown procedures during 2020 and/or 2021 impacted PPCP concentrations and detections and
assist seacoast communities identify sentinel compounds that may pose risk to aquatic species.
Although outside the scope of this thesis, experiments assessing the toxicity of PPCPs is
recommended, especially for mixtures of pharmaceutical compounds common in this region.

Partitioning of 21 Pharmaceuticals and Personal Care Products into Aqueous and
Solid Phases During Wastewater Treatment
An analysis on aqueous and sludge concentrations of PPCPs revealed that pharmaceuticals were
higher in relative abundance compared with personal care products. We measured personal care
products at higher concentrations than pharmaceuticals in all stages of treatment. A review of the
partition coefficient (KD) values for PPCPs analyzed in our study indicated that compounds such
as azithromycin, ciprofloxacin, trimethoprim, phenytoin, primidone, diazepam, fluoxetine, and
DEET should be found at higher abundances in wastewater sludges while the other tested
compounds showed lower KD values in the literature should be found in higher abundance in
aqueous phases.

In accordance with these coefficients, we found a high abundance of

ciprofloxacin and fire retardants in the sludges of four WWTFs sampled, indicating that these
compounds readily sorbed to sludge. Another pharmaceutical detected in sludge samples was
fluoxetine while three personal care products (TCPP, TDCPP, and caffeine) were also commonly
detected in the sludge. Research regarding KD values for fire retardants is needed, as these were
found in high abundances in wastewater sludge yet I as unable to locate KD values for TCPP and
TDCPP in the existing literature.

It is important to note that KD values are determined

experimentally using standard methods (OECD, 2000) and vary based on the type of media used.
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Notably, adsorption coefficients relevant to wastewater sludge may differ considerably from soils
because of system pH, the amount of organic carbon in the solids, and other parameters. As a
result, future experiments could measure adsorption coefficients for PPCPs using solids more
representative of sludge. This is especially important as fire retardants were found in high
abundances in all WWTF sludges in my research, however literature regarding their KD values is
lacking. Research which investigates how PPCPs may be transforming during biological treatment
and disinfection processes is also needed, as we observed a decrease in antibiotics and an increase
in fire retardants in our chlorination and dechlorination samples.

The Microbial Communities and PPCP Degrading Capability of Wastewater Taxa
The 16S rRNA gene sequencing and metagenomics analysis indicated dominant microbial phyla
observed in NH WWTFs were in agreement with those observed in the current literature for other
WWTFs. Non-metric multidimensional scaling (NMDS) indicated that sulfamethoxazole, TCPP,
and DEET exhibited significant influence on microbial classes in wastewater samples, specifically
those communities in the secondary influent. These results indicate that these compounds may
partially drive the composition or diversity of microbial taxa present in certain unit processes of
wastewater treatment.

Sludges in particular, had higher Shannon diversity indices relative to water samples given their
accumulation and recycling within the facility. A better understanding on how composition and
diversity of sludges changes through time, particularly related to operational parameters, could
yield insight into treatment efficiency and processes. While multiple enzymes associated with
PPCP degradation were identified in our study through metagenomic evaluation, my work on this
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subject only scratched the surface of the metabolic potential of wastewater microbial communities
in NH. Wastewater in general is a very complex matrix, sludges even more so, and the use of
advanced analytical techniques could help shed light on the microbial communities of sludges and
the PPCPs they can degrade.

Further investigation into metabolic potential in wastewater

treatment, and which pathways are active, is an area in need of research so we can advance our
understanding on the biotransformation of these compounds during different treatment processes.
We recommend research that targets metabolic pathways of wastewater microbial communities in
order to evaluate how these organisms interact under the influence of varying conditions, including
the presence and concentration of PPCPs.

Conclusions
During the completion of my thesis, I also learned that while I did make contributions to the field
contaminants of emerging concern, this is complex and evolving field of research. Not only are
there many different types of pollutants that are received in municipal wastewater treatment
facilities, but there are so many factors that influence how these compounds behave during
wastewater treatment processes, and ultimately their fate in the environment. The microbial
communities of wastewater also remains an area that scientists and engineers have yet to fully
understand, as these communities can be very complex, and vary across treatment types, processes,
and regions. Additionally, although multiple degradation enzymes were found that could catalyze
PPCP biotransformation in these NH WWTFs, their presence alone does not indicate if these
pathways are active. A combination of advanced fractionation research, enzymatic and
biodegradation analyses, in addition to continued monitoring of PPCPs in wastewater and surface
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water can help advance our knowledge’s on contaminants of emerging concern and their fate in
treatment and the environment.
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APPENDIX A: Supplemental Information for Chapter 1
Table A1.1: The different factors described to influence the removal of PPCPs in wastewater treatment. Green text
indicates the factors that also influence the fractionation of PPCPs to sludge.
Factor
Community the treatment facility serves
Season
Chemical structure & bioavailability of pollutant
Pollutant redox potential
Pollutant pH
Stereo chemical structure of pollutant (molecular
structure)
Pollutant Chemical Properties (complexity stability)
Solubility of pollutant
Volatility of pollutant
Photodegradation
Biodegradability of pollutant

Sludge retention time of WWTF
Hydraulic retenton time of WWTF
pH of WWTF
Temperature of treatment process
Compound Kow (solubility)
WWTF type
Pollutant Physiochemical Properties
Weather/climate (WWTF Location)
WWTF Microbial Activity; Biomass Concentration
Oxidation Reduction Conditions
Sludge Characteristics (pH, Cation concentration
Natural Organic Matter)
Sludge treatment methods
WWTF Operational conditions
Molecular Weight
Kpa
Ionic interactions
Electrostatic reactions
Surface complexation
Sludge Type

Source
Helbling et al., 2015
Tiwari et al., 2017; Verlicchi et al., 2012
Tiwari et al., 2017
Tiwari et al., 2017
Tiwari et al., 2017
Tiwari et al., 2017 (Gaffney et al., 2017)
Dubey et al., 2021; Tiwari et al., 2017; Verlicchi et al., 2012
Tiwari et al., 2017
Tiwari et al., 2017
Tiwari et al., 2017
Mohaptra et al., 2021; Tiwari et al., 2017

Carucci et al., 2006; Chen et al., 2012; Clara et al., 2005;
Gaffney et al., 2017; Jelic et al. 2011; Kreuzinger et al., 2004;
Pomies et al., 2013; Strenn et al., 2004; Suarez et al., 2010;
Tiwari et al., 2017; Tiwari et al. 2018
Archer et al. 2017; Blair et al. 2015; Chen et al. 2012; Gaffney
et al., 2017; Pomiés et al. 2013; Tiwari et al. 2017,
Dubey et al., 2021; Horsing et al., 2011; Polesel et al., 2015;
Pomiés et al., 2013; Twiari et al., 2017
Dubey et al. 2021; Gaffney et al. 2017; Liu et al. 2016; Pomies
et al. 2013; Tiwari et al. 2017
Angeles et al., 2020; Mohaptra et al., 2021; Pomiés et al., 2013;
Tiwari et al., 2017
Gaffney et al., 2017
Archer et al., 2017; Gaffney et al., 2017; Pomiés et al., 2013;
Rostvall et al., 2018
Archer et al., 2017; Gaffney et al., 2017 (Verlicchi et al., 2012)
Archer et al., 2017; Gaffney et al., 2017
Pomies et al., 2013
Chen et al., 2012; Jelic et al., 2011
Chen et al., 2012, Pomiés et al., 2013
Dubey et al., 2021
Mohaptra et al., 2021
Mohaptra et al., 2021
Blair et al., 2015
Polesel et al., 2015
Polesel et al., 2015
Horsing et al., 2011
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Table A1.2: The factors described to influence the microbial taxa and communities in wastewater treatment.
Factor
Pollutant Concentration
Dissolved Oxygen
Temperature
pH
Wastewater characteristics

WWTF operational parameters
Influent total phosphorous
biological oxygen demand
NH4+, total nitrogen, total
phosphorous
Climate; latitude, altitude;
geographical location
Process type
Ecosystem size
Ozone treatment
Seasons
Influent characteristics
Aeration efficiencies
Local human gut microbiome
Biotic interactions (competition,
cooperation)
Local weather effects (rainfall)
watershed effects (soil
composition)
Chemical stress
Reactor scale

Solids retention time
Influent chemical oxygen
demand
biological interactions

Source
Tian and Wang 2020
Tian and Wang 2020
Tian and Wang 2020; Wu
et al., 2019
Tian and Wang 2020
Tian and Wang 2020
Cydzik et al., 2016;
Isazadeh et al., 2016;
Tian and Wang 2020;
Tiwari et al., 2017
Tian and Wang 2020
Tian and Wang 2020; Wu
et al., 2019
Tian and Wang 2020
Isazadeh et al., 2016; Wu
et al., 2019, Tian and
Wang 2020
Tian and Wang 2020
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016
Isazadeh et al., 2016;
Tiwari et al., 2017; Wu et
al., 2019
Wu et al., 2019
Cydzik et al., 2016
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Table A1.3: The microbial taxa associated with degrading antibiotics, specifically sulfonamides and their
corresponding references.
Class/Compound

Microbial Species

Source

Biodegradation efficiency Notes

Kassotaki et al. 2016
Pan et al. 2017
Reis et al. 2018
Reis et al. 2018
Reis et al. 2018
Reis et al. 2018
Reis et al. 2018
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Herzog et al. 2013
Jiang et al. 2014
Reis et al. 2014
Deng et al. 2016
Deng et al. 2016
Mulla et al. 2016
Mao et al. 2018
Mao et al. 2018
Reis et al. 2014
Liao et al. 2016
Liao et al. 2016
Liao et al. 2016
Liao et al. 2016

degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation

Microbacterium sp. BR1
Rhodococcus sp. BR2
Achromobacter sp. BR3
Ralstonia sp. HB1
Ralstonia sp. HB2
Achromobacter sp. S-3
Brevundimonas sp. SMXB12
Microbacterium sp. (SMXB24, SMX348)

Bouju et al., 2012; Ricken et al., 2013;
Birkigt et al., 2013
Bouju et al., 2012
Bouju et al., 2012
Bouju et al., 2012
Bouju et al., 2012
Huang et al., 2012
Herzog et al. 2013
Herzog et al. 2013

mineralization, biodegradation
mineralization
mineralization
mineralization
mineralization
degradation
degradation
degradation

Pseudomonas sp. (SMX321, SMX330, SMX331,
SMX 333*, SMX 336*, SMX 342*, SMX344*,
SMX345)
Variovorax sp. SMX332
Pseudomonas psychrophila HA-4
Achromobacter denitrificans PR1
Acinetobacter sp. W1
Rhodopirellula baltica
Methylibium petroleiphilum PM1
Micrococcus luteus
Delftia acidovorans
Oligotropha carboxidovorans
Achromobacter
Pseudomonas
Betaproteobacteria (mainly Thauera)
Clostridia
Bacteroidia

Herzog et al. 2013
Herzog et al. 2013
B.C. Jiang et al. 2014
Reis et al. 2014, Nguyen et al. 2017
Wang and Wang 2018
Yan et al. 2012
Yan et al. 2012
Yan et al. 2012
Yan et al. 2012
Yan et al. 2012
Wang et al. 2015
Wang et al. 2015
Miran et al. 2018
Miran et al. 2018
Miran et al. 2018

degradation
degradation
degradation
degradation
degradation, mineralization
degradation
mineralization
mineralization
degradation, mineralization
mineralixation, degradation
degradation
degradation
degradation
degradation
degradation

Achromobacter denitrificans strain PR1
Bacillus subtilis
Pseudomonas aeruginosa
Rhodococcus equi
Microbacterium sp. SMXB24
Brevundimonas sp. SMXB12
Achrombacter sp. BR3
Pseudomonas psychrophila HA-4
Acinetobacter sp. W1
pseudomonas
achromobacter
Alcaligenes faecalis

Nguyen et al. 2017, Nguyen et al. 2017
Larcher and Yargeau 2011
Larcher and Yargeau 2011
Larcher and Yargeau 2011
Herzog et al. 2013
Herzog et al. 2013
Bouju et al. 2012
Jiang et al. 2014
Wang and Wang, 2018
Jiang et al. 2014, Yang et al. 2018
Jiang et al. 2014, Yang et al. 2018
Zhang et al. 2016

degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
degradation
enhanced removal

Micropollutants

(Ammonia Oxidizing Bacteria (AOB)
Geobacillus thermoleovorans S-07
Actinobacteria
Proteobacteria
Leucobacter strain GP
Leucobacter genus
A. denitrificans strain PR1
Brevundimonas sp. SMXB12
Microbacterium sp. SMXB24
Microbacterium sp. SMX348
Pseudomonas sp. SMX321
Pseudomonas sp. SMX330
Suldonamide Antibiotics Pseudomonas sp. SMX331
Pseudomonas sp. SMX344
Pseudomonas sp. SMX345
Variovorax sp. SMX332
Pseudomonas psychrophila HA-4
Achromobacter denitrif icans PR1
Arthrobacter sp. D2
Arthrobacter sp. D4
Methylobacterium sp. SDZ-W2-SJ40
S. Oneidensis MR-1
Shewanella sp. strain MR-4
Achromobacter denitrificans PR1
Firmicutes phylum
Bacteroidetes Phylum
Sulfanimalide
Flavobacteria Class
Bacilli Class

Sulfamethoxazole

Highlights Sulfamethoxazole

particularly sulfamethoxazole
particularly sulfamethoxazole
particularly sulfamethoxazole
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Table A1.4: A compiled list of the KD Values found within the existing literature for the PPCPs included in thesis
research.
Analyte
Acetaminophen
Amoxicillin

Range

Source
Kreuzig R et al; Fresnius Environ Bull 12: 550-8 (2003)
Jones et al. 2002
Giebułtowic et al. 2020
Sidhu et al. 2019
Azithromycin
2.4472-7.1
Joss et al. 2006
Gobel et al. 2005
Abegglen et al. 2009
Giebułtowic et al. 2020
Ciprofloxacin
2.5527-7.3
Golet et al. 2003
Sidhu et al. 2019
Hörsing et al. 2011
Hörsing et al. 2011
Hörsing et al. 2011
Giebułtowic et al. 2020
Yang et al. 2019
Fernandez-Fontaina et al. 2012b
Sulfamethoxazole
0.98722-5.1
Abegglen et al. 2009
Stevens-Garmon et al. 2011
Radjenovic et al. 2009
Joss et al. 2006
Gobel et al. 2005
Hyland et al. 2012
Hörsing et al. 2011
Hörsing et al. 2011
Hörsing et al. 2011
Giebułtowic et al. 2020
Fernandez-Fontaina et al. 2012b
Trimethoprim
1.4048-4.8
Stevens-Garmon et al. 2011
Hyland et al. 2012
Gobel et al. 2005
Xue et al. 2010
Radjenovic et al. 2009
Abegglen et al. 2009
Jones et al. 2002
Yang et al. 2019
Fernandez-Fontaina et al. 2012b
Abegglen et al. 2009
Ternes et al. 2004
Carbamazepine
<0-2.1303
Wick et al. 2009
Urase and Kikuta 2005
Stevens-Garmon et al. 2011
Hyland et al. 2012
Radjenovic et al. 2009
Hörsing et al. 2011
Phenytoin (Dilantin)
1.5051-3.6628
Stevens-Garmon et al. 2011
Hyland et al. 2012
Hörsing et al. 2011
Primidone
<1.477-3.2041
Stevens-Garmon et al. 2011
Abegglen et al. 2009
Hörsing et al. 2011
Jones et al. 2002
Atenolol
(-0.6778) to (3.2788) Wick et al. 2009
Stevens-Garmon et al. 2011
Radjenovic et al. 2009
Methadone
1.8808
Wick et al. 2009
Hörsing et al. 2011
Ternes et al. 2004
Diazepam
1.3010-4
Wick et al. 2009
Hyland et al. 2012
Stevens-Garmon et al. 2011
Hörsing et al. 2011
Meprobamate
<1.4771-3.7782
Stevens-Garmon et al. 2011
Hörsing et al. 2011
Stevens-Garmon et al. 2011
Fluoxetine
0.69897-3.7559
Munoz et al. 2009
Hyland et al. 2012
Atorvastatin
1.9685-2.2967
Stevens-Garmon et al. 2011
TCEP
1.8129-2.3636
Stevens-Garmon et al. 2011
TCPP
TDCPP
Hyland et al. 2012
DEET
<1.4771-3.3784
Stevens-Garmon et al. 2011
Xue et al. 2010
Stevens-Garmon et al. 2011
Caffeine
<1.4771-2.7482
Xue et al. 2010
Cotinine
1.6232
0.0253

Media
test sludge
sludge
sludge
biosolids (referring to sludge)
activated sludge
activated sludge
activated sludge
sludge
activated sludge
biosolids (referring to sludge)
primary sludge
secondary sludge, long sludge age
secondary sludge, short sludge age
sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
primary sludge
secondary sludge, long sludge age
secondary sludge, short sludge age
sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
primary sludge
activated sludge
activated sludge
secondary sludge, long sludge age
activated sludge
activated sludge
secondary sludge, short sludge age
sludge
activated sludge
activated sludge
activated sludge
activated sludge
primary sludge
activated sludge
activated sludge
activated sludge
activated sludge
secondary sludge, long sludge age
activated sludge
secondary sludge, short sludge age
activated sludge
activated sludge
activated sludge
activated sludge
activated sludge

activated sludge
activated sludge
activated sludge
activated sludge
activated sludge
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APPENDIX B: Supplemental Information for Chapter 2
Table B1.1: The detections for specific compounds for the WWTFs sampled (indicated by their secondary treatment
processes), including aqueous and solid phases, and surface water detections. A red Asterix indicates that a compound
is frequently detected in the environment. Inf indicates an influent sample, while eff indicates an effluent sample. BL
indicates a potential lab blank concentration. While indicates a compound was note detected in a specific sample,
blue indicates a compound was detected and blue indicates a decreased concentration from influent to effluent. Red
in indicative of an increased concentration of a compound from effluent to influent, which may be described as
“negative removal.” Table sourced from Hidrovo et al. (2020).
Aqueous Phase
Compound
Class

AL+CD: March
Bar-4 +CD1: July

General
Name

Influent

Bar-4 +CD2

Effluent Influent

Bar-4 +CD3

Effluent Influent

Effluent

AS +
UV2

OD + CD

March Influent Effluent

March

Mar. July Mar. July Mar. July Mar. July Mar. July Mar. July Infl Effl Mar.July Mar. July Infl Effl
Analgesic

Great Bay Surface Water

Solid Phase
AS +
UV1

Bar-4 + Bar-4 + Bar-4 +
CD1
CD2
CD3

OD +
CD

Sludge

Sludge

Sludge

Sludge

July

July

July

July

Hilton
Park

Hilton
Park

Mill
Pond

Adams
Point

Great
Bay

Squam
-scott

Mar.

July

Aug.

Aug.

Aug.

Aug.

Acetaminophen*
Amoxicillin
Azithromycin

Antibiotic

Ciprofloxacin*

BL

BL

BL

BL

Pharmaceuticals

Sulfamethoxazole*
Trimethoprim*
Anticonvulsant

Phenytoin
Primidone

B-blocker

Atenolol*

Narcotic

Methadone

Sedative

Personal Care Products

Carbamazepine*

BL

Diazepam*
Meprobamate

SSRI

Fluoxetine*

Statin

Atorvastatin

Flame
retardants

TCEP*

BL

TCPP*

BL

TDCPP
Insecticide

DEET*

Stimulant
Tobacco
metabolite

Caffeine*
Cotinine*

BL

BL

BL

BL

BL

Table B1.2: Concentrations (in ng/L) of PPCPs detected in surface water locations sampled in March, July, and
August of 2019. A red concentration indicates that there was blank contamination. Table adapted from Hidrovo et
al. (2020).
Class

Analyte

Analgesic

Pharmaceuticals

Antibiotic

Anti-convulsant
B-blocker
Narcotic
Sedative

Personal Care
Products

SSRI
Statin
Flame retardants
Insectict Repellent
Stimulant
Tobacco metabolite

Acetaminophen
Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Carbamazepine
Phenytoin
Primidone
Atenolol
Methadone
Diazepam
Meprobamate
Fluoxetine
Atorvastatin
TCEP
TCPP
TDCPP
DEET
Caffeine
Cotinine

Hilton
Park
(Mar.)

Hilton
Mill Pond
Adams
Park (July) (Aug.) Point (Aug.)

Great
Bay
(Aug.)

Squamscott
(Aug.)

18.0

5.8
3.5
2.8

11.0
13.0

8.7
3.6

1.1

4.5

2.1

5.4

1.7

1.2

22.0
3.9
8.5
60.0

3.6
39
18
29
17
3.7

16.0
1.9
15.0
140.0

16.0
16.0
120.0

14.0
2.1
16.0
63.0
2.2

28.0
3.8
28.0
150.0
2.8
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Table B1.3: Detection concentrations for the five PPCPS detected in surface water locations in the year of 2020. GBE
indicates the Great Bay Estuary. A dash indicates that a compound was not detected at a specific location.

Class

Analyte
Clarithromycin
Antibiotics
Sulfamethoxazole
Anti-convulsant
Carbamazepine
Calcium Channel Blocker Diltiazem
Antihistamine
Diphenhydramine

Hilton
-

GBE
1.25

-

-

Squamscott
1.6
0.985
11.6
8.48
1.03
0.653
1.47

Table B1.4: Subset of the antibiotics in focus for this study, and their common medical applications.
General Name

Medical Usage

Ear, nose, and throat infections
Genitourinary tract infecftions
Amoxicillin
Skin infections
Lower respiratory tract infections
Skin infections
Acute bacterial sinitis
Chronic bronchitis
Azithromycin
Community-acquired pneumonia
Pharyngitis/tonsillitis
Acute otitis media (ear infection)
Urinay Tract Infections
Skin infections
Lower respiratory tract infections
Ciprofloxacin
Anthrax
Plague
Cholera
Bacterial Mengitis
Pharyngitis
Acute sinus infection
Aommunity-acquired pneumonia
Clarithromycin
Mycobacterium avium complex (MAC)
Respiratory tract infections
Skin, soft-tissue infections
Urinary infectinos
Sulfamethoxazole Respiratory infections
Gastrointestinal tract infections
Trimethoprim Often prescribed alongside sulfamethoxazole

Source
National Library of Medicine
National Library of Medicine
National Library of Medicine
National Library of Medicine
Clinical Info.HIV.gov
Clinical Info.HIV.gov
Clinical Info.HIV.gov
Clinical Info.HIV.gov
Clinical Info.HIV.gov, National Library of Medicine
National Library of Medicine
Clinical Info.HIV.gov
Clinical Info.HIV.gov
Clinical Info.HIV.gov
National Library of Medicine
National Library of Medicine
National Library of Medicine
National Library of Medicine
Clinical Info.HIV.gov
Clinical Info.HIV.gov
Clinical Info.HIV.gov
Clinical Info.HIV.gov
National Library of Medicine
National Library of Medicine
National Library of Medicine
National Library of Medicine
National Library of Medicine
National Library of Medicine

Table B1.5: Water quality field parameters taken at each surface water sampling location, including one field blank,
at the start and end of sampling. Parameters measured include pH, redox potential, conductivity, dissolved oxygen
(DO), and temperature.
Location
Hilton Park
Mill Pond
Adams Point
Great Bay Estuary
Squamscott
Field Blank

Start of Sampling
End of Sampling
pH Redox (mV) Conductivity (uS/cm) DO (% saturation) DO (mg/L) Temperature (°C) pH Redox (mV) Conductivity (uS/cm) DO (% saturation) DO (mg/L) Temperature (°C)
7.96
-69.9
44.22
84.3
6.3
22.5 8.17
-82.9
44.34
73.3
5.45
22.5
8.02
-73.2
149.1
22.3
4.27
21.7 8.02
-73.5
151.5
84
4.23
22.7
8.06
-75.8
42.65
85
6.24
23.6 8.09
-77.9
42.91
81.2
5.92
24
8.08
-76
137.1
86.5
4.32
24.4 8.16
-81.2
42.5
82.1
6.03
23.7
7.21
-27.5
29.11
63.5
4.27
24.6 7.25
-29.3
29.05
59.9
4.23
25.5
6.1
37.4
36.17
76.4
5.92
29.1 6.25
28.9
35.18
80.6
6.22
29.5
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Table B1.6: The water quality measurements for each surface water sample, including field and blanks, for ammonia
nitrogen, chemical oxygen demand, and orthophosphate. Also included are the detection limits for each measurement.
Location
Ammonia, Nitrogen (mg/L) Chemical Oxygen Demand (mg/L) Orthophosphate (mg/L)
Hilton Park
0.0695
68.8
0.080
Mill Pond
0.106
69.9
0.060
Adams Point
0.0585
79.5
0.030
Great Bay Estuary
0.0697
59.1
0.060
Squamscott
0.157
30.7
0.070
Field Blank
-0.005000
-79.2
0.025
Lab Bank
-0.00133
-22.4
Standard
10.3
81.6
Detection limit
1-12 mg/L NH3-N
3-150 mg/L COD
0.02-2.50 mg/L PO4 3-
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APPENDIX C: Supplemental Information for Chapter 3
Table C1.1: The average detected concentrations of pharmaceuticals and personal care products and the average
parts per billion (PPB) concentrations of pharmaceuticals and personal care products in aqueous and sludge samples.
Numbers shown represent and average of each class across the four WWTFs.
Average Detected Concentration Across Wastewater Treatment Facilities
PPCP Group
Secondary Influent (ng/L) Secondary Effluent (ng/L) Chlorination (ng/L) Dechlorination (ng/L) Sludge (ug/kg)
Pharmaceuticals
4868
367.3
77.86
88.82
23.36
Personal Care Products
9217
668.4
373.2
356.2
42.72
Average Concentration by Weight Across Wastewater Treatment Facilities
PPCP Group
Secondary Influent (PPB) Secondary Effluent (PPB) Chlorination (PPB) Dechlorination (PPB) Sludge (PPB)
Pharmaceuticals
0.487
0.0367
0.007786
0.008882
2.336
Personal Care Products
0.922
0.0668
0.03732
0.03562
4.272

Table C1.2: The detections for secondary influent (Sin), secondary effluent (Sout), chlorination (chl), dechlorination
(Dchl), and sludge (SLG) for each WWTF. Aqueous detections presented in ng/L and sludge detections presented in
ug/kg. An orange box indicates the detection of a specific compound for a sample, and a gray box with “BDL”
indicates that a particular compound was below detection limit. Numbers in red indicate blank contamination.
Detected

Classification
Analgesic

Pharmaceuticals

Antibiotic

Anti-convulsant
B-BDLocker
Narcotic
Sedative

Personal Care
Products

SSRI
Statin
Flame retardants

Insect Repellent
Stimulant
Tobacco metabolite

WWTF 1

Compound
Acetaminophen
Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Carbamazepine
Phenytoin (Dilantin)
Primidone
Atenolol
Methadone
Diazepam
Meprobamate
Fluoxetine
Atorvastatin
TCEP
TCPP
TDCPP
DEET
Caffeine
Cotinine

Sin
BDL
BDL
BDL

Sout

190000 BDL
BDL
BDL
97
92
2500

BDL
BDL
BDL
BDL
BDL
BDL

BDL
BDL
2100 BDL
BDL
BDL

390
64
1200
500
1700
26000
880

Chl

BDL
BDL
BDL
4000 BDL
500
650
490

BDL
0
1400
120
220
2100
3400
140
100
480

WWTF 2
Dchl
BDL
BDL

8
0
300
59
110
150
2
BDL
6
31
1 BDL
58
2100
410
100
64
31

SLG

BDL
BDL
87 BDL
19
17 BDL
0 BDL
320 BDL
91 BDL
110 BDL
170 BDL
2 BDL
BDL
130 BDL
71
BDL
43 BDL
1500
430
110
55 BDL
12 BDL

Sin

18

8

68
13
1

16000
0
140
46
590
140
73
19
170
570
2.7
3.8
79
46
79
80
2100
180
1600
28000
160

Sout

Chl

BDL
BDL
BDL

BDL
BDL
4400
330
260 BDL
120

BDL
BDL
BDL
BDL
BDL
BDL
500
280 BDL
BDL
1400
1200
330
1700
710

WWTF 3
Dchl

BDL
BDL
20 BDL
10 BDL
5
BDL
68
11 BDL
78
240
1.2 BDL
1.7
8.7
31
BDL
37
1000
210
120
25
6.4

SLG

Sin

BDL
BDL
BDL

BDL
580

690
340
86
350
76 BDL
160
1700
110

14 BDL
BDL
67 BDL
1.1
60 BDL
230 BDL
BDL
1.6 BDL
22 BDL
44
BDL
51 BDL
1300
150
150
23
12 BDL

Sout

29000 BDL
9400

BDL
21

150
19
1
5

130
150
720
51
12000
520
6500
68000
600

BDL
830 BDL
200
130
540
170
220
BDL
57
110
97
1.3 BDL
16
96
120
45
1400
400
69
45
84

Chl

Dchl
BDL
BDL
140
30
250
88
230
67
160
66
BDL

23
73
18
48
1300
480
110
250
43

Not Detected

WWTF 4
SLG

BDL
BDL
150 BDL
41
250
100
270
130
61 BDL
190 BDL
78
BDL
21 BDL
81
15 BDL
42 BDL
1200
490
40
23
51 BDL

Sin

Sout

22000 BDL
6000
350
44
1200
1.4
2500
8.6
470
2.1
920
2.9
150
260
1500
3.1
55
BDL
BDL
11
49
220
400
230
260
1300
100
1500
4.2
9600
42
58000
440

BDL
3500 BDL
250
300
410
270
760
210
69
90
57
BDL
2.6
160
320
81
1400
600
69
28
41 BDL

Chl

Dchl

SLG

BDL
BDL
170
38
540
150
850
79
140
220
46

260
66
370
140
820
120
97
280
57
BDL

3.1
130
19
85
1600
790
67
23

BDL
BDL
18
580
BDL
7.6
6
BDL
BDL
BDL
1.9

BDL
47
200
30 BDL
67 BDL
1800
880
73
22
24

0
49

230
84
17
31
0
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Table C1.3: WWTF 1 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent
abundance by weight in sludge. BDL indicates a specific analyte was below the detection limit. Numbers in red
indicate blank contamination. Atomic masses retrieved from PubChem (PubChem 2021).
Compound
Acetaminophen
Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Carbamazepine
Phenytoin (Dilantin)
Primidone
Atenolol
Methadone
Diazepam
Meprobamate
Fluoxetine
Atorvastatin
TCEP
TCPP
TDCPP
DEET
Caffeine
Cotinine

WWTF 1
BDL
BDL
BDL
44
1.4
8.6
2.1
2.9
BDL
BDL
3.1
BDL
BDL
49
BDL
BDL
260
100
4.2
42
BDL

Atomic
Average by Atomic Percent Abundance
Mass (g/mol) Weight (mole/kg)
by Weight
151.16
0
0
365.4
0
0
749
0
0
331.34
1.328E-07
11.49
253.28
5.527E-09
0.4782
290.32
2.962E-08
2.563
236.27
8.888E-09
0.7690
252.27
1.150E-08
0.9946
218.25
0
0
266.34
0
0
309.4
1.002E-08
0.8668
284.74
0
0
218.25
0
0
309.33
1.584E-07
13.70
558.6
0
0
250.19
0
0
790.8
3.288E-07
28.44
430.9
2.321E-07
20.08
191.27
2.196E-08
1.900
194.19
2.163E-07
18.71
176.21
0
0
TOTAL:
1.156E-06

Table C1.4: WWTF 2 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent
abundance by weight in sludge. BDL indicates a specific analyte was below the detection limit. Numbers in red
indicate blank contamination. Atomic masses retrieved from PubChem (PubChem 2021).
Compound
Acetaminophen
Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Carbamazepine
Phenytoin (Dilantin)
Primidone
Atenolol
Methadone
Diazepam
Meprobamate
Fluoxetine
Atorvastatin
TCEP
TCPP
TDCPP
DEET
Caffeine
Cotinine

WWTF 1
BDL
BDL
BDL
44
1.4
8.6
2.1
2.9
BDL
BDL
3.1
BDL
BDL
49
BDL
BDL
260
100
4.2
42
BDL

Atomic
Average by Atomic Percent Abundance
Mass (g/mol) Weight (mole/kg)
by Weight
151.16
0
0
365.4
0
0
749
0
0
331.34
1.328E-07
11.49
253.28
5.527E-09
0.4782
290.32
2.962E-08
2.563
236.27
8.888E-09
0.7690
252.27
1.150E-08
0.9946
218.25
0
0
266.34
0
0
309.4
1.002E-08
0.8668
284.74
0
0
218.25
0
0
309.33
1.584E-07
13.70
558.6
0
0
250.19
0
0
790.8
3.288E-07
28.44
430.9
2.321E-07
20.08
191.27
2.196E-08
1.900
194.19
2.163E-07
18.71
176.21
0
0
TOTAL:
1.156E-06
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Table C1.5: WWTF 3 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent
abundance by weight in sludge. BDL indicates a specific analyte was below the detection limit. Numbers in red
indicate blank contamination. Atomic masses retrieved from PubChem (PubChem 2021).
Compound
Acetaminophen
Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Carbamazepine
Phenytoin (Dilantin)
Primidone
Atenolol
Methadone
Diazepam
Meprobamate
Fluoxetine
Atorvastatin
TCEP
TCPP
TDCPP
DEET
Caffeine
Cotinine

WWTF 3
BDL
BDL
18
580
BDL
7.6
6
BDL
BDL
BDL
1.9
BDL
BDL
49
BDL
BDL
230
84
17
31
BDL

Atomic
Average by Atomic Percent Abundance
Mass (g/mol) Weight (mole/kg)
by Weight
151.16
0
0
365.4
0
0
749
2.403E-08
8.819E-01
331.34
1.750E-06
64.24
253.28
0
0
290.32
2.618E-08
0.9607
236.27
2.539E-08
0.9319
252.27
0
0
218.25
0
0
266.34
0
0
309.4
6.141E-09
0.2254
284.74
0
0
218.25
0
0
309.33
1.584E-07
5.813
558.6
0
0
250.19
0
0
790.8
2.908E-07
10.67
430.9
1.949E-07
7.154
191.27
8.888E-08
3.262
194.19
1.596E-07
5.858
176.21
0
0
TOTAL:
2.725E-06

Table C3.6: WWTF 1 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent
abundance by weight in sludge. BDL indicates a specific analyte was below the detection limit. Numbers in red
indicate blank contamination. Atomic masses retrieved from PubChem (PubChem 2021).
Compound
Acetaminophen
Amoxicillin
Azithromycin
Ciprofloxacin
Sulfamethoxazole
Trimethoprim
Carbamazepine
Phenytoin (Dilantin)
Primidone
Atenolol
Methadone
Diazepam
Meprobamate
Fluoxetine
Atorvastatin
TCEP
TCPP
TDCPP
DEET
Caffeine
Cotinine

WWTF 4
BDL
BDL
BDL
18
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
8
BDL
BDL
68
13
1
BDL
BDL

Atomic
Average by Atomic Percent Abundance
Mass (g/mol) Weight (mole/kg)
by Weight
151.16
0
0
365.4
0
0
749
0
0
331.34
5.432E-08
26.84
253.28
0
0
290.32
0
0
236.27
0
0
252.27
0
0
218.25
0
0
266.34
0
0
309.4
0
0
284.74
0
0
218.25
0
0
309.33
2.619E-08
12.94
558.6
0
0
250.19
0
0
790.8
8.599E-08
42.48
430.9
3.017E-08
14.90
191.27
5.751E-09
2.841
194.19
0
0
176.21
0
0
TOTAL:
2.024E-07
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Carbamazepine
7

Secondary Effluent pH

7
7
R² = 0.0635

7
7
7
7
6
0

100

200
300
400
500
600
Secondary Effluent Concentration (ng/L)

700

800

Figure C3.1: A correlation analysis comparing secondary effluent concentrations of
carbamazepine (ng/L) versus secondary effluent pH levels in the four WWTFs sampled. R2 value
indicates there is an insignificant correlation between the two measurements.
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APPENDIX D: Supplemental Information for Chapter 4
Table D1.1: The 21 PPCPs screened in our analysis and their detections in each wastewater sample analyzed, in ng/L.
WWTF is indicated by the number in front of the sample ID.
PPCP Detected (ng/L)
Sample ID Acetaminophen Atorvastatin Meprobamate Phenytoin (Dilantin) Ciprofloxacin TCEP Azithromycin Primidone Atenolol Sulfamethoxazole Fluoxetine Amoxicillin Caffeine Trimethoprim Carbamazepine Diazepam TCPP Cotinine DEET TDCPP Methadone
1-Sin
190000
0
0
0
97
92
2500
0
0
2100
0
0
0
0
390
64 1200
500 1700 26000
880
1-Sout
0
0
0
4000
500 650
490
0
0
0
0
0
0
1400
120
220 2100
3400
140
100
480
1-SLG
0
0
0
18
0
0
0
0
0
0
0
0
0
8
0
0
68
13
1
0
0
2-Sin
16000
0
140
46
590 140
73
19
170
570
2.7
3.8
79
46
79
80 2100
180 1600 28000
160
2-Sout
0
0
0
4400
330 260
120
0
0
0
0
0
0
500
280
0 1400
1200
330
1700
710
2-SLG
0
0
0
580
0
0
0
1.1
0
0
0
0
0
21
0
0
150
19
1
5
0
3-Sin
29000
9400
0
690
340
86
350
76
160
1700
110
0
130
150
720
51 12000
520 6500 68000
600
3-Sout
0
830
200
130
540 170
220
0
57
110
97
1.3
16
96
120
45 1400
400
69
45
84
3-SLG
0
0
0
44
1.4
8.6
2.1
2.9
0
0
3.1
0
0
49
0
0
260
100
4.2
42
0
4-Sin
22000
6000
350
1200
2500 470
920
150
260
1500
55
0
11
220
400
230 1300
1500 9600 58000
440
4-Sout
0
3500
250
300
410 270
760
210
69
90
57
0
2.6
160
320
81 1400
600
69
28
41
4-SLG
0
0
18
580
0
7.6
6
0
0
0
1.9
0
0
49
0
0
230
84
17
31
0

Table D1.2: The number of ‘hits’ and percent abundances identifying as Archaea,
Bacteria, and Unassigned from 16s rRNA Sequencing.
WWTF
WWTF 1
WWTF 2
WWTF 3
WWTF 4

Number of Sequence 'Hits'
Percent Abundance
Archaea
Bacteria
Unassigned
Archaea
Bacteria
Unassigned
0
30893
8
0 99.9741109 2.5889E-06
0
20771
0
0
100
0
0
39493
18
0 99.9544431 4.5557E-06
11
48166
21 0.02282252 99.9336072 4.357E-06

Table D1.3: The number of ‘hits’ and percent abundances identifying as Archaea,
Bacteria, Eukaryota, Viruses, and Other from Metagenomics Illumina Sequencing.
WWTF Archaea
WWTF 1
46443
WWTF 2
38437
WWTF 3
45437
WWTF 4
45162

Number of Sequence 'Hits'
Bacteria Eukaryota Viruses Other Archaea
8562026
76013
2861
661 0.534564671
7146595
87099
3451
528 0.528263042
7666618
86261
3027
564 0.582383256
8501492
84546
3837
715 0.522965458

Percent Abundance
Bacteria
Eukaryota
Viruses
98.54997765 0.874919026 0.032930464
98.21999667 1.19705447 0.047429189
98.26594959 1.105639942 0.038798207
98.44530042 0.97902302 0.044431568

Other
0.007608192
0.007256625
0.007229002
0.008279534
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Table D1.4: The dimensions and NMDS values calculated from an NMDS in
R studio evaluating the microbial classes within each WWTF sample.
WWTF ID
1
1
1
1
1
2
2
2
2
2
2
2
3
3
3
3
3
3
3
4
4
4
4
4
4
4

ID
Sin
Sout
Sludge
BH
AH
Sin
Sout
Z1
Z2
Z3
Z4
Sludge
Sin
Sout
Z1
Z2
Z3
Z4
Sludge
Sin
Sout
Z1
Z2
Z3
Z4
Sludge

Dim1
-0.2352465
-0.3095274
-0.2858866
-0.2904855
-0.2917918
-0.2591534
7.3734571
-0.286258
-0.3206816
-0.3067278
-0.3103297
-0.2929518
-0.2439664
-0.3236393
-0.2914827
-0.3040896
-0.3121793
-0.3056802
-0.3420225
-0.2630175
-0.302574
-0.303276
-0.2963754
-0.3246966
-0.2995398
-0.2718777

Dim2
-0.2021096
-0.2090716
-0.2297647
-0.2179615
-0.2152291
-0.2371745
5.478038
-0.2075814
-0.2385042
-0.2292846
-0.2271139
-0.2336118
-0.2679149
-0.2093939
-0.2067715
-0.2198512
-0.2199938
-0.2041389
-0.1637471
-0.1987787
-0.2147509
-0.2067287
-0.2268361
-0.2401997
-0.2195295
-0.2319962

NMDS1
-1.258719176
0.267959775
0.241556513
0.255752811
0.21850501
-0.505821548
-0.086544094
0.076903132
0.075529355
0.120943868
0.167135196
0.003347266
-1.187532811
0.310999944
0.363490041
0.397694021
0.324216884
0.344394582
-0.006830318
-1.207862081
0.227308256
0.30109154
0.24746239
0.263773745
0.260816629
-0.21557093

NMDS2
0.04341799
-0.17400149
-0.14311801
-0.16929968
-0.15637172
0.42399761
-0.33609144
0.23182328
0.07391132
0.23100353
0.21542487
0.52616443
-0.09921475
-0.08081971
-0.07880531
-0.10747243
-0.11114889
-0.10611917
-0.73666248
-0.18184885
0.08734252
0.14550154
0.12008626
0.11348469
0.14865617
0.12015973

Table D1.5:The water quality parameters for secondary influent and secondary effluent samples at each WWTF.
WWTF is indicated by the number in front of the sample ID. DO=dissolved oxygen, REDOX=oxidation reduction
potential, Temp=temperature, COD=chemical oxygen demand, NPOC=non-purgeable organic carbon, TDN=total
dissolved nitrogen. Sin and Sout indicate secondary influent and secondary effluent, respectively.
Sample ID
1-Sin
1-Sout
2-Sin
2-Sout
3-Sin
3-Sout
4-Sin
4-Sout

pH
7.7
7
7.3
6.5
7.5
6.7
7.3
6.6

Conductivity DO
885.1
731.1
839.2
667.2
877.6
755.8
1124
816.7

4.4
0.3
4.2
1
1.6
0.9
2.1
1.9

REDOX
Temp
-34.4
-4
-22.5
26.8
-31.3
14.5
-22.1
18.7

COD
20.6
22.5
22.8
23.9
21.3
22.2
23
23.5

288.5
16.4
88.2
24.3
182.4
36.6
314.3
19.8

Ammonia
NPOC
TDN
44.5
42.4
1
5.3
30.7
26.9
1
7.3
38.6
40.3
1
8.8
51.5
54.4
1
6.4

44
12.4
31
3.1
37.8
3.7
46.1
3.4
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Table D1.6: The different diversity indices calculated for each WWTF sample, including Inverse Simpson’s Index,
Simpson’s Evenness, Shannon Diversity Index, Species Richness, and Chao1 Index.
WWTF ID Sample ID Inverse Simpson Simpson's Evenness Shannon Diversity Species Richness Chao1
WWTF 1
Sin
15.58791577
0.115466043
3.637568742
135
135.0625
WWTF 1
Sout
51.22982494
0.209101326
4.533415789
245
245.9
WWTF 1
Sludge
56.96741655
0.210211869
4.651080863
271
271.25
WWTF 1
BH
52.28669605
0.199567542
4.584232908
262 262.2857143
WWTF 1
AH
51.24929844
0.223796063
4.533402047
229
229
WWTF 2
Sin
57.63101904
0.206562792
4.66250634
279 280.1428571
WWTF 2
Sout
23.44197195
0.384294622
3.611035707
61
61
WWTF 2
Z1
59.09100651
0.193107864
4.814455297
306
307.6
WWTF 2
Z2
50.90739045
0.253270599
4.534121194
201
201
WWTF 2
Z3
55.98038497
0.196422403
4.749133266
285
285.125
WWTF 2
Z4
54.76503647
0.19351603
4.737941472
283 283.6666667
WWTF 2
Sludge
68.92579182
0.225247686
4.93443311
306
306.125
WWTF 3
Sin
17.50520847
0.103581115
3.805132236
169
169
WWTF 3
Sout
36.9069196
0.194246945
4.271979818
190
190
WWTF 3
Z1
35.96081933
0.131243866
4.42097523
274
275
WWTF 3
Z2
37.7174655
0.152702289
4.377420737
247 247.6666667
WWTF 3
Z3
35.82344194
0.143869245
4.370099215
249
250
WWTF 3
Z4
34.8654704
0.170909169
4.252033109
204
204.5
WWTF 3
Sludge
10.45788041
0.052029256
3.570429908
201
201.1
WWTF 4
Sin
22.63444143
0.117276899
4.039439037
193
193
WWTF 4
Sout
45.8315644
0.186307172
4.54676569
246
246.5
WWTF 4
Z1
36.26168444
0.163340921
4.412409834
222
222.25
WWTF 4
Z2
34.82509798
0.168237188
4.355714554
207
207.25
WWTF 4
Z3
34.89642225
0.182703781
4.343666272
191
191.4
WWTF 4
Z4
41.74048164
0.172481329
4.505254959
242
242.5
WWTF 4
Sludge
78.09797085
0.261197227
4.895878536
299 299.2222222
NA
NEG CON
76.77456955
0.347396242
4.844548353
221
221
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Table D1.7: The percent abundance of enzyme classes detected via metagenomic sequencing using the KO database
within MG-RAST.
Enzyme Class WWTF1
WWTF2
WWTF3
WWTF4
Allantoicase
0.01573789 0.02678029 0.03014213 0.03662128
Amidase
0.33563604 0.31330422 0.37401424 0.31816055
Arginase
0.04457309 0.04512353 0.04358828 0.04614704
ATPase
1.01866753 0.99494239 1.05469009 1.03167564
Carboxylase
1.0491575 1.06978449 1.0883664 1.07743459
Decarboxylase 0.79192924 0.81600135 0.81119695 0.82891797
Gutamase
0.01295647 0.01150125 0.01466484 0.01150148
Halogenase
0.04386893 0.04134575 0.04988481 0.04032574
Helicase
1.56537439 1.62461503 1.62763424 1.65578965
Hydratase
3.1935243 3.08850634 3.04459857 2.96921626
Hydrogenase
10.2276924 9.88851759 9.99142452 9.89825777
Hydrolase
0.77136788 0.74905062 0.75558432 0.72212355
Hydroxylase
0.21254954 0.19871144 0.17406875 0.20014691
Isomerase
1.09957508 1.11205369 1.11903662 1.04861033
Kinase
4.73714026 4.88123277 4.89984242 4.8171794
Kynureninase 0.07854862 0.07526185 0.07576155 0.08573189
Ligase
1.8427063 1.83075612 1.79252223 1.86962544
Lyase
1.29441509 1.27575767
1.230465 1.27969834
Mannosidase
0.06362051 0.05914331 0.08567351 0.05143913
Minase
0.84122018 0.81709271 0.83228019 0.81879243
Multiple
1.69926968 1.73622756 1.69730236 1.79842917
Other
32.2585211 32.945299 32.9695561 32.8014781
Oxidase
1.87059088 1.80649435 1.94879819 1.90631728
Oxygenase
0.84354389 0.80831986 0.76919296 0.84243044
Peptidase
0.96909494 0.95288306 0.99062791 0.99039732
Permease
2.84510782 2.74858973 2.70795732 2.59280741
Phosphatase
1.19935401 1.21136744 1.24001136 1.27059594
Reductase
5.52537268 5.50477701 5.45604998 5.53108257
Synthase
8.26383605 8.17986785 8.15068301 8.25513386
Synthetase
5.98208838 6.05394088 5.92268423 5.99534014
Tinase
0.07488701 0.05792602 0.07133366 0.06191747
Transferase
9.22701608 9.07385946 8.9774385 9.14512256
Tyrosinase
0.00105623 0.00096543 0.00292484 0.00155235

Table D1.8: The percent removal of four target PPCPs in the four WWTFs sampled.

PPCP
WWTF 1
Carbamazepine
-415.5
DEET
91.76
Sulfamethoxazole
80.40
Caffeine
99.62

Percent Removal
WWTF 2 WWTF 3 WWTF 4
44.07
-58.82
83.60
79.38
98.94
99.28
-64.38
37.14
17.39
93.93
99.93
99.95
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Table D1.9: The microbial phyla detected in each WWTFs, according to MG-RAST RefSeq Database.
Label
Proteobacteria
Actinobacteria
Bacteroidetes
Firmicutes
Planctomycetes
Chloroflexi
Nitrospirae
Cyanobacteria
Acidobacteria
Verrucomicrobia
Chlorobi
Deinococcus-Thermus
Euryarchaeota
Gemmatimonadetes
Spirochaetes
unclassified (derived from Bacteria)
Chlamydiae
Streptophyta
Ascomycota
Chordata
Aquificae
Thermotogae
Candidatus Poribacteria
unclassified (derived from Eukaryota)
Cnidaria
Fusobacteria
Synergistetes
Arthropoda
Deferribacteres
Crenarchaeota
Chlorophyta
Lentisphaerae
Dictyoglomi
Basidiomycota
unclassified (derived from Viruses)
Nematoda
Chrysiogenetes
Tenericutes
Elusimicrobia
Fibrobacteres
Bacillariophyta
Apicomplexa
unclassified (derived from other sequences)
Thaumarchaeota
Echinodermata
Placozoa
Korarchaeota
Hemichordata
Microsporidia
Platyhelminthes
Chytridiomycota
unclassified (derived from Fungi)
Phaeophyceae
Blastocladiomycota
Porifera
Glomeromycota
Nanoarchaeota
Rotifera
Euglenida
Chromerida
Mollusca
Xanthophyceae
Sipuncula
Brachiopoda
Annelida

WWTF 1
WWTF 2
WWTF 3
WWTF 4
52.48533495 59.30079397 53.85412823 61.13414327
17.31033964 9.211666674 7.620854747
7.27480363
13.30363108
14.2985194 17.85019996 15.62629404
3.063488461 3.220718213 3.306371122 2.858372959
2.118887146 1.615492344 2.213715185 1.666629611
1.723387788 2.328854292
4.61469228 1.546651641
1.608839038 0.161611081
0.58162703 1.023790401
1.576058206 1.615725985 1.987924234 1.585976531
1.29242574 1.181579168 1.287210934 1.119578237
1.263063415 2.574796148 2.120250857 1.879720492
0.534725813 0.576599309 0.586087478 0.622169326
0.496086328 0.461235468 0.539304045 0.423819489
0.469003007 0.468107272 0.513348852 0.460041002
0.388627814 0.365868575 0.363526507 0.393167845
0.241298231 0.351231633 0.296055823 0.287571945
0.225978257 0.199763335 0.187044014 0.188055424
0.160819447 0.081939388 0.147681842
0.10507481
0.151093393 0.179024231 0.175495555 0.164096885
0.14800868 0.167960627
0.16916377 0.140798393
0.145372861
0.22157444 0.175751903 0.199276218
0.130225539 0.121287336 0.122931483 0.133178906
0.128717712 0.122043235 0.137415122 0.118252585
0.113133005 0.017495612 0.045373522 0.070381827
0.112465418 0.207927038
0.21630609 0.117256725
0.098860452 0.135704381 0.097245456 0.117152507
0.088800604
0.09074904 0.094169285 0.081984754
0.070499507 0.072703684 0.070662211 0.068065873
0.063432291 0.080372617 0.079967628 0.077225469
0.060923084 0.059825923 0.059113753 0.061291709
0.053453014
0.04910591 0.054396957 0.049607724
0.052371062 0.070944502 0.059062483
0.05777146
0.052232941 0.072621222
0.06518919 0.061303289
0.03446131 0.029699936 0.034812002 0.028104096
0.033736172 0.036379329 0.039695423
0.02988738
0.032930464 0.047429189 0.038798207 0.044431568
0.025368312 0.031912657 0.033568716 0.023946959
0.023457632 0.024504852
0.02494262
0.02589236
0.020108186 0.023680236
0.01775207 0.020079317
0.017875222 0.016437355 0.018277583 0.023240593
0.016551558
0.02255326 0.018636469 0.017705464
0.012569055 0.017110791 0.014201656 0.012587207
0.011659755 0.020807822 0.019674677 0.014277853
0.007608192 0.007256625 0.007229002 0.008279534
0.007516111 0.007215394 0.009215696 0.009379612
0.006721912 0.008947088 0.008446653 0.008603767
0.005145025 0.006761855
0.00635742
0.00646151
0.004523479 0.003532107 0.005229491 0.003670786
0.002612798
0.00449416 0.004306639 0.004249775
0.00185313 0.001992823 0.001986694 0.001875922
0.001657458 0.002652516 0.002255859 0.002292794
0.000828729 0.000233641 0.000128174 0.000370553
0.000310773 0.000659693 0.000820312 0.000196856
0.000264733 0.000659693 0.000281982 0.000162117
0.000172652 0.000302359 0.000358887 3.47393E-05
0.000126611 0.000178667 0.000128174 5.78988E-05
9.2081E-05 9.62053E-05 0.000115356 1.15798E-05
6.90607E-05 0.000302359 0.000192261 0.000266335
4.60405E-05 9.62053E-05 0.000179443 0.000277914
4.60405E-05
6.8718E-05 7.69043E-05 8.10584E-05
3.45304E-05 4.12308E-05 1.28174E-05 1.15798E-05
2.30202E-05 5.49744E-05 3.84521E-05 2.31595E-05
1.15101E-05
6.8718E-05 1.28174E-05 1.15798E-05
1.15101E-05
0.0000000
0.0000000
0.0000000
1.15101E-05
0
0 2.31595E-05
1.15101E-05 2.74872E-05
0
0
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Figure D1.1: Non-metric multidimensional scaling stress plot (A), MDS plot (B), ordiplot (C), MDS plot overlay (D)
for 16S rRNA microbial classes, extracted from R Studio (Version 1.3.1073).

Figure D1.2: Non-metric multidimensional Scaling plots showing the influence of water quality parameters (A) and
PPCP detections (B) on 16S rRNA microbial phyla, extracted from R Studio (Version 1.3.1073).
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Figure D1.3: Correlation analysis of percent carbamazepine removal versus percent enzyme abundance of two
carbamazepine-degrading enzymes, catechol 1,2 dioxygenase and catechol 2,3 dioxygenase.
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Figure D1.4: Correlation analysis of percent DEET removal versus percent enzyme abundance of one DEETdegrading enzyme, trimethylamine dehydrogenase.
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Figure D1.5: Correlation analysis of percent sulfamethoxazole removal versus percent enzyme abundance of one
sulfamethoxazole-degrading enzyme, arylamine N-acetyltransferase.
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Figure D1.6: Correlation analysis of percent caffeine removal versus percent enzyme abundance of one caffeinedegrading enzyme, xanthine dehydrogenase/oxidase.
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NMDS on Microbial Phyla: Procedure
###Carmela Antonellis###
#MS THESIS_NMDS_Phyla & PPCPs
#Input Data files: PhylaSubSam_Sec.csv
#
PhylaSubSamTrans_Sec.csv
#
EnvPPCP.csv
##NMDS with PPCPs - adjusted from Mouser code
##Using secondary in and out, and sludge microbial phylum data along with the PPCPs at each
sample point
#loading the necessary libraries to analyze the data (most important one in Vegan package)
library(stats)
library(ade4)
library(vegan)
library(gclus)
library(FD)
library(BiocManager)
library(ggplot2)
library(MASS)
library(labdsv)
library(cluster)
library(indicspecies)
Alldata=read.csv("PhylaSubSam_Sec.csv", row.names=1, header=TRUE) #loading the microbial
data
#This is what the file look like-how the data was organized:

Alldatat=read.csv("PhylaSubSamTrans_Sec.csv",row.names=1,header=TRUE) #loading the
transposed microbial data
#This is what the file look like-how the data was organized:
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Envdata=read.csv("EnvPPCP.csv",header=TRUE) #loading the environmental data (in this case
PPCP data)
#when just looking at the microbial data and not including environmental inputs, leave out this
line above

dim(Alldata) #finding the dimensions of the microbial data
dim(Envdata) #finding the dimensions of the environmental (PPCP) data
# Inverse of Simpson's Diversity Index, returns "1/D"
invsimpson=diversity(Alldata,index="invsimpson") #calculating the Inverse Simpson's index
write.table(invsimpson, file="InvSimpson_Species_042221.xls", row.names=TRUE, sep="/t")
#exporting the inverse Simpsons index results as an excel spreadsheet
# Finding the Evenness: E 1/D
IS=invsimpson #Computes the inverse Simpson into a new matrix IS
S=specnumber(Alldata) #Computes the species richness into a new matrix IS
EIS=IS/S #dividing the inverse Simpsons by the species number, will give us the evenness
EIS #prints to screen the computed evenness
#this is the output when requesting the values for the computed evenness:
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write.table(EIS, file="Simpson_Evenness_Species_042221.xls", row.names=TRUE, sep="/t")
#exporting table with simpsons evenness calculated
write.table(S, file="Richness_Species_042221.xls", row.names=TRUE, sep="/t") #exporting file
with species richness data calculated
shannondiv=diversity(Alldata,index = "shannon") #calculating Shannon diversity of microbial
data
write.table(shannondiv, file="Shannon_Species_042221.xls", row.names=TRUE, sep="/t")
#exporting the Shannon diversity values calculated
shannondiv #asking R studio to display the Shannon diversity values (doing it here for
instructional purposes, but the species level was used to calculated diversity indices in this
thesis)

#Now finding the Jaccard dissimilarity and Bray Curtis dissimilarity
Alldata.bj=vegdist(Alldata,method="jaccard") #calculating Jaccard index
Alldata.dis=vegdist(Alldata,method="bray") #calculating Bray Curtis distances
Alldata.mdsO=isoMDS(Alldata.dis) #this is making an NMDS from the Bray-Curtis
dissimilarity calculations
scores(Alldata.mdsO) #viewing the scores on screen
###AT THIS POING, PULLED OUT DATA INTO AN EXCEL SHEET, GIVING THE
DIMENSIONS FOR THE BRAY CURTIS DISTANCES###
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stressplot(Alldata.mdsO,Alldata.dis) #view stress plot of data
#What stress plot diplays:

ordiplot(Alldata.mdsO,type="t") #Gives me statement "species scores not available", but still get
a figure
#what ordiplot displays:

#rotating to PC axes (principal component-basically formatting the dimensions and axes we
want)
AlldataPC.mds=metaMDS(Alldata,distance="bray",trace=FALSE,pc=TRUE) #running
metaMDS function on data
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scores(AlldataPC.mds) #viewing the results
####PULL OUT DATA TO PUT INTO EXCEL SHEET (FOR BRAY CURTIS - NMDS
VALS)

plot(AlldataPC.mds) #This will plot the species data on top of the ordination information
#output:

plot(AlldataPC.mds,type="t") #this line of code will plot the phyla data on top of the ordination
information
#output:
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#Now calculating the gradients associated with environmental factors
#when evaluating microbial data without environmental factors, leave these lines of code out of
the analysis
Envdata.vec=envfit(AlldataPC.mds,Envdata,perm=999,na.rm=TRUE)#setting up 999
permutations
#Now will view on screen:
Envdata.vec #view the environmental factors, see what is significant (P value<0.05, also
indicated by an Asterix in R studio)
###AT THIS POINT, PULLED OUT THE ENVIRONMENTAL VECTORS FOR USE IN
MATLAB###
#this is what the output looks like:
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plot(AlldataPC.mds, display="site") #plotting the data
#output:
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plot(Envdata.vec,p.max=0.5) #plotting the environmental vectors on top
#this plots all environmental factors, whether significant or not
#I chose the significant ones when I went to plot this in MATLAB
#output:

##End of NMDS code in R studio -- then imported the Bray-Curtis distances and
environmental data vectors and plotted in MATLAB###
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